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Summary 
This report provides updated, integrated recommendations for services provided to partners of persons with human 
immunodeficiency virus (HIV) infection and three other sexually transmitted diseases (STDs) (i.e., syphilis, gonorrhea, and 
chlamydial infection) and replaces the CDC 2001 Program Operations Guidelines for STD Prevention—Partner Services 
and the 1998 HIV Partner Counseling and Referral Services Guidance (1,2). These recommendations are intended for health 
department program managers responsible for overseeing partner services programs for HIV infection and the three other STDs at 
the state and local levels. The recommendations also might be beneficial for HIV prevention community planning groups, STD 
program advisory bodies, technical assistance providers, community-based organizations, and clinical care providers. 
The value of partner services in the control of syphilis and gonorrhea is widely accepted. However, such services are underused 
among partners of persons with HIV infection. On the basis of evidence of effectiveness and cost-effectiveness of these services, 
CDC strongly recommends that all persons with newly diagnosed or reported HIV infection or early syphilis receive partner 
services with active health department involvement. Persons with a diagnosis of, or who are reported with, gonorrhea or chlamydial 
infection also are suitable candidates for partner services; however, resource limitations and the numerous cases of these infections 
might preclude direct health department involvement in certain instances. Health departments might need to limit direct involvement 
in partner services for gonorrhea and chlamydial infection to selected high-priority cases and use other strategies for the remainder 
(e.g., expedited partner therapy). 
These recommendations highlight the importance of program collaboration and service integration in the provision of partner 
services. Because coinfection with HIV and one or more other STDs is common, all persons with a diagnosis of HIV should be 
tested for other types of STDs, and vice versa; rates of coinfection with HIV and syphilis have been particularly high in recent 
years. Many persons at risk for these infections also are at risk for other infectious diseases, such as tuberculosis and viral hepatitis, 
as well as various other health conditions. STD and HIV partner services offer STD, HIV, and other public health programs an 
opportunity for collaboration to deliver comprehensive services to clients, improve program efficiency, and maximize the positive 
effects on public health. 
Introduction	 determining the role of expedited partner therapy for partners 
of patients with gonorrhea or chlamydial infection. To reduce Inconsistencies in the partner services module of the CDC 
duplication and discrepancies, incorporate new information, 2001 Program Operations Guidelines for STD Prevention and 
and address emerging challenges, this report integrates the 1998 HIV Partner Counseling and Referral Services Guidance 
guidelines for partner services for HIV infection, syphilis, (1,2) have been confusing for providers of partner services for 
gonorrhea, and chlamydial infection into a single set of human immunodeficiency virus (HIV) infection and three 
recommendations. These updated, integrated recommendations other sexually transmitted (STDs) for which partner services 
are often provided: syphilis, gonorrhea, and chlamydial serve as a basis for delivery of partner services and related 
infection. In addition, new information has become available	 training and technical assistance. 
through research and program experience, new technologies These recommendations are intended for health department 
are available (e.g., rapid HIV tests), and new challenges have	 program managers responsible for overseeing partner services 
emerged, such as finding sex partners via the Internet and	 programs for HIV infection, syphilis, gonorrhea, and 
chlamydial infection at the state and local levels and were 
developed to help program managers plan, implement, and Corresponding preparer: Samuel W. Dooley, MD, National Center for
 
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton evaluate partner services for infected persons and their partners.
 
Road, NE, MS D-21, Atlanta, GA 30333; Telephone: 404-639-5229;
 The recommendations should be used to help plan and manage 
Fax: 404-639-0897; E-mail: sdooley@cdc.gov. 
prevention measures, target use of resources, establish program 
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priorities, and develop program policies. The recommendations 
also should influence future training for partner services staff 
members and should be shared with any staff members who are 
involved in any aspect of partner services. 
These recommendations are not intended to provide suffi­
cient detail to be used as an operational or instructional manual 
for the daily activities of disease intervention specialists (DISs), 
nor are they intended to be used as a substitute for a training 
manual or curriculum. Although the recommendations 
address several legal concerns related to partner services, they 
do not provide a review of law relevant to partner services and 
should not be considered legal advice. CDC provides partner 
services training for public health staff members; future imple­
mentation planning (including training) will incorporate these 
revised recommendations. These recommendations also are 
not intended to provide specific technical guidance and 
program requirements for CDC grantees. That information 
can be found in STD and HIV funding opportunity 
announcements and related supplemental guidance. 
These recommendations focus primarily on traditional, 
health department–based strategies for conducting partner 
services. Although other models might be used, the goal of 
partner services is to maximize the number of partners who 
are notified of their exposure to HIV, syphilis, gonorrhea, or 
chlamydia and who are treated or linked to medical, 
prevention, and other services. All partner services programs 
should be able to demonstrate, through monitoring and 
evaluation, that their programs are accomplishing this goal. 
These recommendations support the CDC health protection 
goal “healthy people in every stage of life” (available at 
http://www.cdc.gov/osi/goals/people.html). Although health 
department program managers are the primary intended 
audience, information in this report might be beneficial for 
HIV-prevention community planning groups, STD program 
advisory bodies, trainers and providers of technical assistance, 
community-based organizations (CBOs), clinical care 
providers, and others with an interest in partner services. 
The recommendations in this report focus on partner 
services for HIV infection and three other STDs: early syphilis 
(i.e., primary, secondary, and early latent syphilis), gonorrhea, 
and chlamydial infection. Information and recommendations 
for HIV infection and these three other STDs are integrated 
throughout this report, and many of the recommendations apply 
to all four infections. In certain instances, recommendations 
are different for one or more of the four infections. Information 
about partner management for STDs and clinical syndromes 
other than HIV infection, syphilis, gonorrhea, and chlamydial 
infection are available in the CDC Sexually Transmitted Disease 
Treatment Guidelines (3). 
Published, scientific, evidence-based information on partner 
services is limited. To the extent possible, the recommendations 
in this report were based on published evidence. However, 
when published evidence was lacking or insufficient, 
recommendations were based on program experience, with 
input from subject-matter experts. 
HIV and STD prevention programs exist in highly diverse, 
complex, and dynamic social and health service settings. 
Substantial differences exist in disease patterns, availability of 
resources, and range and extent of services among different 
health department jurisdictions. The recommendations should 
be used in conjunction with local area needs, resources, and 
laws. HIV and STD prevention programs should establish 
priorities, examine options, calculate resources, evaluate the 
distribution of the diseases to be prevented and controlled, 
and adopt strategies appropriate to their specific circumstances. 
Methods 
CDC led a work group that planned and coordinated the 
process of revising and combining the two existing guideline 
documents into a single set of recommendations. 
Simultaneously, numerous organizations and experts with 
potential interest in partner services were notified that the 
guidelines were being revised and invited to provide input; 
approximately 70 stakeholder groups were included in this 
process. In addition, an extensive review was conducted to 
identify relevant published research. 
During 2005–2006, CDC sought input from attendees at 
five national HIV and STD conferences. Detailed reviews of 
HIV partner services programs were conducted at eight health 
departments (six state health departments and two city health 
departments) to identify current program practices and 
challenges and to obtain input from persons directly involved 
in delivering partner services. Discussions with focus groups 
of potential and actual recipients of HIV partner services were 
held in five cities to elicit information about experiences with 
and perceptions of these services. In addition, discussions with 
focus groups of private clinicians were held in seven cities to 
assess their level of awareness and understanding of partner 
services and their perceptions of the importance and 
effectiveness of such services. Finally, a detailed review was 
conducted of state laws related to HIV partner services to 
identify legal concerns and provide a framework of the legal 
and regulatory environment in which partner services are 
delivered. 
A draft of recommendations was developed and in 
November 2006, a meeting was convened in Atlanta, Georgia, 
to obtain input. The meeting was attended by approximately 
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70 participants from 23 states and the District of Columbia 
(DC). Participants included representatives of other federal 
agencies; state and local HIV and STD health department 
directors, program managers, and staff members; academic 
research experts; ethicists; representatives from legal, medical, 
and other professional organizations; and representatives 
from CBOs, correctional facility health organizations, 
community advocacy groups, and training centers with 
expertise in partner services. 
After the meeting, CDC convened seven workgroups, which 
included CDC staff members and non-CDC participants 
recruited from the meeting, to revise the draft of the 
recommendations based on input from meeting participants. 
In January 2008, a revised draft was distributed for review to 
federal agencies, health departments, academic and research 
centers, professional organizations, CBOs, and community 
advocacy groups. In compliance with requirements of the 
Office of Management and Budget for influential scientific 
assessments, CDC also solicited reviews from nonfederal 
subject-matter experts. The recommendations were revised 
after reviewer comments were received. 
How These Recommendations
 




These recommendations integrate previously separate 
guidelines for partner services for HIV infection, syphilis, 
gonorrhea, and chlamydial infection into a single set of 
recommendations; a complete summary of these new 
recommendations is provided (Appendix A). These 
recommendations have increased emphasis on the following: 
• integration of services at the client level; 
• linkage between surveillance and program activities to help 
ensure that partner services are offered to all persons who 
test positive for HIV and early syphilis; 
• direct public health program involvement in partner ser­
vices as quickly as possible after diagnosis; 
• rationale for selection of the preferred notification strat­
egy for each disease; 
• active linkage to medical and prevention services for per­
sons identified as infected with HIV; 
• collaboration with internal and external partners involved 
in all aspects of partner services, including ensuring that 
partner services are available for all HIV-infected persons 
throughout the prevention and care continuum; 
• program monitoring and evaluation and quality improve­
ment; and 
• a focus on which types of activities HIV and STD pro­
grams should be performing rather than precisely how 
they should be performing them 
The 1998 HIV Partner Counseling and Referral Services 
Guidance used the term partner counseling and referral services 
rather than contact tracing or partner notification to describe 
the type and range of public health services recommended for 
sex and drug-injection partners of HIV-infected persons (2). 
The 2001 Program Operations Guidelines for STD Prevention 
used the term partner services to describe similar activities 
(1). This report uses the term partner services to describe 
services offered to persons with HIV or other STDs. The term 
partner services is broad and encompasses services typically 
included in partner counseling and referral services and other 
services (e.g., screening for other STDs, screening for chronic 
infection with hepatitis B virus [HBV] and hepatitis C virus 
[HCV], and vaccination for hepatitis A virus [HAV] and 
HBV). In addition, the principles of notifying an exposed 
person do not differ substantially among diseases, and persons 
with STDs other than HIV often need the same array of 
services as persons with HIV infection. Using the same term 
for partner services for HIV and other STDs emphasizes these 
points. 
Terminology 
Many terms used in this report are familiar to persons with 
experience in partner services for HIV and other STDs; however, 
certain terms might be used differently than they were in previous 
guidelines, and certain new terms are used. Following are terms 
used frequently in this report; a glossary and list of abbreviations 
also are provided (Appendices B and C). 
•	 Client, patient. These recommendations include both 
terms, depending on context. In certain instances, the term 
patient best describes a person receiving a service (e.g., a 
person being treated for an infection), whereas in other 
situations, the term client is a better descriptor of a person 
receiving services (e.g., a person receiving referral services). 
•	 Index patient. Person with newly diagnosed or reported 
STDs/HIV infection. 
•	 Partner. For persons with syphilis, gonorrhea, or 
chlamydial infection: refers to sex partners (i.e., persons 
with whom an index patient has had sex at least once); 
for persons with HIV infection: refers to sex and drug-
injection partners (i.e., persons with whom an index 
patient has had sex or shared drug-injection equipment 
at least once). 
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•	 Drug-injection partner. A person with whom an index 
patient shares drug-injection equipment (e.g., needles, 
syringes, cottons, cookers, or rinse water). 
•	 Disease intervention specialists (DISs). Health 
department personnel who are specifically trained to 
provide partner services. Some health departments use 
different titles for persons providing partner services. In 
addition, in certain jurisdictions, other persons (e.g., HIV 
counselors or clinicians) either inside or outside of the 
health department provide certain or all elements of 
partner services. 
•	 Provider referral. Partner notification carried out by 
health department staff members. 
•	 Third-party referral. Partner notification carried out by 
professionals other than health department staff members 
(e.g., HIV counselors or clinicians who are not part of a 
health department). 
•	 Social contacts. Persons who are named by index patients 
as part of their social network but who are not sex or 
drug-injection partners. Social contacts were referred to 
as suspects in previous STD partner services guidelines. 
Definition and Overview 
of Partner Services 
Partner services are a broad array of services that should be 
offered to persons with HIV infection, syphilis, gonorrhea, or 
chlamydial infection and their partners. A critical function of 
partner services is partner notification, a process through which 
infected persons are interviewed to elicit information about 
their partners, who can then be confidentially notified of their 
possible exposure or potential risk. Other functions of partner 
services include prevention counseling, testing for HIV and 
other types of STDs (not necessarily limited to syphilis, 
gonorrhea, and chlamydial infection), hepatitis screening and 
vaccination, treatment or linkage to medical care, linkage or 
referral to other prevention services, and linkage or referral to 
other services (e.g., reproductive health services, prenatal care, 
substance abuse treatment, social support, housing assistance, 
legal services, and mental health services). The rationale for 
use of partner services is that appropriate use of public health 
resources to identify infected persons, notify their partners of 
their possible exposure, and provide infected persons and their 
partners a range of medical, prevention, and psychosocial 
services can have positive results including 1) positive behavior 
changes and reduced infectiousness; 2) decreased STD/HIV 
transmission; and 3) reduced STD/HIV incidence and 
improved public health (Figure 1). 
The value of partner notification in the control of syphilis 
and gonorrhea is widely accepted (3). In recent times, syphilis 
prevalence peaked in approximately 1990, resulting in a 
concerted national attempt to apply public health resources, 
including partner services, toward its reduction and, later, 
elimination (4). Subsequently, syphilis prevalence decreased 
to historic lows (approximately 6,000 primary and secondary 
cases in 2000). Cost data from the early 1990s on syphilis 
partner services suggest costs per partner treated are 
commensurate with current costs of other syphilis-elimination 
strategies in the United States (5). However, recent increases 
in primary and secondary syphilis cases to approximately 
10,000 cases in 2007 indicate that continued vigilance in 
syphilis control is needed. 
In New York, notification and referral services for gonor­
rhea have targeted specific geographic areas with notification 
services rather than attempting to interview all index patients 
and notify all partners in person. Evaluation of 10 years of 
data from the New York program, as well as of other program 
data, has shown a reduction in gonorrhea prevalence (6,7). 
Treatment of partners is valuable for control of chlamydial 
infection and cost-effective in averting sequelae. When used, 
partner services via provider referral seems to identify enough 
infected partners to decrease transmission and therefore pro­
mote infection-control measures, and more partners are treated 
through partner services than through other strategies (8–10). 
However, provider referral coverage for chlamydial infection is 
low and not a significant contributor to controlling this infec­
tion (8,11,12). For example, one survey indicated that only 
12% of patients with chlamydial infection were interviewed by 
health department staff members about their partners (13). 
Partner services can play an essential role in preventing and 
controlling HIV in the United States. Of approximately 1– 
1.2 million persons living with HIV infection in the United 
States, approximately 25% are not aware of their infection; 
transmission from persons not aware of their infection accounts 
for 54%–70% of new infections (14,15). Partner notification, 
a critical component of partner services, effectively identifies 
persons with previously undiagnosed HIV infection. A review 
of the case-finding effectiveness of partner notification found 
that among partners for whom notification was initiated, the 
median percentage with newly diagnosed cases was 8%, 
approximately the same as for syphilis (8); in the reports 
included in this review, eight index patients were interviewed 
for partner notification to discover one newly diagnosed case 
of HIV, on average. A systematic literature review conducted 
for the Task Force on Community Preventive Services found 
that among the nine studies included, a range of one to eight 
partners was identified per index patient with HIV infection, 
a mean of 67% of partners were notified of their exposure to 
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FIGURE 1. Logic model for partner services programs for human immunodeficiency virus (HIV) infection, syphilis, gonorrhea, 
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• Health department staff members 
• Funding 
• Training and technical assistance 
• Partners and stakeholders: 
– CDC 
– HIV prevention community planning groups 
– Sexually transmitted disease (STD) program advisory bodies 
– Clinical care providers 
– Community-based organizations 
– Providers of training and technical assistance 
• Short term 
– Improved patient health 
– Reduced infectiousness 
– Positive behavior changes 
• Intermediate 
– Decreased STD/HIV morbidity and mortality 
– Decreased STD/HIV transmission 
– Increased public health knowledge of transmission networks 
• Long term 
– Reduced STD/HIV incidence 
– Reduced costs 
– Improved public health 
* 
* Cases may be reported to the health department surveillance unit by clinical providers (including STD and other health department clinics), counseling and testing 
providers, or laboratories. Cases may be reported to the partner services program through the surveillance unit or directly by providers or laboratories. 
† Demographic and risk information obtained from interviews can be provided back to the health department surveillance unit through the Health Department Partner 
Services Program.
 
§ Cases of serofast syphilis (i.e., low and stable titers) are closed at this point.
 
¶ Partners may be notified of exposure via provider referral, third-party referral, self-referral, contract referral, or dual referral.
 
** Adverse outcomes of partner notification include intimate partner violence or relationship dissolution. 
†† Client-centered prevention counseling should be available for partners.
 
§§ Treatment for bacterial STDs (e.g., syphilis, gonorrhea, or chlamydial infection) administered presumptively should be available for partners.
 
¶¶ HIV/STD testing should be available for partners.
 
** Laboratory results confirm new HIV case, STD case, or both.
 
†† Laboratory results are negative for HIV, STDs, or both, but person is at high risk for HIV or STDs.
 
§§ Clients who test positive for bacterial STDs (e.g., syphilis, gonorrhea, or chlamydial infection) who were not treated presumptively are treated or referred for treatment.
 
Clients who test positive for HIV are linked to medical care, which includes STD screening, hepatitis B vaccination, and other medical services. 
¶¶ Clients are referred or directly linked to other services, such as mental health treatment and social services such as housing, case management, and support groups. 
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HIV, a mean of 63% of persons notified of exposure were 
tested, and a mean of 20% of those tested were newly diagnosed 
as infected with HIV (range: 14%–26%). On the basis of this 
review, the task force concluded that sufficient evidence exists 
to demonstrate that partner services, with partner notification 
by a public health professional, increases identification of a 
high-prevalence population for HIV testing and increases the 
identification of HIV-infected persons (16,17). Although 
limited, additional data also suggest that HIV partner services 
are cost-effective (18–22). Despite the potential benefits, HIV 
partner services are highly underused (23). The services are 
more frequently provided to persons who receive diagnoses in 
publicly funded HIV testing sites than outside of public health 
sites (23). 
On the basis of evidence of the effectiveness and cost-
effectiveness of partner services, CDC strongly recommends 
that all persons with newly diagnosed or reported HIV 
infection or early syphilis receive partner services with active 
health department involvement. All persons who receive a 
diagnosis of or who are reported with gonorrhea or chlamydial 
infection also are suitable candidates for partner services; 
however, high numbers of cases and resource limitations might 
preclude direct health department involvement in all instances. 
Health departments might need to limit their direct 
involvement in partner services for gonorrhea and chlamydial 
infection to selected high-priority cases and use other strategies 
for the remainder. 
Principles of Partner Services 
The following principles serve as the foundation for 
providing partner services to persons with HIV infection or 
other STDs and their partners: 
•	 Client centered. All steps of the partner services process 
should be tailored to the behaviors, circumstances, and 
specific needs of each client. 
•	 Confidential. Confidentiality should be maintained and 
is essential to the success of partner services. Confidentiality 
also applies to data collected as part of the partner services 
process. When notifying partners of exposure, the identity 
of the index patient must never be revealed, and no 
information about partners should be conveyed back to 
the index patient. 
•	 Voluntary and noncoercive. Participating in partner 
services should be voluntary for both infected persons and 
their partners; they should not be coerced into 
participation. 
•	 Free. Partner services should be free of charge for infected 
persons and their partners. 
•	 Evidence based. Partner services should be as evidence 
based as possible. 
•	 Culturally, linguistically, and developmentally 
appropriate. Partner services should be provided in a 
nonjudgmental way and be appropriate for the cultural, 
linguistic, and developmental characteristics of each client. 
•	 Accessible and available to all. Partner services should 
be accessible and available to all infected persons regardless 
of where they are tested or receive a diagnosis and whether 
they are tested confidentially or anonymously. Because of 
the chronic nature of HIV infection, partner services for 
HIV should not be a one-time event. They should be 
offered as soon as HIV-infected persons learn their 
serostatus and should be available throughout their 
counseling and treatment. HIV-infected persons should 
have the ability to access partner services whenever needed. 
•	 Comprehensive and integrative. Partner services should 
be part of an array of services that are integrated to the 
greatest extent possible for persons with HIV infection or 
other STDs and their partners. 
Goals of Partner Services 
The goals of partner services for infected persons, their 
partners, and the community are as follows: 
• Infected persons 
— Maximize access to partner services by providing all 
infected persons with support to ensure that the 
partners are confidentially informed of their exposure. 
— Maximize effective linkage to medical care, treatment, 
prevention interventions to reduce the risk for 
transmission to others, and other services. 
• Partners of infected persons 
— Maximize the proportion of partners who are notified 
of their exposure. 
— Maximize early linkage of partners to testing, medical 
care, prevention interventions, and other services. 
• Community 
— Reduce future rates of transmission by aiding in early 
diagnosis and treatment (or linkage to treatment, for 
those with HIV infection) and provision of preven­
tion services to infected persons. 
Benefits of Partner Services 
Partner services programs offer substantial benefits to three 
principal groups: persons infected with HIV infection or other 
STDs, their partners, and the community (Figure 1). A 
primary benefit for index patients is that DISs can help them 
ensure that partners are notified of their possible exposure to 
the infection, while protecting the confidentiality of the 
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patients. For index patients who expect to notify partners 
themselves, DISs can provide coaching and assistance with 
this process and provide support if the index patient is unable 
to complete the notification successfully. In addition, when 
interviewing index patients, DISs can assess whether they have 
been adequately treated or linked to appropriate medical and 
prevention services and, for those who have not, facilitate access 
to these services. DISs also can assess whether index patients 
need other services (e.g., reproductive health services or 
substance abuse treatment) and make appropriate referrals for 
such services. Finally, when persons are repeatedly reported as 
index patients for syphilis or gonorrhea or have been previously 
reported with HIV infection, DISs can provide additional 
prevention counseling or help them access more intensive risk-
reduction interventions. For persons having difficulty achieving 
and maintaining behavior changes, these services can help 
develop skills to reduce their risk for repeatedly acquiring new 
STDs or transmitting HIV to current or future partners. 
Partners of persons with HIV infection or other types of STDs 
are at high risk for infection, as indicated by the high prevalence 
of infection among notified partners (8,16). In the case of HIV, 
many partners are not aware of their risk and have never been 
tested for HIV (24). Partner services provide a confidential process 
for these persons to become aware of their risk and access 
appropriate diagnostic, treatment, and prevention services. 
Recently exposed partners of persons with early syphilis and 
gonorrhea who do not yet have evidence of infection can be treated 
preventively, and partners with evidence of infection can be treated 
for cure. All partners can be assessed to determine whether they 
need other services (e.g., reproductive health services or substance 
abuse treatment) and receive appropriate referrals. 
Partner services might also benefit the community by helping 
reduce transmission rates, reducing effects of disease, and 
facilitating earlier identification and treatment of previously 
undiagnosed STDs/HIV infection among its members. 
Demonstrating that a specific prevention intervention (e.g., 
comprehensive risk counseling and services) reduces 
transmission rates at the community level is difficult. 
Nevertheless, studies have demonstrated that 1) quality 
prevention counseling can reduce risk for acquiring a new 
STD, 2) behavioral interventions can reduce transmission risk 
behaviors, and 3) persons with HIV infection who are aware 
of their infection have substantially lower levels of transmission 
risk behaviors than those who are not aware (15,25–31). Thus, 
by increasing access to prevention counseling and other 
prevention interventions and by providing counseling and 
testing to persons at very high risk for infection (i.e., known 
partners of infected persons), partner services should result in 
lower transmission rates. In addition, by reducing the viral 
load in HIV-infected persons to undetectable levels, 
antiretroviral therapy (ART) likely reduces (but does not 
eliminate) infectiousness and risk for sex- and injection-related 
transmission (32–37). Therefore, identifying persons with 
previously undiagnosed HIV infection and linking them to 
medical care services, and possibly to ART, also might reduce 
transmission within the community. Finally, partner services 
can improve disease surveillance and identify sex and drug-
injection networks at high risk for infection that can then be 
targeted for screening and prevention services (38). 
Challenges for Partner Services 
Challenges for partner services include whether the services 
will be accepted by patients, the potential for abuse resulting 
from partner notification, and potential negative effects on 
relationships after partner notification. DIS training includes 
methods to maximize acceptability of partner services among 
patients. A recent systematic review of the acceptability of HIV 
partner counseling and referral services found that among 
participants in the studies reviewed, 1) the majority of surveyed 
potential clients (i.e., HIV-positive or HIV-negative persons 
who had no direct experience with HIV partner counseling 
and referral services) indicated that they would be willing to 
participate in client referral (i.e., notify a partner themselves); 
2) most potential clients would be willing for health 
department personnel to notify their partners; 3) the majority 
of HIV-positive clients receiving partner counseling and referral 
services used provider referral to notify one or more partners; 
4) the majority of partners either wanted to be notified or 
were comfortable with a health-care provider notifying them; 
and 5) the majority of providers were in favor of partner 
notification (39). The high level of acceptability of HIV partner 
services among diverse groups suggests that, when provided 
appropriately, they are considered a service rather than an 
imposition by those for whom they are intended. 
A second challenge is the potential for emotional or physical 
abuse by or against the index patient as a result of partner 
notification. Available data suggest that the rate of violence 
attributable to partner notification is likely low; however, data 
are limited, and additional study is needed (40–43). 
A third frequently cited challenge is the potential negative 
effect of partner notification on relationships (e.g., dissolution 
of a long-standing relationship) (39,40,44). In one study, the 
rate of partnership dissolution was 46.8% among partnerships 
involving syphilis or HIV cases, with no significant difference 
between the two infections; however, the rate was lower in 
partnerships for which partner notification was completed than 
in those for which notification was not completed (24.3% 
and 75.7%, respectively) (40). A similar study addressing the 
effect of HIV partner notification on partnership dissolution 
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found that although the rate of partnership dissolution was 
high (65% at 6 months postinterview), the rate was not 
increased by partner notification (44). Study design and low 
enrollment make drawing firm conclusions from these studies 
difficult; however, the studies suggest that partner notification 
itself does not increase rates of partnership dissolution. 
Legal and Ethical Concerns 
Well-implemented partner services balance the interests of 
infected persons, their partners, and the community. 
Describing a single plan for successfully balancing the interests 
of all involved parties is difficult because the legal context 
within which partner services programs operate varies among 
states and jurisdictions. Nonetheless, recognition of and 
adherence to certain principles is essential for all partner 
services programs. 
This report does not include a comprehensive discussion of 
all areas of law relevant to partner services. Program managers 
should consult with the legal counsel of their agency to gain a 
thorough understanding of the legal framework in which their 
specific programs operate, including their own legal authorities 
and those of other agencies (e.g., law enforcement) with whom 
they might interact. These CDC recommendations should 
not be taken as legal advice or as CDC interpretation of the 
laws of any jurisdiction. 
Legal Authorities 
States hold the legal authority for the notification and referral 
of partners of persons with HIV infection and other types of 
STDs. One federal law specifically addresses HIV partner 
notification services for spouses: the Ryan White CARE Act 
Amendments of 1996 (Pub. L. No. 104-146 [May, 2, 1996]) 
require that states receiving funds under part B of title XXVI 
of the Public Health Service Act (42 U.S.C. Sect. 300ff-27a 
[1996]) take “administrative or legislative action to require 
that a good faith effort be made to notify a spouse of a known 
HIV-infected patient that such spouse might have been 
exposed to the human immunodeficiency virus and should 
seek testing.” A spouse is defined as any person who is the 
marriage partner of an HIV-infected patient or has been the 
marriage partner of that patient at any time within the 
10-year period before the diagnosis of HIV infection. 
Voluntary and Informed Nature 
of Participation in Partner Services 
Participation in partner services is voluntary only if it is 
informed and not coerced. The effectiveness of partner services 
as a public health intervention relies on the voluntary 
cooperation and participation of index patients, partners, social 
contacts, and associates. These persons voluntarily choose to 
1) provide information about themselves and others in response 
to questions and requests from a DIS; 2) notify others of their 
possible exposure to HIV, syphilis, gonorrhea, or chlamydia; 
3) accept STD/HIV testing and treatment; and 4) engage in 
behaviors that promote health and reduce risk for transmission 
or acquisition of HIV infection and all other types of STDs. 
Ethically, for a public health official or health-care provider to 
coerce, deceive, or withhold information from persons to 
influence them to take any of these actions is inappropriate. 
In addition, persons who believe that they are being coerced 
might lie or withhold information. These considerations do 
not preclude use of persuasive reasoning to gain the 
cooperation of index patients and others and to motivate them 
to participate actively in partner services. However, for partner 
services to be truly voluntary, all persons should be clearly 
informed of the known benefits and risks for themselves and 
others that might result from their participation. 
Confidentiality 
In the context of partner services, confidentiality refers to 
keeping information obtained from or about index patients, 
partners, social contacts, and associates in confidence; 
information is not divulged to others or obtained or 
maintained in a way that makes it accessible to others. The 
concept of confidentiality is related to privacy, which might 
be a legal right in certain instances. That is, laws might prohibit 
forcing persons to reveal certain types of information, and 
persons who decline to provide certain types of information 
are not prevented from receiving services. When a person agrees 
to disclose private information, especially in the context of a 
service aimed at helping others, such information should be 
held in strict confidence, both because of its private nature 
and as a sign of respect for the person who is volunteering to 
share the information. 
Research has demonstrated that the degree to which 
confidentiality is maintained by partner services programs is 
an important determinant of the acceptability of those services 
to clients and client willingness to participate in partner services 
(39,45–47). Real or perceived breaches of confidentiality can 
endanger persons being served, who might face stereotyping; 
social isolation; loss of social or financial support; barriers to 
accessing housing, employment, and various social and medical 
services; and physical or emotional abuse (48,49). Such 
breaches also can undermine community trust in and access 
to essential public health programs and services. For these 
reasons, policies and procedures for protecting confidentiality 
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are critical. State laws generally protect the confidentiality of 
all STD information, including information related to HIV 
and acquired immunodeficiency syndrome (AIDS). In certain 
states, specific laws or regulations prescribe the parameters of 
information to be kept confidential and establish penalties 
for confidentiality breaches. 
Although confidentiality is a central principle of partner 
services, it is subject to legal exceptions such as those stipulated 
in certain duty-to-warn laws, which in certain situations require 
medical or public health officials to notify known partners 
who are at risk for infection, even against the specific wishes 
of the index patient. Confidentiality also is subject to practical 
limits, including the possibility that partners might guess the 
identity of the index patient at any point during the process. 
Because partner services programs cannot absolutely guarantee 
patient or partner anonymity, health officials must make all 
reasonable attempts to ensure that the confidential nature of 
communication with a DIS is respected and protected to the 
fullest extent allowed by law. 
Duty and Privilege to Warn 
The legal duty to warn has its foundation in a 1976 case, 
Tarasoff v. Regents of the University of California, in which the 
family of a murdered woman sued because the killer’s therapist 
did not warn their daughter that his patient planned to kill 
her (49). The Tarasoff decision indicates that a patient’s 
intention to seriously harm another person could result in a 
provider’s duty to warn. The Tarasoff decision does not 
overshadow the importance of confidentiality and trust in a 
therapeutic relationship but emphasizes that the threatened 
harm must be serious, imminent, targeted at an identified (or 
identifiable) person, and articulated in the context of an 
existing therapeutic relationship. 
At the state level, the legal concept of the duty to warn is 
complex; consultation with legal counsel is necessary. Certain 
states have laws requiring practitioners (directly or with the 
assistance of public health authorities) to warn persons they 
know to be at risk for infection with a communicable disease, 
an STD, or HIV by their patients. Many other states have 
laws permitting but not requiring practitioners to warn persons 
that they are at risk (i.e., privilege to warn). 
DISs generally must avoid disclosing the name of an index 
patient. However, because cases involving duty to warn require 
the health-care providers to provide sufficient information for 
partners to protect themselves, situations involving a duty to 
warn might require a provider to reveal the name of an index 
patient to at-risk partners, thereby breaching the confidential 
relationship between the provider and the patient (50). 
Programs that too readily assume that the duty to warn is 
applicable in a specific case and alert partners against the will 
of or without the knowledge of an index patient might find 
future patients reluctant to be honest about sexual or drug-
sharing activities or unwilling to accept testing or medical care. 
In such situations, important opportunities for counseling, 
support for disclosure, and prevention education might be 
lost. Accordingly, health-care providers and public health 
program managers should proceed cautiously and seek legal 
counsel before assuming that a duty to warn has been triggered 
or that they have a privilege to warn. 
Criminal Transmission and Exposure 
Despite extensive education and counseling to prevent 
transmission and acquisition of HIV infection and other types 
of STDs, certain persons persistently engage in behaviors that 
put themselves and others at risk for infection. Certain criminal 
laws of general application, such as assault, battery, or reckless 
endangerment laws, might be used to prosecute a person who 
intentionally exposes another person to infection. However, 
many states have enacted criminal laws focusing either 
specifically on HIV transmission or generally on transmission 
of sexually transmitted infections. These laws vary according 
to several factors, including 1) which types of conduct are 
considered criminal (e.g., with HIV, most states proscribe 
engaging in conduct that exposes someone else to HIV rather 
than limiting liability to situations in which transmission has 
occurred) (51); 2) the specificity with which the proscribed 
conduct is described (e.g., most statutes that consider exposing 
someone to HIV to be a criminal act do not define exposure, 
although certain statutes specifically proscribe exposure by 
transfer of body fluids or tissues, engaging in sexual activities, 
or needle sharing) (51); and 3) the knowledge required (e.g., 
for exposure to be considered criminal, almost all states require 
that infected persons who expose another person to HIV must 
have had knowledge of being infected with HIV) (51). Laws 
might also vary depending on whether disclosure of HIV status 
before engaging in the conduct 1) means that no crime has 
been committed, 2) is an affirmative defense that can be raised 
by a person charged with criminal transmission or exposure, 
or 3) means that the person is not legally liable. 
Depending on the unique circumstances of each case, 
options available to partner services program managers in cases 
involving persons who persistently engage in behaviors that 
put themselves and others at risk might include 1) initiating 
increasingly intensive prevention interventions (e.g., 
comprehensive risk counseling and services); 2) facilitating 
access to HIV primary care; 3) arranging linkage to substance 
abuse treatment, mental health services, or other relevant 
services; 4) initiating epidemiologic investigation of situations 
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involving possible exposure of persons to infection; and 5) 
seeking legal advice when public health interventions are not 
sufficient or appropriate. Determining the most appropriate 
course of action requires consideration of the details of the 
specific situation; every case must be managed carefully and 
confidentially. 
Recommendations for Legal 
and Ethical Concerns 
• Public health agencies responsible for partner services 
should conduct a thorough review of all laws relevant to 
their provision of these services. This review should serve 
as a basis for developing policies and procedures for partner 
services programs. Program managers should also ensure 
that program staff members understand the implications 
these laws have for conducting partner services. Laws 
relevant to provision of these services include the 
following: 
— the legal authority for the public health agencies for 
partner services; 
— provisions related to privacy and confidentiality (e.g., 
requirements of the federal Health Insurance 
Portability and Accountability Act [HIPAA]); 
— provisions related to duty or privilege to warn and 
criminal transmission and exposure; and 
— the ability of the public health agencies to coordinate 
with other agencies (e.g., law enforcement). 
• Program managers should ensure that their staff members 
understand the legal basis for their work, legal restrictions on 
their practice (e.g., duty or privilege to warn), the extent to 
which they are protected from civil litigation, and how to 
coordinate with law enforcement officials in ways that protect 
the civil and procedural rights of the persons involved. 
• To ensure that program staff members invoke their duty 
or privilege to warn appropriately, partner services 
programs should have written policies and procedures to 
guide staff members in handling complex cases. Guidelines 
and protocols should be based on the jurisdiction’s 
statutory and case law and developed in consultation with 
legal counsel. Legal counsel should also be consulted 
regarding specific cases in which duty to warn or privilege 
to warn might apply. 
• Program managers should be aware of the applicable laws 
regarding criminal transmission and exposure in their 
jurisdictions and should coordinate with legal counsel 
regarding specific cases in which allegations of criminal 
transmission or exposure are made. 
Elements of Partner Services 
Partner services include several essential elements (Figure 1). 
In general, these elements are relevant for partner services for 
HIV, early syphilis, gonorrhea, and chlamydial infection, 
although differences in how they are implemented vary by 
infection. Program managers should ensure that policies and 
procedures adequately address each of these elements. 
Index Patients 
• identifying index patients (i.e., infected persons who are 
candidates for partner services) and prioritizing them for 
partner services; 
• introducing partner services to index patients and 
conducting interviews to elicit information about their 
partners; 
• counseling index patients about reducing their risk for 
acquiring or transmitting infection to others and referring 
them for additional prevention services, if needed; 
• treating index patients or linking them to medical care 
and treatment; and 
• referring index patients to other services. 
Partners 
• notifying partners of their exposure; 
• counseling partners about reducing their risk for acquiring 
HIV infection and other types of STDs and referring them 
for additional prevention services, if needed; 
• offering partners STD/HIV testing; 
• treating partners or linking them to medical care and 
treatment; and 
• referring partners to other services. 
Identifying Index Patients 
Identifying persons who are candidates for partner services 
(i.e., index patients) is a critical step in the partner services 
process. For early syphilis and, in certain instances, gonorrhea, 
standard identification of index patients occurs 1) when 
persons seek care with no prompting (i.e., volunteers) and 2) 
when persons receive screening or testing and their case reports 
are provided to STD programs for treatment, case 
management, and partner services. For early syphilis, public 
health records indicate that since the 1940s, index patients 
routinely have been interviewed and their partners followed. 
In modern times, a survey of partner notification for STDs/ 
HIV found that 89% of syphilis-infected persons in high-
morbidity geographic areas were interviewed (13). The same 
survey found that a markedly lower proportion (17%) of 
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persons with gonorrhea were interviewed, although certain 
jurisdictions still attempt to interview all patients with 
gonorrhea. Other jurisdictions that lack resources to interview 
all patients with gonorrhea have focused their interviews on 
patients in high-morbidity areas (i.e., core areas) (7). Interview 
strategies for chlamydial infection tend to be similar to those 
for gonorrhea, although interviews are generally considered 
lower priority than interviews for gonorrhea. Among high-
morbidity jurisdictions in a survey of STD/HIV partner 
services, only 12% of persons with chlamydial infection were 
interviewed (13). 
The workload for health departments is related to the 
number of cases reported, which is an essential factor affecting 
approaches to partner services for early syphilis, gonorrhea, 
and chlamydial infection. During 2000–2007, fewer than 
50,000 cases of early syphilis (i.e., primary, secondary, and 
early latent) were diagnosed each year. In contrast, estimates 
of annual prevalence of gonorrhea and chlamydial infection 
are one to two orders of magnitude higher (52,53), far too 
many patients for public health staff members, at the current 
staffing level, to interview directly. 
Available evidence suggests that the majority of HIV-infected 
persons are not interviewed for HIV partner services. A survey 
found that in 22 jurisdictions with HIV reporting, health 
departments interviewed 32% of 20,353 persons with newly 
reported HIV infection (23). Active strategies for identifying 
more candidates for partner services are needed. Because an 
extensive literature search did not identify any published 
studies or program evaluations that examined this topic, 
recommendations in this report for identifying HIV index 
patients were based on input from consultants with partner 
services expertise. For HIV, although the main emphasis of 
partner services programs should be on persons with newly 
diagnosed or reported infection, partner services also might 
be appropriate for persons with previously diagnosed infection 
on an as-needed basis (54). 
Persons with Newly Diagnosed HIV 
Infection, Syphilis, Gonorrhea, 
or Chlamydial Infection 
Diagnoses Received in STD or Other Health 
Department Clinics 
Partner services are provided almost exclusively by health 
departments, often by STD program staff members. When 
all partner services are provided by STD program staff 
members, persons with an STD diagnosis, including HIV, in 
health department STD clinics can easily be linked to partner 
services. However, when HIV and STD programs are separate, 
some or all HIV partner services might be provided exclusively 
by HIV program staff members. In these situations, managers 
of both programs should establish policies and procedures to 
ensure that persons with a diagnosis of HIV infection, syphilis, 
gonorrhea, or chlamydial infection by either program receive 
appropriate partner services. Systems also are needed to ensure 
that persons with a diagnosis of HIV infection or any of these 
three other STDs in other health department clinics (e.g., 
tuberculosis [TB] or reproductive health clinics) are linked to 
the partner services program. Certain patients receive a diagnosis 
of HIV infection and of another STD simultaneously. Policies 
and procedures are needed to ensure that these patients and 
their partners receive partner services for both infections from 
only one DIS to improve services for the patients and partners 
and maximize program resources. 
Identification of syphilis cases can be complicated because 
treated and noninfectious persons can have reactive syphilis 
tests indefinitely. Titration of the rapid plasma reagin (RPR) 
test can yield elevated RPR titers for persons who have already 
been treated and clinically cured of syphilis. Therefore, CDC 
encourages programs to use syphilis treatment registries and 
algorithms for prioritizing follow-up investigations of persons 
with reactive syphilis tests (i.e., reactors). A syphilis reactor 
grid is constructed from a combination of quantitative test 
results, age, and sex to identify which persons with reactive tests 
are most likely to be both untreated and infectious. Individual 
programs vary in precisely how they use a reactor grid but 
generally investigate all persons with RPR titers higher than a 
specified level, all persons younger than a certain age, and persons 
most at risk for negative outcomes (e.g., pregnant women). A 
recent evaluation of syphilis reactor grids suggested that most 
missed cases of early syphilis were among men aged 30–50 years 
and women aged 20–40 years with low RPR titers (55). 
Diagnoses Received in Settings Other than 
Health Department Clinics 
Most types of STDs are frequently diagnosed in settings 
other than health departments (56), such as public hospitals 
and clinics, private hospitals and medical practices, community 
health centers, Veterans Administration health-care facilities, 
Indian Health Service and tribal health-care facilities, 
correctional facilities, CBOs, reproductive health service 
organizations, substance abuse treatment centers, and student 
health centers. In particular, chlamydial infection and 
gonorrhea are more frequently diagnosed in private care 
settings. Reporting delays, especially for cases diagnosed when 
patients are the most infectious, diminish the effectiveness of 
partner services in infection control. Approximately 90% of 
all HIV tests and 70% of positive HIV tests are performed in 
settings other than health department clinics (57). 
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Persons diagnosed in settings other than health department 
clinics might not be directly linked to partner services if the 
provider does not notify the partner services program; 
therefore, program managers should establish strategies for 
rapidly identifying these persons and offering them partner 
services. This can be accomplished by linking disease reporting 
systems and partner services programs, conducting active 
outreach to service providers (e.g., physicians and health-care 
facilities that frequently diagnose STDs/HIV infection, HIV 
counseling and testing providers, and case managers) and 
diagnostic laboratories, or using a combination of these 
strategies. Each strategy has potential advantages and 
disadvantages. For example, linking disease reporting activities 
and partner services programs might maximize the number of 
newly diagnosed persons identified for partner services, but 
reporting delays might reduce the timeliness with which 
partner services are initiated. In contrast, active outreach to 
health-care providers might improve the timeliness of partner 
services but result in more missed cases because reaching all 
providers is difficult. For most programs, a combination of 
these two strategies will likely be most effective. Program 
managers might also develop other strategies for identifying 
persons with newly diagnosed infection. Strategies should be 
monitored for how effectively they identify index patients and 
the timeliness with which they provide services. 
Linkage with Disease Reporting. For surveillance purposes, 
cases of HIV/AIDS and other STDs might be reported to 
health departments by service providers (e.g., clinicians or 
CBOs providing testing services), diagnostic laboratories, or 
both. Data collected through HIV/AIDS and STD surveil­
lance systems are used for many complementary public health 
purposes at the national, state, and local levels. Examples of 
such uses include disease monitoring, estimating incidence of 
infection, identifying changing trends in transmission, tar­
geting and evaluating prevention interventions, and allocat­
ing funds for care and prevention services. Certain states and 
territories also use case reports to initiate partner services for 
infected persons and offer referrals for prevention, medical 
care, and supportive services. In 2007, the Council of State 
and Territorial Epidemiologists (CSTE) conducted a national 
assessment of HIV/AIDS surveillance capacity and training 
by surveying HIV surveillance coordinators in 65 state, large 
city, and territorial health departments. Several questions as­
sessed current practices regarding use of HIV surveillance data 
to support partner services. Seventy-one percent of respon­
dents (30 of 42 respondents to the question) reported sharing 
data in some form with partner services programs; 43% (24 
of 56 respondents to the question) reported sharing individual-
level data that included personal identifiers with partner ser­
vices (CSTE, unpublished data, 2007). 
Sharing information between HIV/AIDS and STD surveil­
lance programs and partner services programs is important 
for comprehensive disease intervention and offers many po­
tential mutual benefits, including the following: 
• Surveillance data can provide information about 
demographic and behavioral characteristics of persons 
newly diagnosed with HIV, leading to a more complete 
understanding of the population of persons in need of 
partner services in both the public and private sectors. 
• Using surveillance data to initiate partner services can help 
ensure that partner services are offered to the greatest 
possible number of newly identified or reported infected 
persons for whom services are appropriate, thereby 
supporting the public health goal of maximizing access 
to partner services. 
• Linking surveillance and partner services can help ensure 
that patients who test positive receive and understand their 
test results, that they receive appropriate treatment or are 
linked to medical care services, and that they receive 
appropriate prevention counseling. 
• Surveillance data can supplement client-level program 
information regarding demographic and risk characteristics 
and testing history and inform DISs before initial contact 
with clients. 
• Partner services programs can supplement surveillance data 
by obtaining more complete and accurate demographic 
and risk information and identifying duplicate reporting. 
• Sharing information might help streamline surveillance 
and partner services activities and increase efficiency (e.g., 
might limit the number of times the same medical record 
is reviewed or a medical provider is contacted about the 
same person). 
• Partner services programs can use surveillance data to 
identify health-care providers who diagnose and treat 
persons with HIV infection and other STDs; DISs can 
then contact these providers and ensure that they are well 
informed about the benefits of partner services. 
• Through collaborative relationships with health-care 
providers, partner services can encourage complete and 
timely reporting of HIV/AIDS and other STDs. 
Before using surveillance data to identify candidates for partner 
services, health departments should consider staffing and 
resources, relevant state and local laws and regulations, and 
level of community awareness and acceptance. The 
organizational structure of the health department also affects 
the way surveillance and partner services programs interact. 
For example, health departments in which surveillance and 
partner services programs are integrated often share staff 
members, have similar missions, have programmatic and 
administrative commonalities, and receive oversight from a 
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shared overall responsible party (ORP, an official who has 
overall responsibility for implementing and enforcing HIV/ 
AIDS and STD surveillance security standards), all of which 
might facilitate information sharing for partner services 
purposes. Potential barriers to sharing surveillance data include 
a negative impact on provider reporting because of concerns 
about confidentiality of information, increased workload for 
surveillance staff members, and, for HIV, perceived negative 
effects on HIV-testing behaviors of providers or persons at 
risk for infection. For most STDs, data from a physician survey 
suggest that although physicians might be reluctant to collect 
partner services data themselves, they are willing to report cases 
to health departments to ensure that their patients receive 
partner services (58). Although the data from this survey do 
not include HIV, other surveys have found that the majority 
of health-care providers favor HIV partner notification (39). 
To facilitate information sharing between partner services 
and surveillance programs, health departments should review 
state and local laws and regulations that might apply to data 
sharing. Engaging key stakeholders such as medical providers, 
community advocates, and CPGs in the design and 
implementation of surveillance and partner services data 
linkage processes can result in support of and success in these 
measures. Clear, well-defined security and confidentiality 
policies and procedures that are followed by both surveillance 
and partner services program staff members increase the 
likelihood that surveillance data will be kept secure and patient 
information confidential, leading to patient and medical 
provider trust and cooperation with partner services programs. 
Historically, certain programs have limited the sharing of 
HIV/AIDS surveillance data with partner services programs. 
In certain situations, programs imposed these limits after 
collaboration with communities and medical providers on 
implementation of named-based HIV reporting, which 
resulted in use of reporting methods that separate surveillance 
and partner services. When considering changes in data-sharing 
policies, programs should use the same careful collaboration 
and deliberation with medical providers and affected 
communities to prevent erosion of the public trust and of the 
integrity of the systems already in place. 
Levels of Surveillance Information. Three levels of sur­
veillance data can support partner services: 1) individual, 2) 
provider, and 3) aggregate. These range from very sensitive 
data requiring high levels of security and confidentiality (in­
dividual level) to substantially less sensitive data (aggregate 
level). Individual-level data are the most valuable for immedi­
ate provision of partner services, although provider- and ag­
gregate-level data also can be useful. 
•	 Individual-level data. Accurate information for locating 
and identifying index patients is essential for delivering 
partner services efficiently. Surveillance programs routinely 
collect and maintain individual-level data that can be 
provided directly to partner services programs. Data shared 
with partner services programs might include name, 
address, telephone number or other contact information, 
date of birth, race/ethnicity, test results, notification status 
of test results, sex, date of diagnosis, type of test, other 
laboratory data (e.g., CD4 cell counts and HIV viral load 
or syphilis titers), risk behaviors, and provider name. At a 
minimum, DISs need sufficient locating and identifying 
information to initiate partner services with index patients. 
In turn, effective index patient interviews might elicit 
information missing from the surveillance case report, 
which can be shared with the surveillance program. 
Certain surveillance programs might be able to provide 
individual-level data on all reported HIV cases to partner 
services programs, whereas others might be limited by law 
or regulation to providing data on a subset of cases (e.g., 
in persons who have not been notified of their positive 
HIV test results, persons diagnosed by public providers, 
persons with drug-resistant strains of HIV, or persons 
whose providers request partner services). Surveillance and 
partner services programs should identify which types of 
case information can be shared among programs and 
include this in their written policies. 
•	 Provider-level data. Surveillance data can be used to 
identify which health-care providers and facilities are 
diagnosing and reporting the most cases. Once identified, 
these providers and facilities can be contacted by staff 
members from either the surveillance program or partner 
services program to explain partner services and encourage 
the providers to refer current and future patients to the 
partner services program. Sharing provider-level data with 
partner services programs allows them to focus on facilities 
with the majority of cases. For example, certain health 
departments have used provider-level data to identify health-
care facilities that have numerous persons with a diagnosis 
of HIV infection or other STDs and then have developed 
agreements with these facilities to periodically review charts 
or place partner services staff members on-site. 
•	 Aggregate-level data. Aggregate-level data might consist 
of the number of new cases identified during a defined 
reporting period (e.g., 1 week or 1 month) in a defined 
geographic area (e.g., a county or zip code). They also 
can help describe demographic and exposure risks. 
Aggregate-level data can be used to identify communities 
with large or increasing needs for partner services. Health 
care providers who work in these communities can be 
contacted to encourage partner services for their patients. 
14 MMWR November 7, 2008 
Security and Confidentiality. Partner services data for HIV 
infection and other types of STDs, with or without data ob­
tained from disease reporting systems, are among the most 
sensitive public health data routinely collected and should re­
ceive careful protection. HIV and STD partner services pro­
grams have an excellent record of maintaining confidentiality, 
and continued vigilance is critical to future success. Programs 
considering operational and policy changes, should carefully 
review the proposed changes to ensure that they will not de­
crease security or confidentiality. 
CDC and CSTE have published technical guidance describ­
ing minimum standards for HIV/AIDS data security and con­
fidentiality that should be met by surveillance programs; these 
standards reflect best practices for protecting HIV/AIDS sur­
veillance data (59). With minor adjustments to accommo­
date practical realities encountered in many health 
departments, the same standards should be upheld by any 
partner services program with which HIV/AIDS surveillance 
programs share individual-level data (Appendix D). To en­
sure that appropriate policies and procedures are developed 
and followed, HIV/AIDS surveillance programs designate an 
ORP, who is responsible for security of the program’s infor­
mation collection and management systems, including pro­
cesses, data, information, software, and hardware. Although 
this guidance was developed specifically for HIV/AIDS sur­
veillance activities, it might be useful for data and informa­
tion collected and used by all programs conducting partner 
services. 
Outreach to Service Providers and Diagnostic Labora­
tories. Persons might receive a diagnosis of HIV or other STDs 
from various service providers outside of health department 
clinics. In addition to using disease reporting systems to iden­
tify potential candidates for partner services, programs can 
collaborate with service providers and diagnostic laboratories 
to help ensure that persons who receive a diagnosis of STDs/ 
HIV are linked rapidly to health department partner services 
programs. Although reaching all service providers is unlikely 
to be feasible, a small number of providers or laboratories might 
account for a large proportion of new diagnoses. In this case, 
health department partner services program managers can 
collaborate with surveillance coordinators to identify these 
providers and laboratories to establish procedures for partner 
services referrals. Certain partner services programs have iden­
tified health-care facilities that diagnose large numbers of cases 
and have placed DISs in those facilities to meet with persons 
with new diagnoses. This strategy might reduce the need for 
extensive field work to locate individual index patients. How­
ever, such strategies should be monitored closely to assess their 
effectiveness and cost-effectiveness; no systematic evaluations 
of these strategies have been published. 
CDC recommends that in all health-care settings, volun­
tary screening for HIV infection should be performed rou­
tinely for all patients aged 13–64 years unless a patient declines 
HIV testing or has been tested recently (60). These recom­
mendations might produce a substantial increase in new HIV 
diagnoses. Therefore, program managers responsible for HIV 
partner services should work with health-care providers who 
implement the screening recommendations and diagnose nu­
merous HIV-infected persons to help ensure that those per­
sons are linked to partner services. 
Anonymous HIV Testing 
Anonymous testing accounts for a small but significant pro­
portion of all HIV tests and might reach a subset of persons 
who might not otherwise be tested (61,62). Persons who test 
positive for HIV anonymously should be strongly encouraged 
to transfer to a confidential system; however, if they decline, 
HIV partner services can still be offered and performed. Part­
ner services might be more difficult to provide for persons 
using anonymous testing than for those using confidential 
testing. A study in Colorado assessed provider-referral part­
ner notification for persons who tested HIV positive during 
October 1990–March 1992 at a single anonymous test site in 
Denver and 13 confidential test sites throughout the state (63). 
The average number of named, notified, and counseled part­
ners was 30%–50% greater among index patients tested at 
sites offering confidential testing than among those tested at 
sites offering anonymous testing. A North Carolina study 
found that the number of partners notified and counseled per 
index patient interviewed was 2.7 times greater for index pa­
tients tested confidentially compared with those tested anony­
mously (64). A literature review of this topic indicated that 
two to three times more partners are notified when persons 
are tested confidentially than when they are tested anony­
mously (8). However, one study, conducted by the Multistate 
Evaluation of Surveillance for HIV Study Group in five states 
with name-based HIV reporting, found no difference in the 
number of notified partners between persons who were tested 
anonymously and those tested confidentially (65). Therefore, 
program managers who are responsible for HIV partner ser­
vices should work with providers who offer anonymous HIV 
testing to develop strategies for offering and providing part­
ner services to persons who test positive anonymously and 
elect not to enter a confidential system. 
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Persons with Previously Diagnosed 
HIV Infection, Syphilis, Gonorrhea, 
or Chlamydial Infection 
Recurrent Infections 
Acquisition of a new STD of any type by persons with 
previous infections, including HIV, indicates ongoing sexual 
risk behaviors and a need for additional partner services, 
prevention counseling, and other prevention interventions, 
such as comprehensive risk counseling and services. Identifying 
HIV-infected persons who have new STDs is particularly 
important because infection with other STDs facilitates 
transmission and acquisition of HIV (66). Persons with 
recurrent STDs of any type might be identified in STD clinics, 
other care and service venues, or STD/HIV reporting systems. 
Partner services programs should have systems in place to 
identify these persons, counsel them, offer them partner 
services, and link them to more intensive prevention 
interventions, as indicated. 
Ongoing Partner Services for Persons with HIV 
Infection 
Certain persons who received a previous diagnosis of HIV 
might have declined partner services at the time of diagnosis, 
might have partially participated but subsequently become 
interested in participating fully, or might have new partners. 
These persons can be reached through outreach to HIV care 
providers or case managers. CDC, the Health Resources and 
Services Administration, the National Institutes of Health, and 
the HIV Medical Association of the Infectious Diseases Society 
of America collaborated to create recommendations for 
incorporating HIV prevention into the medical care of persons 
living with HIV infection (54). These recommendations urge 
HIV clinical care providers to 1) ask patients at the initial 
visit whether all their partners have been informed of their 
exposure to HIV; 2) regularly screen patients for HIV 
transmission risk behaviors, STDs, and pregnancy; 3) inquire 
at routine follow-up visits whether patients have had any new 
sex or drug-injection partners who have not been informed of 
their exposure; and 4) refer patients to the appropriate health 
department to discuss partners who have not been informed 
of their exposure and arrange for their notification and referral 
for HIV counseling and testing. Program managers responsible 
for HIV partner services can work actively with HIV clinical 
care providers and case managers to engage them in identifying 
patients who need partner services, offering them these services, 
and linking them to health department DISs when indicated. 
Persons who previously received a diagnosis of HIV also 
might be named as partners in the course of conducting partner 
services with other index patients. These persons should be 
interviewed to assess behavioral risk, provided partner services, 
and referred for more intensive prevention interventions, when 
indicated. 
Recommendations for Identifying 
Index Patients 
General 
• All persons with newly diagnosed or reported early syphilis 
infection should be offered partner services. All persons 
with newly diagnosed or reported HIV infection should 
be offered HIV partner services at least once, typically at 
diagnosis or as soon as possible after diagnosis. Partner 
services program managers should develop strategies with 
written policies, procedures, and protocols for identifying 
as many persons as possible with newly diagnosed or 
reported infection and ensuring that they are offered 
services. 
• Resources permitting, all persons with newly diagnosed 
or reported gonorrhea should be offered partner services. 
Programs should consider which resources and services 
they can devote to partner services for chlamydial 
infection. Persons with newly diagnosed or reported 
chlamydial infection should either be offered partner 
services (e.g., as are those with gonorrhea), or programs 
should plan alternative strategies to enable partners to be 
notified. 
• Partner services programs should use surveillance and 
disease reporting systems to assist with identifying persons 
with newly diagnosed or reported HIV infection, syphilis, 
gonorrhea, or chlamydial infection who are potential 
candidates for partner services. To maximize the number 
of persons offered partner services, health departments 
should strongly consider using individual-level data, but 
only if appropriate security and confidentiality procedures 
are in place (Appendix D). At a minimum, health 
departments should use provider- and aggregate-level data 
from their surveillance systems to help guide partner 
services. 
• Strategies for identifying potential index patients for 
partner services should be carefully monitored and 
evaluated for completeness, timeliness, effectiveness, and 
cost-effectiveness. 
• Partner services programs should establish and adhere to 
strict, jurisdiction-specific guidelines, policies, and 
procedures for information security and confidentiality. 
These should incorporate the guiding principles and 
program standards (Appendix D) and should adhere to 
all applicable laws. They should be applied to all 
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individual-level information used by partner services 
programs, including hard-copy case records and electronic-
record systems or data-collection systems. 
• All partner services and surveillance programs that share 
information should meet the minimum security and 
confidentiality standards (Appendix D). 
• Penalties for unauthorized disclosure of information 
should exist for both surveillance and program staff 
members. All staff members should be informed of these 
penalties to ensure that data remain secure and 
confidential. 
• For successful sharing of individual-level information, 
open communication channels between surveillance and 
partner services programs, adequate resources, clear 
quality-assurance standards, community inclusion and 
awareness of the processes, recognition of the rights of 
infected persons, and sensitivity to health-care providers’ 
relationships with their patients are all needed. 
• Jurisdictions that plan to initiate use of disease reporting 
data to prompt partner services should consider 
information flow, develop written protocols, and pilot test 
the proposed system. Protocols should cover practical 
considerations, such as which types of information will 
be shared and who will have access, staffing, security 
measures, and methods for evaluating the system. 
• To ensure that appropriate policies and procedures are 
developed and followed, partner services programs should 
designate an ORP who has responsibility for the security 
of the program’s information collection and management 
systems, including processes, data, information, software, 
and hardware. Preferably, a single person should serve as 
the ORP of both the surveillance and partner services 
programs. 
• Partner services programs that involve CBOs in partner 
services (e.g., for interviewing index patients receiving 
diagnoses in their counseling and testing programs) should 
assess the CBOs’ ability to meet the minimum standards 
for data security. CBOs that cannot meet these minimum 
standards should have limited access to data, although 
they can still participate in partner services. 
IV Infection 
• HIV partner services programs should collaborate with 
health-care providers who provide HIV screening or 
testing, other HIV counseling and testing providers, HIV 
care providers, and HIV case managers to ensure that their 
clients and patients are offered HIV partner services as 
soon as possible after diagnosis and on an ongoing basis, 
as needed. 
H
• HIV partner services programs should work with providers 
of anonymous HIV testing services to develop strategies 
for providing partner services to persons who test positive, 
even if the person decides not to enter a confidential 
system. These providers should be trained on how to offer 
partner services and elicit partner information from 
persons with newly diagnosed HIV infection. 
Prioritizing Index Patients 
All persons with newly diagnosed or reported HIV infection 
or early syphilis should be offered partner services and 
prioritized for interview, although some of these patients have 
a higher priority than others. Because of the high incidence of 
gonorrhea and chlamydial infection in many jurisdictions, 
attempts to reach and interview all patients might be hampered 
by various factors, including insufficient funds and staffing. 
Therefore, for these infections, programs might need to use 
partner services strategies that do not require interviews by 
DISs, focusing their interviewing on specific subsets of patients. 
To maximize available resources, programs should establish 
criteria for determining which index patients are prioritized 
for interview. In general, these criteria should include 
behavioral and clinical factors that affect the likelihood of 
additional transmission and, thus, increase the epidemiologic 
consequences of delayed receipt of partner services. This 
information might not be known until the index patient is 
interviewed; however, it might be available from the diagnosing 
clinician or counselor or through record review. Criteria for 
prioritizing index patients vary somewhat according to the 
infection involved. Program effectiveness and efficiency can 
be improved by periodically reviewing and adjusting criteria 
for prioritizing index patients for partner services. 
The following categories of persons are considered high-
priority index patients for partner services, regardless of the 
infection involved: 
•	 Pregnant women and male index patients with 
pregnant partners. Pregnant women are at risk for 
transmitting HIV and other types of STDs to their fetus 
both in utero and during delivery. Newborns also are at 
risk for becoming infected with HIV through breastfeeding. 
Prioritizing pregnant women for interview gives DISs an 
opportunity to verify that the women have received 
appropriate treatment or, for those with HIV infection, 
have been successfully linked to medical services so that 
they can be treated with ART to reduce the risk for mother­
to-child transmission. 
•	 Index patients suspected of or known to be engaging 
in behaviors that substantially increase risk for 
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transmission to multiple other persons (e.g., have 
multiple sex or drug-injection partners). Such persons 
can facilitate rapid spread of infection through a 
community. This group includes persons who were 
previously named as partners by other index patients. 
•	 Persons coinfected with HIV and one or more other 
STDs. Evidence suggests that STDs (both ulcerative and 
nonulcerative) facilitate transmission of HIV, increasing 
the likelihood that the index patient has transmitted or 
will transmit HIV to a partner (66). 
•	 Persons with recurrent STDs. Recurrent infections might 
indicate nonadherence to treatment, untreated partners, 
continued exposure to STDs through high-risk behaviors, 
or infection with drug-resistant strains. In certain geographical 
areas and among certain closely defined populations, 
prevalence is sufficiently high that otherwise moderate risk 
behavior confers high risk for STD exposure (67). 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
The following categories of persons also are considered 
high-priority index patients for partner services for syphilis, 
gonorrhea, and chlamydial infection. 
•	 Persons with clinical signs or symptoms suggestive of 
infection. Symptomatic persons have a high risk for 
disease transmission (68,69). Presence of clinical 
symptoms suggests recent sexual exposure and risk 
behavior, so partner services programs might have an 
opportunity for a primary disease intervention. 
•	 Infected persons from core areas. Prioritizing gonorrhea-
infected persons from core areas might offer an opportunity 
to reduce transmission at the community level. 
HIV Infection 
The following categories of persons also are considered high-
priority index patients for partner services for HIV. 
• Persons with a high HIV viral load (e.g., >50,000 RNA 
HIV copies/ml). High serum viral load is associated with 
increased risk for HIV transmission (32). Therefore, index 
patients with a high viral load generally are more likely to 
have transmitted infection to partners. High viral load 
often is associated with acute infection but also can occur 
at different points during the course of the disease. 
•	 Persons with evidence of acute infection (e.g., HIV 
RNA positive and HIV antibody negative) or recent 
infection (e.g., current positive HIV antibody test with 
recent negative HIV antibody test). Rapid follow-up for 
recently infected persons might provide information about 
networks in which transmission is active and ongoing and 
offer an opportunity to interrupt chains of transmission (70). 
Recommendations for Prioritizing 
Index Patients 
General 
• Program managers should establish criteria for prioritizing 
index patients to determine which patients will be 
interviewed first. In general, these criteria should include 
behavioral and clinical factors that affect the likelihood 
of additional transmission. Pregnant women should always 
be considered a high priority, regardless of behavioral or 
other clinical factors. 
• Persons with evidence of ongoing risk behaviors for 
transmission (e.g., recurrent STDs or being repeatedly 
named as a partner of other infected persons) might be 
playing an important role in transmission in the overall 
community and should be prioritized for partner services. 
Syphilis 
• Many program areas use a reactor grid to assist with 
determining investigative priorities for syphilis reactors. 
The reactor grid is based on age and syphilis serology 
laboratory results (titers). Programs that use a reactor grid 
are strongly encouraged to validate its performance 
annually and during suspected outbreaks. 
Interviewing Index Patients 
With the exception of interview period and timing of 
interviews, the following information is applicable to partner 
services for HIV infection, early syphilis, gonorrhea, and 
chlamydial infection. The success of partner services depends 
on the cooperation of index patients. If index patients do not 
provide complete, accurate information about partners, partner 
services are not effective. Obtaining accurate information 
largely depends on treating index patients with respect and 
gaining their trust. Withholding relevant information is likely 
to generate mistrust. When offering partner services, public 
health personnel should delicately balance the need to provide 
these important services with the knowledge that index patients 
can choose whether to participate. Index patients should have 
the following types of information explained to them: 
• the purpose of partner services; 
• what partners services entail; 
• benefits and potential risks of partner services for index 
patients and their partners and steps taken to minimize risks; 
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• how and to what extent privacy and confidentiality can 
be protected; 
• the right to decline participation in partner services 
without being denied other services; and 
• available options for notifying partners. 
The amount of information an index patient needs about 
each of these topics varies. Regardless, all patients should be 
offered ample opportunities to ask questions and voice 
concerns. 
Types of Interviews 
Interviewing index patients to elicit partner information is a 
cornerstone of partner services. Two types of interviews are used: 
the original interview and the reinterview. A supplementary 
approach, clustering, also is used by certain programs to obtain 
information about the index patient’s social network. 
Original Interviews and Reinterviews 
The purpose of the original interview is to gather 
information from index patients about partners they have had 
within a defined period (i.e., the interview period). In addition 
to eliciting as many partner names as possible, the interviewer 
attempts to obtain enough information about the partners so 
that they can be located and notified of their possible exposure. 
Most programs conduct a subsequent interview, the 
reinterview. The reinterview has several purposes: 1) to gather 
additional location information on partners identified by index 
patients in the original interview, if sufficient information was 
not initially obtained; 2) to follow up on the status of partners 
that index patients initially elected to notify themselves; 3) to 
elicit additional partners index patients might not have recalled 
in the original interview; and 4) to verify that index patients 
have received adequate treatment or additional tests. 
Frequently, more than one reinterview is conducted. 
Few studies have been conducted regarding the yield of 
reinterviewing or the relative yield of the original interview 
compared with the reinterview. Second interviews of 1,000 
persons with STDs in a clinic in Berlin, Germany, in 1976 
resulted in elicitation of 9% more partner names (D Brewer, 
unpublished manuscript, 2003). A subsequent sample of 110 
persons from the same clinic were interviewed before diagnosis 
with gonorrhea then reinterviewed twice after diagnosis. The 
second and third interviews together elicited 12% more partner 
names compared with the first interview, resulting in an 11% 
increase in the total number of partners located and a 13% 
increase in the number of infected partners identified. In a 
study of forgetfulness as a cause of incomplete reporting of 
partner names, patients recalled roughly equal numbers of 
partners in the first and second interview; however, the sets of 
partners recalled in the two interviews tended to differ (71). 
Finally, in a randomized trial of supplementary techniques 
used during contact interviews for chlamydial infection, 
gonorrhea, and early syphilis, use of a combination of five sets 
of recall cues increased the number of partner names elicited 
by approximately 23% and the number of partners notified 
by approximately 11% per index patient. This approach was 
approximately two to three times as effective in eliciting 
additional partners as a second interview (72). Reinterviews 
are recommended for all early syphilis investigations and are 
standard practice in most partner services programs. 
Persons who have just been informed that they are infected 
with HIV are often willing to provide partner information 
and might address the topic of partners without being 
prompted. Other patients might be too overwhelmed by the 
new diagnosis to focus on identifying partners effectively or 
to hear and understand messages regarding prevention or linkage 
to care during the original interview. In these instances, using 
the first interaction with an index patient to help with various 
challenges arising from the HIV diagnosis and addressing partner 
elicitation in a subsequent interview might increase the 
likelihood that the index patient will identify partners. This 
approach must be weighed against the possibility that the index 
patient might not be available for a second interview. 
Clustering 
A technique known as clustering has been recommended 
for use when interviewing index patients (1). Clustering 
involves eliciting information from index patients about 
persons in their social networks, other than partners, who 
might benefit from counseling, testing, and other services. 
These persons, referred to as social contacts (and referred to 
as suspects in previous guidelines), might include persons with 
symptoms suggestive of disease, partners of other persons 
known to be infected, or others who might benefit from 
examination (e.g., pregnant females). Clustering also might 
include eliciting information about venues in which the index 
patients and their social contacts interact socially (e.g., bars or 
clubs). Clustering differs from cluster interviewing, which 
involves asking uninfected partners or social contacts of index 
patients about their own social networks. Cluster interviewing 
is addressed in more detail in the section on partners. 
Data on the effectiveness of clustering for case finding are 
limited. A 6-month pilot project was conducted in which a 
network approach was used for routine syphilis partner 
notification in an Atlanta, Georgia, zip code with a high rate 
of early syphilis (260 cases per 100,000 population) (73). 
Among sex partners of syphilis index patients, 23.1% were 
infected with syphilis, whereas 5.9% of nonsexual contacts 
were infected. Another study included an analysis of 1993– 
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1996 partner notification data for 12,927 patients with syphilis 
throughout Louisiana (74). Of 19,188 partners located and 
examined, 19% were newly identified as having syphilis; of 
3,121 social contacts of index patients, 11% were newly 
identified as infected. A review of the effectiveness of partner 
notification and cluster investigations for identifying HIV and 
other STD cases indicated that, based on a small number of 
studies from the previous 20 years, the yield of cluster 
investigation for cases early syphilis was substantially less than 
the yield from partner notification for early syphilis (mean 
number of newly diagnosed cases found from interviewing one 
index patient was 0.002–0.11 for cluster investigation compared 
with 0.05–0.46 for partner notification) (8). Furthermore, the 
same review found that, compared with a few reports from 
previous years of syphilis control, the yield of cluster investigation 
has declined considerably, possibly related to the marked decline 
in early syphilis prevalence. 
In summary, data from a small number of reported studies 
suggest that the case-finding yield of clustering for early syphilis 
is substantially lower than that of partner notification. 
However, the yield is highly variable, and clustering might be 
more productive in areas with relatively high early syphilis 
case rates. Clustering and cluster investigation might be 
particularly useful during an outbreak. Published data on the 
case-finding yield of clustering for HIV are not available. 
Although data regarding the effectiveness of clustering for 
case finding are limited, information obtained through 
clustering has potential epidemiologic value. By obtaining and 
analyzing information about social contacts and venues of 
index patients, programs can gain insight into how and where 
infection is being transmitted in the community and develop 
strategies for conducting screening or other prevention 
interventions (e.g., social marketing campaigns) at the 
community level. 
Interview Environments 
Because of confidentiality concerns, interviews generally 
should be conducted in environments that are private and 
comfortable enough that clients do not feel afraid or coerced. 
Public health clinics provide a safer environment for partner 
services staff members and a more confidential setting for 
interviewing and counseling than field settings. However, 
interviews conducted in settings other than the clinic might 
allow index patients to feel more comfortable discussing highly 
personal information. 
Interviews have traditionally been conducted in person; 
however, this approach is time and labor intensive and not 
always possible. The next most common method (and the 
most common in certain settings) is interview by telephone. 
Other interview methods, such as use of self-administered 
questionnaires and audio computer-assisted self-interviews 
have been suggested as alternatives or supplements to in-person 
interviews; however, little research has been done on this topic 
(D Brewer, unpublished manuscript, 2003). Although self-
administered questionnaires are frequently used in medical 
care settings to obtain information from patients before they 
are seen by a clinician, no studies of this approach for partner 
services have been published. Likewise, little data are available 
on telephone interviews and partner services. Previous CDC 
recommendations for STD partner services suggested that a 
telephone interview might be considered if attempts to meet 
with an index patient in person are unsuccessful or the index 
patient is in a different geographic location than the 
interviewer. One study, in which STD and community clinic 
attendees responded to varying hypothetical partner services 
providers and interview and notification conditions, showed 
that interview settings that were not in clinics were less 
favorably viewed than clinic interviews (75); telephone 
notification and letters by partner services providers were also 
less favorably viewed, although not significantly so. Although 
the available evidence suggests that audio computer-assisted 
self-interviews might effectively elicit partner information from 
index patients, no studies examining this particular use were 
found (76–85). 
Interview Techniques 
Incomplete reporting of partner names might stem from 
various factors, such as concern about potential negative 
consequences (e.g., fear of partner violence), perceived social 
undesirability of acknowledging participation in stigmatized 
or illegal activities, and forgetting or memory errors (71). 
However, although partner elicitation can be challenging, its 
effectiveness can be improved through systematic use of simple 
techniques. In a study of forgetting as a cause of incomplete 
reporting of partner names, using simple and nonspecific 
prompting (e.g., “Who else have you had sex with in the last 
12 months?”) and reading back the list of partners already 
named improved recall substantially (71). On average, these 
methods accounted for 10% of all partners recalled during an 
interview. In a randomized trial of interviewing techniques 
for persons at high risk for HIV infection, administering a set 
of five types of cues to participants, after they had freely recalled 
their partners, increased the number of sex and drug-injection 
partners elicited by an average of 40% and 123%, respectively 
(86). Eliciting partners in reverse chronological order, as 
suggested in previous CDC recommendations, was no more 
effective than using free recall. In a subsequent study of 
supplementary interview techniques for eliciting partners from 
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index patients with chlamydial infection, gonorrhea, and early 
syphilis, patients were asked to freely recall partners, were 
prompted nonspecifically, and had the list of elicited partners 
read back (72). They were then administered three sets of cues, 
which increased the number of new cases found by 12% and 
identified network branches not previously recognized. 
Using supplementary interview techniques might be an 
efficient strategy for increasing the number of partners 
elicited and located. This approach seems to be effective for 
persons at risk for HIV as well as those with other STDs, 
suggesting that comprehensive, systematic use of such 
techniques during the original interview might enhance the 
yield of new partners identified. 
Interview Period 
The interview period is the time interval for which index 
patients are asked to recall their partners. Ideally, the interview 
period covers the time from the earliest date an index patient 
could have been infected up to the date of treatment (i.e., the 
time period during which the patient could have become 
infected or transmitted the infection to others). Anyone who 
had sex with or, for those with HIV infection, shared drug-
injection paraphernalia with the index patient during this 
interval is at high risk for infection. Because of differences in 
biological factors and natural history, the interview periods 
for HIV, early syphilis, gonorrhea, and chlamydial infection 
differ (Table 1). 
Syphilis, Gonorrhea, and Chlamydial Infection 
The interview period for early syphilis varies according to 
the stage of disease (primary, secondary, or early latent) because 
stages develop within well-defined timelines. Thus, the 
interview is used not only to find early syphilis cases but also 
to estimate which partners are most likely to have infected the 
index patient (i.e., the source) and which partners the index 
patient is most likely to have infected (i.e., spread). Source 
and spread information aid in defining the epidemiology of 
the infection and can be used to identify networks of infection. 
To some extent, source and spread can be estimated for 
gonorrhea and chlamydial infection but almost exclusively on 
the basis of interview results and generally not on the basis of 
stage of disease. 
The interview period for syphilis is based on the disease 
stage at the time of diagnosis and incorporates all maximum 
time periods for incubation and stage of disease. The interview 
period for a person with a diagnosis of primary syphilis is 4 
months and 1 week, based on a 90-day maximum incubation 
plus 5 weeks (35-day maximum duration of lesion). The 
interview period for a person with a diagnosis of secondary 
syphilis is 8 months (34 weeks), based on a maximum 90-day 
incubation period and 5-week duration of primary syphilis, 
10-week primary-secondary latency, and 6-week maximum 
duration of secondary symptoms. The maximum interview 
period is 12 months for early latent cases unless a credible 
primary or secondary history can be established and for cases 
of unknown duration. 
Unlike syphilis, which has multiple increases and decreases 
in level of infectivity, infectivity for gonorrhea and chlamydial 
infection increases to a single peak and then decreases. The 
standard interview period is 60 days before the date of 
specimen collection and should be extended through the date 
of treatment if the patient was not treated at the time the 
specimen was collected. For persons who seek treatment at a 
clinic because of signs or symptoms of gonorrhea and 
chlamydial infection, incubation is almost entirely covered 
within this 60-day period (although a few programs use 90 
days). For asymptomatic cases of either STD (e.g., cases 
discovered during screening), the number of cases identified 
from partner notification can decrease substantially. This is 
especially relevant for chlamydial infection, which is most likely 
to be asymptomatic and for which widespread screening is 
most likely. In such instances, attempts to ascertain source 
and spread would have to be established on behavioral reports 
during interviews. However, data are useful for describing 
networks and the epidemiology of infection. 
HIV Infection 
Determining when an index patient was infected with HIV 
often is difficult. Therefore, HIV programs frequently establish 
an interview period based on the estimated likelihood of being 
able to locate and contact the partners (e.g., 1–2 years before 
HIV diagnosis). The recommended interview period in a 
particular jurisdiction might subsequently be modified based 
on analysis of local data or availability of resources. Additional 
considerations might influence the interview period for specific 
index patients. 
Previous Negative HIV Test. A confirmed history of a nega­
tive HIV antibody test might be useful for defining the ap­
propriate interview period for a specific index patient. Knowing 
the date of the patient’s most recent negative test and consid­
ering the window period (i.e., the time interval following in­
fection during which an HIV test might be negative because 
antibodies have not yet developed to a detectable level), the 
interviewer can establish how far back in time the interview 
period should extend. An estimated 95% of persons infected 
with HIV develop detectable HIV antibody within 6 months 
of infection, suggesting 6 months might be an appropriate 
interval to use as a window period; however, these estimates 
were developed using previous, less sensitive versions of the 
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TABLE 1. Interview periods* for partner services programs for chlamydial infection, gonorrhea, human immunodeficiency 
virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), and syphilis 
Disease Interview period 
Chlamydial infection 
Symptomatic 60 days before onset of symptoms through date of treatment
 
Asymptomatic 60 days before date of specimen collection (through date of treatment if patient was not treated at time specimen was collected)
 
Gonorrhea 
Symptomatic 60 days before onset of symptoms through date of treatment
 
Asymptomatic 60 days before date of specimen collection (through date of treatment if patient was not treated at time specimen was collected)
 
HIV infection, AIDS 1 or 2 years before date of first positive HIV test through date of interview; might be mitigated by evidence of recent infection or
 availability of verified previous negative test results 
All current or former spouses during 10 years before diagnosis 
Syphilis† 
Primary 4 months and 1 week before date of onset of primary lesion through date of treatment 
Secondary 8 months before date of onset of secondary symptoms through date of treatment 
Early latent 1 year before start of treatment 
* The time interval for which an index patient is asked to recall sex or drug-injection partners. 
†The interview period is based on patient diagnosis and incorporates all maximum time periods. The interview period is not shortened, regardless of 
patient symptoms, serological history, or incidental treatment. If the patient claims having had no partners during the interview period, then the most 
recent partner before the interview period should be identified and notified. 
HIV enzyme immunosorbent assay (EIA) (87,88). More 
recent EIA tests (e.g., second-generation immunoglobulin 
G [IgG] tests and third-generation IgG/immunoglobulin 
M [IgM] tests) are considerably more sensitive than the previ­
ous tests and might allow the estimated window period to be 
shortened to 3 months (89,90). 
Evidence of Recent Infection. For certain patients, recent 
infection might be suggested by a clear history of an acute 
retroviral syndrome, which might result in the interview pe­
riod being shortened for these specific patients (91). Recently, 
HIV RNA testing has been used to screen pooled, HIV anti­
body–negative specimens to identify persons with acute or 
very recent infections (i.e., HIV RNA–positive and HIV an­
tibody–negative) (70,90,92–98). For these index patients, the 
likely period of the date of infection can be narrowed consid­
erably, and the interview period can be adjusted accordingly. 
Spouses. As noted previously, the Ryan White CARE Act 
Amendments of 1996 require that states receiving funds un­
der part B of title XXVI of the Public Health Service Act en­
sure that a good-faith effort is made to notify the current spouse 
of an HIV-infected person or persons who have been legal 
spouses of that person during the 10 years before the diagno­
sis that such spouse might have been exposed to HIV and 
should seek testing. The 10-year interview period might be 
modified if a confirmed history of a negative HIV test or other 
laboratory testing indicates that the index patient was infected 
more recently; however, states should consult with their legal 
counsel to determine whether their laws allow them to make 
this modification. 
Timing of Interviews 
The time in which partner services should be offered to 
reduce the disease transmission rate and the likelihood of 
reinfection might vary somewhat by disease. However, in 
general, partner services should be offered as soon as possible. 
Syphilis, Gonorrhea, and Chlamydial Infection 
The pattern of infectiousness for early syphilis requires rapid 
notification and treatment of sex partners to have an effect on 
subsequent disease progression or transmission; therefore, 
partners should be notified quickly. For gonorrhea and 
chlamydial infection, the vast majority of additional 
transmission (i.e., by infected and untreated partners of the 
index patient) occurs quickly, and a delay in the interview is 
inadvisable. The morbidity for these two infections, especially 
chlamydial infection, have led to investigation of various 
notification and treatment options that are not widely 
advocated for syphilis (e.g., contact slips for patients to deliver 
to partners or patient delivery of oral medications). 
HIV Infection 
Persons who test positive for HIV should be contacted and 
offered partner services as soon as possible after being identified 
by the partner services program, ideally within a few days. 
Rapid identification, notification, and testing of partners can 
reduce risk for additional transmission. A rapid interview 
allows partners to be identified and notified of possible 
exposure as soon as possible so that they can 1) obtain HIV 
counseling and testing; 2) take steps to avoid becoming infected 
or, if already infected, to avoid infecting others; and 3) access 
medical care and other services as soon after infection as 
possible. Patient reactions to learning about their HIV 
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infection vary, and personal circumstances differ among 
patients. Partner services providers should recognize and, 
within reason, accommodate index patients who need 
particular concerns resolved before feeling ready to participate 
fully in partner services. For index patients who decline or are 
not ready to participate in an initial partner services interview 
at the time of first contact, a follow-up appointment should 
be arranged to discuss partner services concerns more 
thoroughly, preferably no later than 2 weeks after the initial 
contact. 
No studies are available related to introducing partner 
services to persons with reactive rapid HIV tests and 
interviewing them to elicit partner information. Partner 
services providers might consider conducting an initial 
interview and eliciting partner information when the reactive 
rapid test result is obtained and before results of confirmatory 
testing are available if the index patient accepts partner services 
at that time. However, persons with considerable partner 
services experience have suggested that partners not be 
contacted and notified until a positive confirmatory test is 
obtained. If a confirmatory test is not performed at the time 
the rapid test is found to be reactive, attempts can be made to 
locate the patient and obtain confirmatory testing. If the 
patient cannot be located or declines confirmatory testing, 
and the rapid test was performed on a blood specimen, the 
DIS can then contact the partners and notify them about their 
possible exposure to HIV through someone who had a reactive 
rapid test result. This suggestion is based on the high predictive 
value of a reactive rapid test, in most circumstances, when 
performed on a blood specimen. Local policies might preclude 
use of this approach. 
Interviewers 
Traditionally, index patients have been interviewed by health 
department DISs. Certain evidence indicates that health 
department specialists might elicit more partner names from 
index patients with gonorrhea or chlamydial infection than 
other, presumably untrained, interviewers (99). A cohort study 
of the efficacy of partner notification for HIV infection found 
that although patients counseled by health department 
specialists reported more locatable partners than those 
counseled by physicians, the number of partners per index 
patient interviewed who were then identified as having a new 
diagnosis of HIV infection was similar for both groups of 
health-care providers (100). No such comparative data exist 
for gonorrhea or chlamydial infection, although the frequency 
with which both STDs are diagnosed outside public settings 
(especially STD clinics) suggests that collaboration with 
physicians is appropriate. Health departments might be able 
to expand access to and coverage of partner services by 
developing agreements with providers who are not in health 
departments to elicit information about partners and provide 
that information to a health department DIS. The DIS can 
then notify the partners. Existing relationships and rapport 
between these providers and their patients might facilitate 
partner elicitation; providers must inform patients that the 
information will be shared with health department DISs. 
Documented experience with this strategy is scarce; however, 
such approaches have been used by health departments in 
several jurisdictions, with anecdotal reports of success. 
Other than DISs, types of providers who might elicit partner 
information from index patients on behalf of partner services 
programs include the following: 
• other health department personnel (e.g., physicians, 
nurses, counselors, or case managers); 
• health care or service providers who are not in health 
departments (e.g., primary care providers) who provide 
STD screening and HIV counseling and testing to their 
patients; 
• counselors in publicly funded HIV counseling and testing 
sites; 
• counselors in other HIV counseling and testing sites; and 
• health care or service providers who are not in health 
departments (e.g., physicians, physician assistants, nurse 
practitioners, nurses, CBO staff members, or HIV case 
managers) who provide services, including screening for 
other STDs, to persons with HIV infection. These 
providers, who often have ongoing relationships with 
HIV-infected persons, might be particularly useful in 
providing ongoing partner services to their clients (i.e., 
periodically inquiring about new partners who might be 
at risk and initiating partner services as needed). 
If other types of providers participate in this way, roles and 
responsibilities should be clearly defined. 
Unique Circumstances of Index 
Patients 
Unique characteristics of index patients and their individual 
circumstances might affect the partner services process. In 
certain instances, the mental health status and decision-making 
capabilities of an index patient might affect the approach to 
providing partner services. Guardians or others might be 
charged with making legal and health-care decisions for such 
persons. Local laws, regulations, and policies might address 
these concerns. Programs should develop policies and 
procedures that describe how to work with index patients who 
might have limited comprehension or other mitigating 
circumstances; this might require consultation with persons 
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who have expertise in these areas. Examples of concerns that 
should be considered when developing protocols include age 
and developmental level, literacy level, language barriers, 
cultural concerns, hearing or visual impairments, alcoholism 
or abuse of other substances, mental health concerns, or 
potential violence (either on the part of index patients or their 
partners). 
Recommendations for Interviewing 
Index Patients 
General 
• In general, partner names should be elicited (partner 
elicitation) during the original interview. If this is not 
possible, a reinterview should be scheduled. 
• Programs should establish clear policies and procedures 
for the timing of interviews relative to date of diagnosis 
or report. 
• Index patients should be provided information about the 
following: 
— the purpose of partner services; 
— what partner services entail; 
— benefits and potential risks of partner services for index 
patients and their partners, and steps taken to minimize 
any risks; 
— how and to what extent privacy and confidentiality 
can be protected; 
— the right to decline participation in partner services 
without being denied other services; and
 
— options available for notifying partners.
 
• Program managers should ensure that policies and 
protocols are in place to safeguard the confidentiality of 
information shared with health department staff members 
during the partner notification process. Specifically, staff 
members must be trained to maintain confidentiality in 
both their professional and private lives. Confidentiality 
is particularly salient in rural areas, where a DIS might 
have substantial contact with clients outside of the 
professional environment (e.g., because they are neighbors, 
parents of children’s classmates, or members of the same 
church) (101). 
• To ensure confidentiality, interviews should not be 
conducted with other persons present, except for quality 
assurance or for interpreting. 
• In general, partner-elicitation interviews should be 
conducted by trained health department specialists. 
However, to expand partner services coverage, health 
departments should consider enlisting other types of 
providers to conduct interviews on their behalf. 
Successfully eliciting information about partners requires 
skilled counseling and interviewing; therefore, all providers 
conducting interviews on behalf of the health department 
should receive appropriate training. The yield of interviews 
conducted by other providers should be carefully 
monitored. 
• In general, interviews should be conducted in person. 
Telephone interviews might be conducted if no reasonable 
alternative exists, with strict safeguards in place to verify 
the identity of the person being spoken with and ensure 
that privacy and confidentiality are protected. 
• Programs should use interview techniques that maximize 
the amount of information gathered in the original 
interview about the index patient’s partners. Policies, 
procedures, and protocols should establish criteria for 
instances in which reinterviews should be done, how soon 
they should be done, and when they are unnecessary. The 
yield of original interviews and reinterviews should be 
monitored closely and policies, procedures, and protocols 
adjusted accordingly. 
• In addition to information about partners, interviewers 
also can elicit information about the index patient’s social 
network, including venues frequented, for use in planning 
additional prevention activities. 
• Policies, procedures, and protocols should address 
circumstances that might require specific consideration 
in interviews with index patients (e.g., age and 
developmental level, literacy, language barriers, hearing 
or visual impairment, alcoholism or abuse of other 
substances, mental health concerns, or potential violence). 
Syphilis, Gonorrhea, and Chlamydial Infection 
• For early stages of syphilis, policies, procedures, and 
protocols should specify that all index patients receive an 
original interview as close to the time of diagnosis and 
treatment as possible. Every reasonable effort should be 
made to ensure the partner notification process begins on 
the date of the original interview. 
• For cases of gonorrhea and chlamydial infections that 
partner services staff members will follow up, policies, 
procedures, and protocols should specify that all index 
patients receive an original interview as close as possible 
to the time of diagnosis and treatment. Unless the index 
patient has evidence of recent infection, notification 
primarily serves case-finding goals and might be briefly 
delayed, if necessary. 
• For cases of gonorrhea and chlamydial infection that 
partner services staff members will not follow up, patient 
referral instructions should be provided as close as possible 
to the time of diagnosis and treatment. 
24 MMWR November 7, 2008 
• For STDs other than HIV, partner services programs 
should follow established recommendations for interview 
periods (Table 1). 
HIV Infection 
• Policies, procedures, and protocols should specify that all 
index patients receive an original interview as soon as 
possible after diagnosis, ideally within a few days. For index 
patients who are not willing or able to provide partner 
information during the original interview, a reinterview 
should be scheduled, preferably no later than 2 weeks after 
contact was first made (and sooner, if possible, for index 
patients with acute infections). 
• Programs should develop criteria for establishing the 
interview period for index patients with HIV infection 
(Table 1). Criteria for prioritizing partners should be 
developed in consultation with persons who have expertise 
in clinical and laboratory aspects of HIV (e.g., viral and 
serologic markers of HIV infection). 
• Program managers should ensure that policies and 
procedures regarding notification of spouses adhere to 
requirements of the Ryan White CARE Act Amendments 
of 1996 and any other applicable laws. 
• Policies, procedures, and protocols should address 
interviews for persons with reactive rapid HIV tests, 
including when partner names should be elicited, when 
partners should be notified, and policies about notifying 
partners when a confirmatory test is not available. 
Risk-Reduction Interventions 
for Index Patients 
Many HIV-infected persons are knowledgeable about STD/ 
HIV transmission and prevention; however, misconceptions 
and inadequate information about transmission and methods 
for reducing transmission risk are common (102–105). All 
index patients likely can benefit from receiving information 
and brief prevention messages about adopting and maintaining 
safer behaviors to protect their own health and that of their 
partners (25,106). In the case of HIV infection, this includes 
discussing the index patients’ responsibility for disclosing their 
HIV serostatus to current and future partners. These messages 
can be integrated easily into the activities of DISs. 
In addition to provision of information and brief prevention 
messages, prevention counseling can be relevant for all infected 
persons, regardless of the STD diagnosis. Project RESPECT, 
a risk-reduction intervention trial conducted during the mid­
1990s, was aimed at preventing HIV and other STDs in HIV-
negative, heterosexual STD clinic patients (25). Approximately 
one third of participants had an STD at the time of enrollment. 
Participants were randomly assigned into three groups and 
received either two sessions of interactive risk-reduction 
counseling; four sessions of enhanced interactive, theory-based 
counseling; or two brief sessions of didactic information. 
Compared with baseline, participants in all three groups 
reported higher levels of condom use at 3, 6, 9, and 12 months 
follow-up. At 3 and 6 months, participants receiving either of 
the two counseling interventions reported significantly higher 
levels of condom use than those receiving only didactic 
information. At 9 and 12 months, participants in all three 
groups continued to report higher levels of condom use than 
at baseline, but the differences between those in the two 
counseling groups and those in the didactic information group 
were no longer significant. In addition, compared with 
participants in the didactic information group, 30% fewer 
participants in the two counseling groups had new STDs after 
6 months, and 20% fewer participants in either counseling 
group had new STDs through the 12-month interval. The 
relative effectiveness of counseling was greater among 
participants who had an STD diagnosis at enrollment than 
among those with no STD. Interactive and individually 
tailored counseling is likely similar to the communication 
between many DISs and patients regarding partner services 
and future behavior. However, use of the intervention in STD 
clinics, with at least two sessions, has been limited (107). 
Another study of counseling to prevent STDs and HIV 
infection in STD clinic patients compared the effectiveness of 
two 20-minute individual counseling sessions with four 
1-hour group sessions with a follow-up session 2 months later. 
After 12 months, both groups had similar and significant 
increases in condom use, decreases in number of partners, and 
decreases in numbers of new infections with gonorrhea (14%), 
chlamydia (10%), or syphilis (2%) (108). 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
Although prevention counseling is relevant for persons with 
early syphilis, gonorrhea, or chlamydial infection, prevention 
counseling other than individualized attempts during an 
interview is typically composed of brief prevention messages 
delivered once. With early syphilis patients, repeated contact 
with DISs during the course of an investigation is common 
enough that they can establish a record of behavioral change 
or reinforce previous counseling. Except for repeat cases, health 
department–mediated prevention counseling with gonorrhea 
or chlamydial infection is almost certain to be a one-time 
session. The gap between demonstrated efficacy and 
implementation merits additional examination. 
25 Vol. 57 / RR-9 Recommendations and Reports 
Certain aspects of counseling for patients with syphilis, 
gonorrhea, and chlamydial infections are devoted to promoting 
rescreening at 3 months, which CDC recommends, given 
frequently high rates of reinfection among STD clinic attendees 
(3,109). In one study of STD clinics in Los Angeles County, 
California, and Maryland, telephone reminders and point-
of-care interviews (approximately 20 minutes) to reinforce the 
importance of rescreening to the patient were both associated 
with increased rates of return at 3 months (110). Subsequent 
efficacy and cost-effectiveness analyses suggested the telephone 
reminder alone would be most efficient and most cost-effective, 
although the point-of-care interviews should be used in 
situations in which telephone contact is unlikely (110,111). 
Another condition tested in the study, a $20 incentive with 
brief instructions, was associated with higher return rates for 
men but not women. Although programs might consider 
incentives to improve return rates, offering them only to men 
would have ethical implications. Data on interventions to 
promote follow-up testing for syphilis recurrence would 
broaden the scope of evidence available for making program 
decisions about this disease. 
HIV Infection 
Many persons substantially reduce HIV transmission risk 
behaviors after learning they are infected (28,30,112–114). A 
metaanalysis of high-risk sexual behavior in HIV-infected 
persons aware and not aware of their infection found that the 
prevalence of unprotected anal or vaginal intercourse with any 
partner was an average of 53% lower for HIV-infected persons 
aware of their infection compared with HIV-infected persons 
not aware of their infection and 68% lower after adjusting 
data to focus on unprotected anal or vaginal intercourse with 
partners who were not already HIV infected (29). However, a 
considerable percentage (range: 10%–60%) do not 
consistently practice safer behaviors and might transmit 
infection to others or put themselves at risk for acquiring other 
STDs (26). Thus, although certain HIV-infected index patients 
might already have reduced their level of risky behaviors by 
the time they are interviewed for partner services, others are 
continuing risky behaviors and require additional prevention 
counseling or other more intensive prevention intervention. 
Index patients who need additional counseling or other risk-
reduction interventions can be identified through brief 
behavioral risk screening that can be integrated easily into the 
interview process (54). Questions used for behavioral risk 
screening need to be broad enough to identify most index 
patients engaging in risky behaviors. This includes index 
patients currently or recently engaging in risky sex or drug-
injection practices, those who have a current or recently 
diagnosed STD, those who might be pregnant or at risk for 
unintended pregnancy, those with other characteristics 
associated with risky behaviors (e.g., alcohol or other 
noninjection drug use), and those who were previously 
identified and are now named as partners by other index 
patients, which suggests ongoing risky sex or drug-injection 
behavior. 
Index patients whose risk screening indicates continuing 
risky behavior should be informed of the risks involved in 
continuing the behavior. They should also be provided 
prevention counseling or referred for counseling or more 
intensive prevention services. Several risk-reduction 
interventions designed specifically for HIV-infected persons 
have been demonstrated to be effective. Most of these 
interventions involve multiple sessions provided over time, 
usually in a group format (26,27,31). Most do not focus only 
on reducing transmission risk; rather, they address multiple 
life concerns faced by HIV-infected persons, which might 
increase the likelihood that patients can make and sustain 
behavioral changes. These interventions are not feasible to 
provide through partner services but might be available 
through CBOs in the area or as part of ongoing prevention 
activities incorporated into the medical care of persons living 
with HIV infection (54). 
Certain partner services programs might have adequate 
resources to assess and provide prevention counseling to index 
patients whose screenings indicate continued risky behaviors. 
However, health department DISs often have limited numbers 
of interactions with index patients. Furthermore, the time 
available for DISs to provide prevention counseling to index 
patients might be limited, especially if health departments 
expand their partner services activities to ensure that all persons 
with newly diagnosed or reported HIV infection receive 
adequate partner services. Consequently, in certain programs, 
health department DISs might have difficulty providing 
prevention counseling to all index patients for whom it is 
indicated. In these situations, and for index patients requiring 
more intensive prevention interventions, referral or linkage to 
agencies that provide these services or to case managers who 
can arrange them is appropriate. 
Recommendations for Risk-Reduction 
Interventions for Index Patients 
• Program managers should develop protocols that establish 
the minimum amount of information and prevention 
messages that should be provided to all index patients. 
For patients with HIV infection, the information should 
include the index patients’ responsibility for disclosing 
their HIV serostatus to current and future partners. 
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• Program managers should develop protocols for screening 
HIV index patients for current or recent behavioral risks 
and other factors that facilitate transmission. Screening 
should include asking all HIV index patients about 
possible signs or symptoms of other STDs, which enhance 
risk for HIV transmission and indicate current or recent 
risky sex behaviors. 
• Protocols should address management of HIV index 
patients with risky sex or drug-injection behaviors or who 
have signs or symptoms of any type of STD. All index 
patients with ongoing risk behaviors or recurrent STDs 
of any type should be provided prevention counseling or 
referred for counseling or other prevention interventions. 
• Program managers should assess the program’s capacity 
for providing prevention counseling to all index patients 
without interfering with partner elicitation. For partner 
services programs that do not have the internal capacity 
to regularly provide prevention counseling to all index 
patients or are limited by resource or logistical factors, 
program managers should establish formal relationships 
with other agencies that can provide prevention counseling 
and more intensive behavioral intervention services and 
develop clear policies and procedures for making and 
following up on referrals. 
• Program managers should develop protocols to ensure that 
DISs conducting prevention counseling receive adequate 
training and supervision and should ensure that quality 
assurance plans are in place. 
Treatment for Index Patients 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
The CDC 2006 STD treatment guidelines provide preferred 
and alternative treatments for syphilis, gonorrhea, and 
chlamydial infection (3). DISs should verify that index patients 
have been treated appropriately. Because each of these STDs 
is curable, linkage to additional medical care (in the absence 
of coinfection with HIV) generally is not needed, although 
recommendations for follow-up testing are appropriate. 
HIV Infection 
Effective and timely medical evaluation, initiation of 
currently recommended combination ART, and provision of 
appropriate vaccinations and other preventive health 
interventions have led to substantial reductions in HIV-related 
morbidity and mortality (115,116). HIV-infected persons who 
begin receiving (or reestablishing) medical care not only can 
benefit from ART but also can receive screening for other STDs 
and bloodborne infections (e.g., HBV and HCV), appropriate 
vaccinations for vaccine-preventable infections, and other 
medical services. In addition, through medical care and HIV 
case management, patients can be evaluated and receive 
referrals for a wide range of other medical and psychosocial 
services, and the medical care setting offers an opportunity 
for patients to be more completely assessed for HIV 
transmission risk and provided or referred for appropriate HIV 
prevention services (54). Furthermore, ART might decrease 
infectiousness and reduce risk for transmission to others by 
reducing the patient’s viral load (32,117,118). However, delays 
in accessing medical care and inadequate use of care are 
common among persons who receive an HIV diagnosis 
(14,119,120). Linking HIV-infected persons to medical care 
and ongoing HIV case management as soon as possible after 
diagnosis is essential. 
Brief HIV case management for persons with newly 
diagnosed HIV infection increased attendance at HIV care 
facilities. The Antiretroviral Treatment Access Study, a 
multisite, randomized control intervention for persons with 
newly diagnosed HIV infection, directly compared passive 
referral (i.e., giving patients a list of medical providers) with 
brief HIV case management and found that those who received 
HIV case management were significantly more likely to be 
linked to and attend clinic visits over a 12-month period 
(121,122). In certain situations, these brief HIV case-
management services were provided by DISs. This underscores 
the importance of DISs actively helping index patients with 
newly diagnosed or newly reported HIV infection to access 
medical care either directly or by linking them to HIV case 
managers. DISs also might be able to facilitate reestablishment 
of reentry into HIV case management and medical care for 
HIV-infected persons who are not currently receiving medical 
care but have in the past. 
Recommendations for Treatment 
for Index Patients 
Syphilis, Gonorrhea, and Chlamydial Infection 
• Program managers should ensure that patients are treated 
according to CDC treatment guidelines for timely and 
efficacious treatment with appropriate instructions and 
attention to recommendations regarding the importance 
of follow-up testing. 
HIV Infection 
• Program managers should create strong referral linkages 
with HIV care providers and case managers to help ensure 
that the medical needs of index patients are addressed. 
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• HIV-infected index patients who are not receiving medical 
care should be referred or directly linked to medical care or 
to case managers who can then link them to care services. 
Referring Index Patients 
to Other Services 
Many index patients have underlying problems that impede 
their ability to access medical care or adopt and maintain safer 
behaviors and would benefit from referrals to various 
psychosocial services. Because of the numerous U.S. cases of 
gonorrhea and chlamydial infection, and because medical 
management of syphilis, gonorrhea, and chlamydial infection 
does not generally require an ongoing care relationship with 
partners, the process of referral to other services for index 
patients with these STDs is less intense than it is for index 
patients with HIV infection. Nevertheless, many jurisdictions 
offer referrals for care on request or if the need for other services 
is ascertained during the course of interviewing the index 
patient. For index patients whose infections are likely related 
to their living conditions (e.g., homelessness or partner 
violence), attention to need for supportive services might 
reduce the likelihood of reinfection and contribute to infection 
control. Program collaboration and service integration facilitate 
this process. Index patients might need a range of services, 
such as the following: 
• domestic violence prevention; 
• crisis intervention; 
• rape crisis intervention; 
• legal services; 
• child or adult protective services; 
• intensive HIV prevention intervention; 
• mental health counseling; 
• substance abuse treatment; 
• prenatal care; 
• reproductive health assistance; 
• social services (e.g., assistance with housing); 
• screening and treatment for other STDs; 
• hepatitis screening or vaccination; and 
• TB screening. 
DISs usually do not have the time or skills to address these 
concerns; they can best be addressed through referral. For HIV-
infected index patients, these services most likely will be 
available through linkage to medical care and HIV case 
management. At a minimum, program managers should 
identify updated referral resources and develop procedures for 
making successful referrals. 
Recommendations for Referring Index 
Patients to Other Services 
• Because of the diverse needs of many index patients with 
HIV infection and other STDs, program managers should 
identify resources for psychosocial and other support 
services. DISs should routinely be provided updated 
information about referral resources. 
• Many referral needs can be addressed through linkage to 
medical care and HIV case management; however, DISs 
should screen for immediate needs and make appropriate 
referrals. 
Notifying Partners of Exposure 
Notification Strategies 
After index patients have identified partners, the partners 
should be notified of the exposure as soon as possible. 
Traditionally, four strategies have been used to accomplish this: 
provider referral, self-referral, contract referral, and dual 
referral. Provider referral notification involves a partner being 
notified of their possible exposure by a health department 
specialist who has been specifically trained to locate and notify 
partners. The specialists then link the partners to medical, 
prevention, and support services while protecting the 
confidentiality of the index patient. The term provider referral 
has sometimes led to confusion, because health-care providers 
other than health department specialists might conduct some 
or all steps in the partner services process, especially for index 
patients who receive a diagnosis in a setting other than the 
health department. Therefore, these recommendations use the 
term provider referral to specifically describe notification 
carried out by health department staff members and the term 
third-party referral to describe partner notification carried out 
by other professionals (e.g., HIV counselors and clinicians 
who are not in health departments). Self-referral notification 
(also called client or patient referral notification) gives the index 
patient full responsibility for informing partners of exposure 
and referring them to appropriate services. Contract referral 
notification involves index patients selecting specific partners 
they prefer to notify themselves and agreeing to a specific time 
frame in which they will do so. Patients agree that if they do 
not notify the selected partners within the established time 
frame, the DIS will notify the partners. Dual referral 
notification involves an index patient and a provider (a DIS 
or third party) jointly notifying a partner of exposure. 
The notification strategies primarily differ in the degree of 
responsibility assumed by the DISs. Variations in the extent 
of DIS involvement, in turn, contribute to differences among 
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the strategies in terms of effectiveness, intensity of resource 
use, and acceptability to index patients and partners (Table 2). 
The limited available data suggest the following: 
• Provider referral is the most effective single method for 
notifying partners. 
• Self-referral is the least effective single method for notifying 
partners. 
• Maximum notification rates for HIV are achieved when 
the provider and index patient share the responsibility for 
notification. 
• No data are available on the relative timeliness of the 
various partner notification strategies. 
Provider Referral Notification 
STDs Other than HIV. A 1977 study comparing provider 
referral with self-referral for gonorrhea found that similar pro­
portions of partners were evaluated and treated, although pro­
vider referral follow-up was required for a small number of 
partners who originally had been randomly assigned to the 
self-referral group (123). In a study of partner notification for 
syphilis, for which provider referral is most strongly empha­
sized of all the STDs, a comparison of three referral approaches 
(two groups with provider referral, one with contract referral) 
revealed no clear evidence of increased effectiveness or cost-
effectiveness for any strategy compared with another (5). Be­
cause the majority of spread of infection of primary and 
secondary syphilis is likely to occur near the same time as the 
interview, infection control requires almost immediate part­
ner notification and referral. Such swift notification is most 
reliably accomplished through provider referral (although 
notification of Internet partners might be an exception). 
The effectiveness of provider referral (or third-party refer­
ral) depends on the ability and willingness of index patients 
to provide sufficient identifying and locating information. 
Index patients often cannot provide sufficient information to 
conduct provider referral for all partners, and other strategies 
might be needed. For example, during syphilis outbreaks in 
several U.S. cities during 2002–2005 among men who have 
sex with men (MSM) (124,125), program staff members con­
sidered using Internet-based notification when index patients 
could provide only e-mail addresses or chat-room nicknames 
as identifiers. 
Gonorrhea and chlamydial cases are frequently too numer­
ous to permit provider referral. The basis for notification in 
such instances should be self-referral, although basic instruc­
tions can be supplemented with brief oral counseling, written 
instructions, and contact information for patients to give to 
partners (most commonly known as contact slips or referral 
cards) (126,127). Circumstances in which index patients also 
are provided with medications or prescriptions to deliver to 
partners are known as patient-delivered partner therapy, a form 
of expedited partner therapy. 
HIV Infection. Provider referral has been found to be an 
effective means of identifying new cases of HIV. In nine stud­
ies that qualified for inclusion in the Guide to Community 
Preventive Services review, a range of one to eight partners were 
identified per index case. A mean of 67% of named partners 
were found and notified of their exposure to HIV (range: 44%– 
89%), a mean of 63% of those notified were tested, and of 
those tested, a mean of 20% were newly identified as HIV 
infected (range: 14%–26%) (16). 
Only two U.S. studies comparing provider referral with other 
referral strategies for HIV partner notification have been pub­
lished; both were included in the Guide to Community Pre­
ventive Services review. In one study comparing the 
effectiveness of provider referral and self-referral (i.e., patient 
referral) notification in three health departments in North 
Carolina, index patients were randomly assigned to provider 
referral or patient referral groups (128). In the provider refer­
ral group, index patients were given the option of selecting 
between provider referral conducted by a health department 
counselor and contract referral. With contract referral, they 
were given 2 weeks to notify a partner themselves, after which 
time a counselor attempted to notify any partners who had 
not been notified by the index patient. In the patient referral 
group, index patients were asked notify all of their partners 
themselves and were not given the option of requesting pro­
vider referral for any partners. Patients were given 1 month 
for notification, after which time the counselors attempted to 
notify any partners who had not been notified by the index 
patient. In the provider referral group, counselors notified 70 
(45%) of 157 partners. In the patient referral group, index 
patients notified only 10 (7%) of 153 partners. Thus, in this 
study, provider referral was approximately 6.5 times more ef­
fective than patient referral. Of the 143 partners who were 
not notified by index patients in the patient referral group, 
counselors were able to notify only 40 (28%) partners. A sec­
ond study analyzed results of HIV partner notification ser­
vices provided by the Colorado Department of Health in 1988 
(129). Of 84 partners for whom provider referral was intended, 
71 (85%) were notified by providers. Of 30 partners for whom 
patient referral was intended, 17 (57%) were notified by in­
dex patients. Thus, in this analysis, provider referral was ap­
proximately 1.5 times more effective than patient referral. 
Self-Referral Notification 
Syphilis, Gonorrhea, and Chlamydial Infection. Although 
provider referral is favored and generally expected for notify­
ing partners of persons with syphilis, self-referral is the typical 
form of partner notification for persons with chlamydial in­
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TABLE 2. Advantages of various partner referral strategies for partner services programs for human immunodeficiency virus 
(HIV) infection, syphilis, gonorrhea, and chlamydial infection 
Referral strategy 
Advantage Provider Contract Self Third party Dual 
Might allow more partners to be notified of their exposure Yes Yes — — Yes 
Protects index patient confidentiality (including loss of index patient anonymity with respect 
to partners and others who partners might subsequently inform) 
Yes Yes* — Yes — 
Protects partner confidentiality Yes Yes* — Yes — 
Allows for immediate prevention counseling and testing for HIV and other sexually 
transmitted diseases 
Yes Yes* — Yes Yes 
Allows for immediate responses to address questions and concerns from partners Yes Yes* — Yes Yes 
Allows disease intervention specialist (DIS) to identify need for additional behavior 
change interventions 
Yes Yes* — Yes Yes 
Allows DIS to provide and follow up on immediate referrals to various services Yes Yes* — Yes Yes 
Might increase timeliness (because of familiarity with identity and location of partners) — Yes † Yes — Yes 
Uses index patient ability to locate partners and index patient familiarity with partner 
circumstances that might affect notification 
— Yes † Yes — Yes 
Might enable DIS to defuse any partner anger and decrease potential for violence or other 
adverse consequences 
Yes Yes* — Yes Yes 
Increases the likelihood that accurate information about HIV transmission, available 
services, protection of confidentiality, or other concerns are provided 
Yes Yes* — Yes Yes 
Facilitates verification and documentation that partners have been notified and offered 
counseling and testing services 
Yes Yes* — — Yes 
Optimizes financial and health department personnel resource requirements (including time
demands on program staff members) 
— Yes† Yes Yes — 
Provides direct and immediate support for index patients who choose to notify their own partners — — — — Yes 
Might increase index patient disclosure skills — Yes† Yes — Yes 
Provides program information about social, sex, and drug-injection networks that facilitate 
transmission 
Yes Yes* — — Yes 
* Only when partner is notified by provider. 
†Only when partner is notified by index patient. 
fection. Successful public health involvement with partner no­
tification for chlamydial infection is likely to be limited to 
improving self-referral effectiveness through interventions 
provided at the time of diagnosis or treatment (e.g., brief 
counseling) and possibly through increased monitoring of the 
proportion of those seeking care who have been referred by a 
partner (11). Gonorrhea is somewhat more likely than chlamy­
dial infection to be targeted for provider referral in public 
clinic settings; nonetheless, strategies for chlamydial infection 
often are applicable for gonorrhea (especially outside public 
clinic settings); basic instructions can be supplemented with 
brief verbal counseling. A randomized, controlled trial in 
Brooklyn, New York, showed male notification rates of part­
ners could be improved with a brief counseling session (ap­
proximately 20 minutes) aimed at identifying and reducing 
barriers (130). Index patients’ intentions, skills, and belief in 
their ability to notify (i.e., self-efficacy) have been associated 
with more successful referrals, including among adolescents, 
and interventions to increase the effectiveness of self-referral 
typically have incorporated approaches aimed at improving 
self-efficacy (131). 
Written instructions for index patients to deliver to part­
ners are known as contact slips or referral cards. Referral cards 
are used to add legitimacy to the index patient’s notification 
of the partner, provide information to the partner, and pro­
vide information and a short history of exposure to any clini­
cian from whom the partner seeks evaluation. This ensures 
that the clinician has sufficient, accurate information to guide 
appropriate evaluation and management of the partner. In 
ideal circumstances, the referral card with treatment notes from 
the evaluating clinician is returned to a public health pro­
gram, but this situation rarely occurs. A referral card can in­
clude the specific type of exposure, where to go for timely 
evaluation, what to expect in an evaluation, the recommended 
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treatment, and what to do until treatment begins (e.g., ab­
stain from sexual activity). For confidentiality reasons, no ju­
risdictions permit names on a referral card, and many 
jurisdictions have policies prohibiting naming the type of in­
fection. One British study showed that partners of index pa­
tients with chlamydial infection were much more likely to 
seek evaluation if their referral card specifically referred to 
chlamydial infection (84% versus 33%, p<0.01) (132). Among 
program evaluations in the United States and other industri­
alized nations, use of referral cards typically has been associ­
ated with improved notification and treatment rates. In one 
trial, their use was associated with reduction in reinfection of 
index patients but not improved notification (11,126). 
HIV Infection. As noted previously, a randomized, con­
trolled trial in North Carolina and an analysis of program 
data in Colorado both found self-referral notification strate­
gies to be less effective than provider referral for notifying 
partners of exposure, especially when index patients were re­
quired to notify their own partners and given no other op­
tions (128,129). However, in the North Carolina study, 
patients notified 14% of all partners who were eventually 
notified, and in the Colorado report, patients notified 20% 
of all partners who were eventually notified. 
Research of HIV disclosure practices and attitudes toward 
partner notification might offer insight into index patient and 
partner characteristics associated with higher likelihood of 
disclosure or self-referral. Disclosure or self-referral is more 
likely for partners described by the patient as primary, regu­
lar, or main partners than for partners described as nonmain, 
casual, or one-time partners, regardless of patient age or risk 
behaviors (133–137). Intention to notify also is associated 
with a higher likelihood of disclosure. In turn, intention is 
related to factors such as sense of duty or responsibility to the 
partner and an HIV-infected person’s perceived self-efficacy 
for disclosing serostatus (138–143). Increasing number of 
partners is inversely related to likelihood of disclosure; as the 
number of partners increases, the likelihood that the index 
patient will notify any of them decreases (134,144–147). 
Contract Referral Notification 
Syphilis, Gonorrhea, and Chlamydial Infection. Con­
tract referral has not been widely evaluated for syphilis, gon­
orrhea, or chlamydial infection. A trial including provider and 
contract referral notification for syphilis infection revealed no 
clear advantages to either method (5). DISs must balance the 
efficiency gained by having to notify fewer partners in the 
short term (i.e., partners who are notified by the index pa­
tient and also seek evaluation) with the efficiency lost by con­
ducting additional interviews with index patients who did not 
notify partners as intended and with the potential for addi­
tional transmission because of delayed notification. 
HIV Infection. No published study has assessed directly 
the notification and case-finding effectiveness of contract re­
ferral for HIV partner notification. However, some insight 
might be gained from the previously discussed North Caro­
lina and Colorado studies (128,129). In the North Carolina 
study, 128 (41%) of 310 partners were notified by a combi­
nation of providers and patients, whereas of the 292 partners 
who providers attempted to notify alone, 110 (38%) were 
notified. In the Colorado study, 104 (91%) of 114 partners 
were notified by a combination of providers and patient, 
whereas of the 91 partners who providers attempted to notify 
alone, 81 (89%) were notified. These findings suggest that 
including index patients in the notification process might be 
as effective as relying solely on providers to carry out all noti­
fications and that the strategy certainly is efficient. 
Dual Referral Notification 
Dual referral notification involves an index patient and 
provider, together, notifying a partner of exposure. Dual 
referral provides the index patient direct support in the 
notification process and might decrease the possibility of 
negative consequences such as violence or severe emotional 
reactions. The DIS is available to offer immediate counseling, 
provide accurate information, answer questions, address 
concerns, and provide referrals to other services. At the same 
time, participation by index patients might help patients begin 
to think about their infection status, increase the likelihood 
that partners are located and notified, and increase the 
acceptability of the partner services process to partners. In 
theory, dual referral has substantial advantages over other 
approaches; however, the frequency with which this approach 
is used and its effectiveness (either absolute or relative to other 
notification methods) are not known. 
Third-Party Referral Notification 
Third-party referral notification involves partners being 
notified by providers who are not with health departments 
(e.g., private physicians). The frequency with which this 
strategy is used, its feasibility and effectiveness, and its 
acceptability to index patients, providers, and partners are not 
known. In general, the most appropriate roles for third parties 
in partner services are likely interviewing index patients to 
elicit partner information and possibly participating in partner 
notification when dual referral strategies are used. Because no 
data are available on the effectiveness and safety of third parties 
conducting field notification, the level of training and skill 
needed for third-party referral is unclear. State and local laws 
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might have specific requirements related to duty to warn for 
third-party providers. 
Prioritizing Partners for Notification 
All identified partners should be notified of their possible 
exposure as soon as possible, unless partner violence resulting 
from the notification is a concern. However, prioritizing certain 
partners for the most immediate notification is appropriate. 
In general, criteria for prioritizing partners for more immediate 
notification include behavioral and clinical factors that increase 
the likelihood of the partner having been infected as a result 
of exposure or of transmitting infection to others if the partners 
are infected. Criteria vary somewhat according to the infection 
involved. Program effectiveness can be improved by 
periodically reviewing and adjusting prioritization criteria. 
HIV Infection, Syphilis, Gonorrhea, 
and Chlamydial Infection 
Following are categories of partners who are considered to 
have the highest priority for notification of exposure, regardless 
of the infection involved: 
• Female partners who are known or likely to be pregnant 
• Partners suspected of or known to be engaging in behaviors 
that substantially increase the risk for transmission to 
multiple other persons (e.g., those who have multiple 
partners) 
• Partners with whom the index patient reports having had 
unprotected anal or vaginal sex 
HIV Infection 
Following are examples of other categories of partners who 
are considered to have the highest priority for notification of 
exposure to HIV: 
• Partners who have been exposed within the past 72 hours 
and might be candidates for nonoccupational 
postexposure prophylaxis (PEP), if available. 
• Partners who are more likely to have become infected 
with HIV: 
— Partners of index patients who are known (e.g., via 
review of medical records) to have a high HIV viral 
load (e.g., >50,000 HIV RNA copies/ml), which 
significantly increases the risk for HIV transmission 
(32). High viral load often is associated with acute 
infection but also can occur at different points during 
the course of the disease. 
— Partners of index patients who are known (e.g., via review 
of medical records) to have acute HIV infection (e.g., 
presence of HIV RNA with negative HIV antibody test 
results) or recent infection (e.g., current positive HIV 
antibody test with recent negative HIV antibody test). 
Rapid follow-up of persons in networks with evidence 
of active, ongoing transmission might offer an 
opportunity to interrupt chains of transmission (70). 
— Partners of index patients who had another STD at 
the time of exposure or partners who might have had 
another STD themselves at that time. Evidence suggests 
that STD infection (both ulcerative and nonulcerative) 
might increase HIV viral load in genital secretions and 
facilitate transmission and acquisition of HIV, 
increasing the likelihood that the partner might have 
become infected (66). 
• Partners who, if infected, are more likely to transmit HIV 
to others: 
— Partners whose earliest known exposure has been within 
the past 3 months. Studies suggest that the incubation 
period for HIV infection (time from infection to acute 
retroviral syndrome) ranges from 5 to 75 days, that 
serum viral load is likely to be highest in the month 
after infection, and that viral load in seminal and 
cervicovaginal fluid is likely to be highest in the first 2 
months after infection (148–150). Therefore, partners 
who are likely to have been infected within the previous 
3 months might be more likely to spread HIV to others. 
Confidentiality 
When notifying partners of exposure, the identity of the 
index patient must never be revealed. Partners might correctly 
guess the identity of the index patient and pressure health 
department staff members to confirm their suspicions, but 
well-trained DISs avoid such confirmations, either orally or 
through body language. In addition, information about 
partners should not be reported back to the index patient. 
Steps can be taken to reduce the likelihood that neighbors, 
family, friends, or others are able to discern the purpose of 
health department staff members in the field looking for index 
patients or named partners, such as not wearing identification 
badges, not using marked vehicles, and not explaining to others 
the reason a particular person is being sought. 
Screening for Potential Partner 
Violence 
The potential for violence initiated either by a partner or by 
an index patient during the process of partner notification is 
an important concern. Published data on violence associated 
with partner notification are limited. A study conducted in 
New Orleans, Louisiana, examining the effect of HIV and 
syphilis partner notification on partnerships found that, at 
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baseline, 42.3% of index patients reported having experienced 
emotional abuse from a partner in the 3 months before 
interview and 23.6% reported having experienced physical 
violence from a partner during the same interval (40). No 
difference between HIV and syphilis partnerships was found 
in terms of the proportion of participants reporting either 
emotional abuse or physical abuse at baseline; during the 6 
months after partner notification, emotional abuse and 
physical abuse decreased significantly among both HIV and 
syphilis partnerships, with no difference between the two. 
However, this study did not determine whether any of the 
abuse or violence was directly related to partner notification. 
A study of Mexican-American and African-American women 
with nonviral STDs examined factors related to whether the 
women had notified their male partners or intended to do so 
(43). Of 775 women in the study, 63% reported having ever 
been physically or sexually abused, but history of abuse was 
not associated with notification status. The women reported 
having experienced abusive behavior in relationships with 19% 
of the male partners; however, this also was not associated 
with notification status, and only 4% of the women cited 
concern about violence as a reason for not notifying a partner. 
Additional insight into the topic of notification-associated 
violence might be gained through studies of partner violence 
associated with disclosure of positive HIV serostatus, although 
the findings are less likely to apply to other STDs. A small 
number of surveys of HIV-infected women have indicated 
that rates of disclosure-associated partner violence might range 
from 0.5% to 4% (41). Interviews with 336 HIV-positive 
and 298 HIV-negative pregnant women in Brooklyn, New 
York; Connecticut; Miami, Florida; and North Carolina found 
that the proportion of women reporting violence was not 
higher among 142 HIV-positive women who received the HIV 
diagnosis during the current pregnancy (5.8%) than among 
seronegative women (10.7%) or HIV-positive women who 
previously received the diagnosis (9.4%) (42). Of 260 HIV-
positive women with main male partners, 206 (79.2%) said 
their partner knew their serostatus; of these, one (0.5%) 
reported being physically assaulted when her partner found 
out she was infected. Thus, this study indicates that disclosure-
associated partner violence was rare. However, 21% of the 
women had not disclosed their serostatus to their partners; 
the estimated risk for violence might have been higher had all 
these women disclosed their status 
Although the rate of violence directly attributable to partner 
notification is likely low, the available data are limited, and 
additional study is needed. The prevalence of partner violence 
among the populations studied in the few published reports 
is of substantial concern, regardless of whether the violence 
was precipitated by partner notification or was coincidental. 
Therefore, screening for potential risk for partner violence 
before notifying partners is important. 
Recommendations for Notifying 
Partners of Exposure 
Partners 
• All identified partners should be notified of their possible 
exposure as soon as possible, typically within 2–3 working 
days of identification, unless a potential for partner 
violence exists. 
• Program managers should ensure that protocols include 
screening for potential violence with each partner named 
before notification. If the provider considers a violent 
situation possible, the provider should seek expert advice 
before proceeding with notification. DISs should follow 
up on referrals for partner violence services to verify that 
referred persons are safe and have accessed these services. 
• Programs should establish criteria for prioritizing the order 
in which partners are notified. Criteria should be based 
on behavioral and clinical factors that confer a higher 
likelihood of the partner having been infected as a result 
of exposure or, if already infected, of transmitting infection 
to others. In addition, the Ryan White CARE Act 
Amendments of 1996 require that states receiving funds 
under part B of title XXVI of the Public Health Service 
Act should ensure that a good-faith effort is made to 
identify spouses of HIV-infected patients. Criteria should 
be reviewed at regular intervals (at least annually). 
• Programs should accommodate various notification 
strategies that allow the DIS and index patient to 
collaborate on the best approach for notifying each partner 
of exposure and ensure that the partner receives 
appropriate counseling and testing. Regardless of which 
strategy is used, the DIS and index patient should plan 
for potential unanticipated outcomes. 
• For partners for whom the index patient has provided a 
name (or other identifying information, such as an alias) 
and locating information, programs should strongly 
encourage provider referral but be supportive of index 
patients who choose contract referral for selected partners. 
• When contract referral is chosen, the DIS should establish 
an agreement with the index patient specifying when 
partners should be notified (typically within 24–48 hours), 
how the provider will confirm that partners were notified, 
and which follow-up services will be required for situations 
in which the index patient does not notify the partner 
within the allotted time frame. 
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• Programs should allow for self-referral as permitted by 
state and local laws and regulations. Index patients who 
choose self-referral for certain or all partners should be 
informed of its disadvantages and informed about methods 
for accomplishing the notification safely and successfully. 
Self-referral should be discouraged if screening indicates 
a potentially violent situation. 
• Protocols for self-referral should, when possible, 
incorporate interventions that enhance its effectiveness 
and include instructing the index patient about the 
following: 
— when to notify the partner (e.g., within 24–48 hours); 
— where to notify the partner (e.g., private and safe 
setting); 
— how to tell the partner; 
— how to anticipate potential problems and respond to 
the partner’s reactions; 
— how and where the partner can access counseling and 
testing for HIV and other types of STDs; 
— for persons with HIV infection, how to address the 
psychological and social impact of disclosing infection 
status to others; and 
— how to contact the DIS with any questions or concerns 
that might arise. 
• To the extent possible, programs should develop methods 
of monitoring whether partners who are to be notified by 
the index patient (i.e., via contract or self-referral) are 
actually notified and receive appropriate counseling and 
testing. 
• Dual referral should be an option for index patients who 
prefer to be directly involved in the notification but express 
a need for assistance and support from the DIS. When 
dual referral is chosen, the DIS and index patient should 
plan in advance how the session will be conducted. 
• Program managers should ensure that policies and 
procedures, consistent with applicable laws, are in place 
to protect the identities of index patients when informing 
partners of their exposure and to ensure that information 
about partners is not reported back to index patients. 
• Local reporting laws relating to domestic violence, 
including child abuse and abuse of older adults, must be 
followed when clients report risk or history of abuse. 
• Program managers should ensure that DISs are the 
following: 
— knowledgeable about HIV and STD infections, 
transmission, and prevention; 
— well informed about relevant laws and regulations; 
— familiar with HIV and STD program standards, 
objectives, and performance guidelines; 
— culturally competent in providing partner services; 
— skilled at problem solving and dealing with situations 
that might be encountered in the field (e.g., personal 
safety, intimate partner violence, and violence to 
others); and 
— trained how to screen for and address partner violence 
concerns. 
Social Contacts 
General. In general, notification of partners should have a 
higher priority than notification of individual social contacts 
identified through clustering. Routine follow-up of social con­
tacts should be carried out only after the program is success­
fully interviewing most new patients with cases and locating 
and notifying most partners and only after carefully consider­
ing the potential case-finding yield and resource implications. 
If this strategy is used, the number of cases identified should 
be carefully monitored, and the approach should be contin­
ued only if its effectiveness and cost-effectiveness equal or ex­
ceed those of other case-finding strategies. Notification of social 
contacts might be given higher priority during an outbreak. 
HIV Infection. For persons with HIV infection, informa­
tion about social contacts should be used as an aid to under­
standing transmission dynamics in the community and to help 
guide additional prevention interventions at the community 
level (e.g., screening and social marketing). In general, if indi­
vidual social contacts are to be recruited for HIV testing, a 
self-referral approach rather than provider referral should be 
used. A provider referral approach should be used only after 
careful consideration of potential individual and community 
concerns about privacy and confidentiality. Provider referral 
might be appropriate during an outbreak. 
Risk-Reduction Interventions 
for Partners 
Providing Information, Brief Prevention 
Messages, or Interactive Prevention 
Counseling 
Misconceptions and inadequate information about STD/ 
HIV transmission and methods for reducing transmission risk 
are common; all partners likely can benefit from receiving 
information and brief prevention messages about adopting 
and maintaining safer behaviors to reduce their risk for 
acquiring or transmitting STDs/HIV (25,106). These messages 
can be integrated easily into DIS activities. 
Previous CDC guidelines for HIV partner counseling and 
referral services and STD partner services have recommended 
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interactive, client-centered prevention counseling for partners 
(1,2). No published studies are available regarding the 
effectiveness of prevention counseling specifically in the context 
of partner services. Some reduction in risk behavior after 
partner notification has been reported; however, overall, data 
are too limited to allow any conclusions to be drawn (44,151). 
A metaanalysis of HIV counseling and testing research 
published during 1985–1997 concluded that HIV counseling 
and testing did not seem to reduce risk behaviors among HIV-
negative persons (112). However, the studies included generally 
provided little or no detail about the type of counseling used. 
Subsequently, the previously mentioned Project RESPECT 
trial (25) demonstrated that heterosexual STD clinic patients 
who tested negative for HIV and received either two sessions 
of brief, interactive, client-centered prevention counseling 
intervention or four sessions of enhanced, interactive, theory-
based prevention counseling reported higher levels of condom 
use at 3- and 6-month follow-up than those who received two 
sessions of didactic information only; all three groups 
continued to report higher levels of condom use at 9 and 12 
months than at baseline, but the difference between the two 
counseling groups and the didactic information group was no 
longer significant. Compared with participants in the didactic 
information group, 30% fewer participants in the two 
counseling groups had new STDs during the first 6 months 
following enrollment, and 20% fewer had new STDs during 
the entire 12-month follow-up period. A later study examined 
the effect of adding a follow-up counseling session 6 months 
after the initial 2-session counseling intervention (152). 
Participants who received the follow-up counseling session and 
those who did not had similar rates of new STDs during the 
subsequent 6 months. At the 9-month follow-up visit (3 
months after the follow-up counseling session), participants 
who received the follow-up counseling session reported 
significantly less sexual risk behavior than those who did not 
receive the follow-up counseling; however, at the 12-month 
follow-up, this difference was no longer significant. Another 
study examined the relative efficacy of a single prevention 
counseling session in conjunction with rapid HIV testing 
compared with two prevention counseling sessions in 
conjunction with standard HIV testing (153). The incidence 
of new STDs among participants in the two groups during 
the subsequent 12 months was not significantly different 
(19.1% among rapid testers vs. 17.1% among standard testers). 
Brief group-level counseling of STD clinic patients also has 
been found to be effective (154–156). The possibility that 
prevention counseling might be more effective for notified 
partners than for persons in a more general population, given 
that the exposure risk for partners is personal and certain rather 
than hypothetical, has not been studied. As previously 
mentioned, many persons testing positive for HIV reduce 
transmission risk behaviors after learning they are infected 
(30,112,114). 
Other Prevention Interventions 
For certain partners, more intensive prevention interventions 
might be appropriate. Behavioral risk screening might be useful 
for identifying these persons. Several more intensive risk-
reduction interventions have been demonstrated to be effective 
(26,27,31,157). As mentioned previously, these interventions 
cannot reasonably be delivered through partner services 
activities but might be available through other service providers 
in the area (e.g., CBOs) or as part of ongoing prevention 
activities incorporated into the medical care of persons living 
with HIV infection (54). DISs can play an important role in 
referring partners to these services. 
Many partners who are notified of exposure to HIV do not 
receive counseling and testing. In one review, only 63% of 
notified partners were known to have been counseled and tested 
(16). One reason for this might be that partner services programs 
are unaware when partners are counseled and tested by another 
provider or receive counseling and testing at a later date. 
Recommendations for Risk-Reduction 
Interventions for Partners 
• Program managers should develop protocols that describe 
the minimum amount of general information and 
prevention messages that should be provided to all partners 
at the time of notification. 
• All partners of STD/HIV-infected index patients should 
receive prevention counseling. 
• Because a substantial proportion of partners decline to or 
do not keep appointments for counseling and testing, 
prevention counseling should be provided by the DIS at 
the time of notification. 
• Prevention counseling should be based on counseling 
models that have demonstrated efficacy (e.g., the Project 
RESPECT model). 
• Program managers should develop protocols for screening 
partners to determine whether they need additional risk-
reduction interventions and refer them for such 
interventions. 
• Program managers should develop protocols to ensure that 
DISs conducting prevention counseling receive adequate 
training and supervision and ensure that quality 
improvement plans are in place. 
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Cluster Interviewing Partners 
Previous CDC guidelines for STD partner services have 
recommended the use of cluster interviews with partners (1). 
Cluster interviews involve eliciting information from 
uninfected partners about their own partners and other persons 
in their social networks who might benefit from counseling 
and testing. These persons, referred to as associates, might 
include persons with symptoms suggestive of disease, partners 
of other persons known to be infected, or others who might 
benefit from examination (e.g., pregnant females). Cluster 
interviewing might also include eliciting information about 
venues in which partners and their associates interact socially 
(e.g., bars or clubs). As with clustering of index patients, cluster 
interviews of partners can be used for identifying additional 
cases or for epidemiologic purposes. 
Data on the effectiveness of cluster interviewing for case 
finding are limited. In one study, a network approach was 
used to notify partners of persons with syphilis in an Atlanta, 
Georgia, zip code with a high syphilis rate. Among sex partners 
of uninfected partners, social contacts, and associates, 5.7% 
were infected with syphilis, whereas 5.3% of nonsexual 
contacts were infected (73). Another study analyzed partner 
notification for syphilis in Louisiana and found that a total of 
29 (6%) of 503 associates who were located and examined 
had newly diagnosed cases of syphilis (74). As previously 
mentioned, a review of the case-finding effectiveness of cluster 
investigation for HIV and other STDs found that the number 
of cases identified through cluster investigations for syphilis is 
substantially less than the number identified from syphilis 
partner notification (8). Finally, during an outbreak of syphilis 
in a suburban Atlanta, Georgia, community, interview of social 
contacts and associates facilitated identification of an extensive 
sexual network that might otherwise have gone undetected 
(158). 
Data from a small number of reported studies suggest that 
the case-finding yield of cluster interviews for syphilis is 
substantially lower than that of partner notification, that this 
approach might be more productive in areas with relatively 
high syphilis case rates, and that it might be particularly useful 
during an outbreak. Published data on the case-finding yield 
of cluster interviews for HIV are not available. As with 
clustering of index patients, information obtained through 
cluster interviews has potential value for providing insight into 
how and where infection is being propagated in the community 
and might help guide screening or other prevention 
interventions (e.g., social marketing campaigns) at the 
community level. 
Recommendations for Cluster 
Interviewing Partners 
General 
• When notifying partners of their possible exposure, DISs 
might also elicit information about the partners’ social 
networks, including venues frequented, for use in planning 
additional prevention activities. 
• In general, notification of partners should be prioritized 
over follow-up of individual associates identified through 
cluster interviews. Routine follow-up of associates should 
be done only after the program is successfully interviewing 
most new patients with cases and locating and notifying 
most partners, and only after carefully considering the 
potential case-finding yield and resource implications. If 
this strategy is used, its case-finding yield should be carefully 
monitored, and the strategy should be continued only if its 
effectiveness and cost-effectiveness equal or exceed those of 
other case-finding strategies. Follow-up of associates might 
be given higher priority during an outbreak. 
HIV Infection 
• For persons with HIV infection, information about 
associates should be used as an aid to understanding 
transmission dynamics in the community and to help 
guide additional prevention interventions at the 
community level (e.g., screening and social marketing). In 
general, if individual associates are to be recruited for HIV 
testing, a self-referral approach rather than provider referral 
should be used. A provider referral approach should be used 
only after careful consideration of potential individual and 
community concerns about privacy and confidentiality. A 
provider referral approach might be appropriate during an 
outbreak. 
Testing Partners 
After partners are notified of possible exposure to STDs/ 
HIV, they must have access to appropriate diagnostic testing 
and treatment as soon as possible. Many partners who are 
notified of possible exposure to HIV do not receive counseling 
and testing. The number of partners who are examined and 
receive counseling and testing might be increased if testing is 
performed at the time of notification, whether this occurs at 
the clinic or another health-care facility or in the field. 
Syphilis 
Serologic testing remains the standard for syphilis testing 
and requires a blood sample (159). Blood can be drawn easily 
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in a clinical setting; certain DISs are trained in phlebotomy 
and can draw blood in the field. Rapid tests have been 
developed but are not yet approved by the Food and Drug 
Administration for use. Moreover, rapid tests do not indicate 
stage of disease like reagin-based tests (i.e., through measuring 
titers). Whether partners are interviewed or have blood drawn 
in the field, they should be referred for evaluation and possible 
treatment. 
Gonorrhea and Chlamydial Infection 
Gonorrhea and chlamydial infection both can be detected 
via culture; however, chlamydia cultures are demanding and 
lack sensitivity, and transport of both types of organisms require 
careful attention to ambient conditions. However, nucleic acid 
hybridization tests, and, increasingly, nucleic acid amplification 
tests (NAATs) have been used more frequently in recent years. 
Non-NAATs are less sensitive than NAATs, and NAATs can 
be used with urine samples as well as urethral (men) and 
endocervical (women) samples (160,161). Testing of samples 
in the field is not feasible; therefore, partners tested at the 
point of notification can only be referred for evaluation or 
dispensed medication on a prophylactic basis (i.e., via field-
delivered therapy). 
For those who are notified via telephone, follow-up 
evaluation can be conducted by obtaining urine samples via 
mailed kits; kits can be mailed to the partners and returned in 
person or by mail. No data are available on the application of 
mailed kits for testing, but use of this option for program-
level rescreening was moderately successful (i.e., a 22% 
response rate and 3% positivity) in one study with women 
(162). Although 22% is not a strong response rate in many 
settings, public health agents who are rescreening per CDC 
guidelines have 22% fewer patients (3). A similar approach 
was used for chlamydial screening (not rescreening) of men in 
a managed care organization; 7.8% of men who received a kit 
were tested, although this rate was higher than the rate achieved 
by a letter alone (3.6%) (163). However, testing rates might 
rise if tests were conducted in conjunction with notification, 
because partners might be more concerned about being 
infected. 
HIV Infection 
Testing in clinic settings can be conducted with conventional 
test procedures or with rapid tests using oral fluid or blood. If 
notification is carried out in the field, a rapid test can be 
performed, an oral fluid specimen can be obtained or blood 
drawn for conventional testing, or the partner can be escorted 
or referred to a public health clinic or other test provider. 
Ensuring that partners who are tested, especially those who 
test positive, receive their test results is critical. At publicly 
funded counseling and testing sites in 2004, only 84% of 
persons testing positive and 78% of those testing negative 
received their test results (61). Research has shown that rapid 
testing is acceptable and feasible in various settings and that 
more persons might get tested and learn their results if they 
are tested with rapid rather than conventional tests (164–170). 
Rapid testing has also been found to promote earlier initiation 
of care compared with conventional testing (167). Although 
the use of rapid testing in partner services has not been well 
studied, in one survey of health departments, 16 (37.2%) of 
43 departments that responded reported using rapid tests in 
their partner services programs (171). 
Partners might be infected with HIV but test negative 
because of the window period between infection and 
development of detectable levels of HIV antibodies. With 
recent EIA tests (e.g., second-generation IgG-sensitive tests 
and third-generation IgG/IgM-sensitive tests), most infected 
persons develop detectable antibody within 3 months of 
infection (89,90). Therefore, partners who test negative but 
whose last date of exposure is unknown might ordinarily be 
advised to be retested 3 months later; those known to have 
been exposed recently might be advised to be retested 3 months 
after the date of last known exposure. In partner services, 
suggestions for retesting are complicated because reference to 
any date might compromise the index patient’s identity. For 
this reason, routinely suggesting that partners be tested at the 
time of notification and retested 3 months later might be the 
best course of action. 
Persons with acute or recent HIV infection might test negative 
because of the window period. HIV RNA testing has been used 
to screen pooled, HIV antibody–negative specimens to identify 
persons with acute or very recent infection (i.e., HIV RNA 
positive and HIV antibody negative) (70,90,92–98). Given the 
high prevalence of previously undiagnosed HIV infection among 
partners and the possibility that partner notification might lead 
to earlier detection of HIV than other strategies, HIV RNA 
testing might also be useful in this context. However, prospective 
use of testing for acute or recent infection in the context of 
partner services has not been reported. 
Screening for Concomitant Infections 
Although rates of coinfection vary considerably in different 
areas and settings, partners who are notified about exposure 
to one STD often are at risk for other STDs, including HBV. 
Drug-injection partners are at risk for both HBV and HCV 
(172). Consequently, partners being notified of exposure to 
any STD, including HIV, might benefit from 1) screening 
and treatment for other STDs and 2) HBV vaccination (and 
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HAV vaccination for MSM) (3). Those with a history of 
injection drug use should be screened for both HBV and HCV. 
Screening for HIV, syphilis, chronic HBV, and chlamydial 
infection is currently recommended for all pregnant women, 
as is screening for gonorrhea and HCV in pregnant women at 
risk (3). For sexually active MSM, current screening 
recommendations include serologic tests for HIV and syphilis, 
tests for urethral gonorrhea and chlamydial infection in men 
who have had insertive intercourse in the preceding year, tests 
for rectal gonorrhea and chlamydial infection in men who 
have had receptive anal intercourse in the preceding year, and 
a test for pharyngeal gonorrhea in men who have had receptive 
oral intercourse in the preceding year (3). HBV vaccine is 
recommended for all nonvaccinated, uninfected persons being 
evaluated for an STD (3,173,174). HAV vaccine is 
recommended for MSM and users of illicit drugs (both 
injection and noninjection) (3,175). Specific details about 
hepatitis vaccination, including prevaccination serologic 
testing, are available at http://www.cdc.gov/hepatitis. Partner 
services provide an opportunity to integrate these services at 
the client level. Although integration might be difficult for 
logistical reasons (e.g., testing being done in the field by a 
person not authorized to administer vaccines) or because of 
limited resources, partner services and other health department 
program managers might be able to collaborate to make these 
services available to partners. 
Recommendations for Testing Partners 
General 
• To the extent possible, testing for HIV and other types of 
STDs should be done at the time of notification. Partners 
who are not tested at the time of notification should be 
escorted or referred to the health department for testing 
or linked to other health-care providers who can provide 
these services. 
• DISs should follow up on partners not tested at the time 
of notification to verify that testing has occurred, test 
results were received and understood, and other referral 
services were accessed. If another health jurisdiction has 
been asked to contact a partner, follow up should be 
conducted by the initiating health department to 
determine whether services have been received. 
• Program managers should explore ways in which screening 
for HIV, screening and treatment for other types of STDs, 
screening for HBV and HCV, and vaccination for HAV 
and HBV might be integrated in partner services programs. 
Syphilis 
• Blood should be drawn in the field when DISs are trained 
to do so and when specimen maintenance conditions can 
be met. Partners should be referred for evaluation 
regardless of whether a specimen has been collected. 
Gonorrhea and Chlamydial Infection 
• If provider referral is used, programs should consider 
protocols for collecting specimens in the field. 
HIV Infection 
• Partner services programs should consider using rapid HIV 
tests to maximize the number of partners who are tested 
and receive test results. 
• When notification is done in the field, rapid tests should 
be used or a blood or an oral fluid specimen should be 
collected for conventional testing. If neither of these is 
possible, the partner should be escorted or referred to the 
clinic for testing. 
• Partners who test negative for HIV antibody should be 
advised to be retested in 3 months. 
Treatment for Partners 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
The principal goal for syphilis, gonorrhea, and chlamydial 
infection is immediate treatment, whether curative for infected 
partners or preventive if a partner tests negative or has an 
unknown status. Timely treatment of partners serves as a 
primary means of minimizing subsequent transmission. 
Expedited partner therapy (EPT) is a process through which 
treatment for partners of persons with a diagnosis of gonorrhea 
or chlamydial infection is administered before the clinical 
evaluation occurs. Most uses of EPT involve patient-delivered 
partner therapy (PDPT), or delivery of medications or 
prescriptions via the index patient. EPT is recommended as a 
clinical option for heterosexual men and women, especially 
for partners who are not likely to seek evaluation (3,176). On 
an individual basis, clinicians and patients decide whether to 
use EPT; at the program level, no evidence suggests that 
partners of persons with either gonorrhea or chlamydial 
infection seek care in sufficient proportions to stem 
transmission. Randomized, controlled trials of single-dose oral 
therapy for both STDs have shown reduced rates of reinfection 
among index patients exposed to EPT compared with controls; 
approximately 20% for chlamydial infection and 50% for 
gonorrhea (126,177,178). A 2007 metaanalysis of trials 
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revealed that these were statistically significant overall 
reductions (179). Use of EPT also was associated with increased 
rates of index patient notification of partners and of partner 
treatment. However, EPT was not associated with reduced 
reinfections among women with trichomoniasis; in addition, 
EPT with MSM should be used cautiously because of lack of 
data showing efficacy of EPT for MSM, and because the risk 
of potential comorbidity with HIV is higher among MSM 
with STDs than among heterosexual males or females (3,127). 
Ensuring that EPT is accompanied by written instructions is 
important, including instructions for the medication, for the 
length of time to avoid sexual activity, and advice to seek 
evaluation. Essentially, instructions are equivalent to a referral 
card. Single-dose therapy with EPT is the most likely to result 
in treatment being administered appropriately and completely, 
just as with therapy prescribed to a patient. EPT with multidose 
regimens has not been evaluated (e.g., doxycycline for chlamydial 
infection). Other general treatment recommendations relevant 
to EPT include cotreatment for chlamydial infection in persons 
with a diagnosis of gonorrhea, but not vice versa. 
Although the high caseload of gonorrhea and chlamydial 
infections have inhibited provider referral, a few programs have 
used EPT through DIS delivery of medications, or field-
delivered therapy (FDT). The DIS (or public health nurse) 
delivering FDT should be licensed to do so under a protocol 
for standing orders or another similar arrangement. In 1999, 
the San Francisco Department of Public Health used FDT 
for partners of patients with gonorrhea and chlamydial 
infection (180). By 2000, the proportion of partners 
completing treatment increased from 62% to 81%. The 
advantage of FDT over PDPT is that DISs can be trained to 
watch for immediate adverse reactions (e.g., allergic reactions) 
and can verify treatment and deliver prevention messages 
directly, an approach similar to directly observed therapy for 
TB infections. The disadvantage of FDT is that a public health 
staff person is required to trace and notify partners; therefore, 
resources remain a vital consideration. Although unevaluated, 
FDT is a possible strategy for treating syphilis if 1) a person 
licensed to administer injections and monitor and respond to 
adverse reactions accompanies the DIS and 2) the partner’s 
stage of disease and coinfection can be adequately addressed 
during the contact interview. 
Although treatment on the basis of exposure is a well-known 
public health strategy, the absence of a clear physician-patient 
relationship places EPT (especially in the form of PDPT) in an 
uncertain legal status in many jurisdictions. To aid programs in 
establishing formal programs that are clinically useful and legally 
defensible, CDC has a website (available at http://www.cdc.gov/ 
std/ept) with CDC guidance, guidance models from states in 
which EPT is specifically permitted, and a state-by-state analysis 
of the legal landscape of EPT, based on a recent survey of laws, 
regulations, court decisions, and policies (181). 
HIV Infection 
As mentioned previously, effective and timely medical 
evaluation, initiation of currently recommended combination 
ART, provision of appropriate vaccinations and other 
preventive health interventions, and referrals for a wide range 
of other medical and psychosocial services are critical for 
persons with a new diagnosis of HIV infection. Linking 
partners who test positive for HIV to medical care and HIV 
case management is essential as soon after diagnosis as possible. 
The importance of linking HIV-infected partners to medical 
care and verifying that they have had a medical evaluation or 
received HIV case management at least once cannot be 
overemphasized. 
Accumulated data from animal and human clinical and 
observational studies suggest that PEP for sexual, injection-
drug use, and other substantial nonoccupational HIV exposure 
might prevent HIV infection and that potential risks from 
PEP (e.g., increase of risky sexual behavior, adverse reactions 
to medications, and selection of resistant virus) might be 
minimal (182). PEP is intended to be initiated within 72 hours 
of exposure to HIV, and antiretroviral medications must be 
taken for 28 days. Partners who have been exposed and can be 
notified within this time frame might be candidates for PEP 
(3). Because PEP is only intended for persons who are HIV 
negative and because partners might not be aware of their 
HIV status, access to rapid testing is necessary for this option 
to be offered. 
Incorporating PEP into partner services programs poses 
substantial logistical and resource challenges; however, certain 
health departments have developed program recommendations 
for PEP that might be useful for jurisdictions considering 
implementing such a program (183). Although PEP might 
be useful in certain partner services contexts (e.g., with new 
partners of the index patient), health departments will 
ultimately need to evaluate whether integrating PEP into their 
partner services programs is feasible and consistent with 
program objectives. 
Recommendations for Treatment 
for Partners 
Syphilis, Gonorrhea, and Chlamydial Infection 
• Program managers should ensure that partners are treated 
according to CDC treatment guidelines as soon as possible 
after notification. 
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• Programs should consider FDT for gonorrhea and 
chlamydial infection when partners are notified via 
provider referral. 
• Because single-dose oral therapy is used for gonorrhea and 
chlamydial infection, programs should consider PDPT 
for partners who will not be notified via provider referral. 
• Programs should be sure that all appropriate parties are 
consulted to ensure that any EPT strategy in the 
jurisdiction is medically and legally sound. Appropriate 
parties vary by jurisdiction but might include state health 
commissioners or legislative bodies. 
HIV Infection 
• Program managers should create strong referral linkages 
with HIV care providers and case managers to help ensure 
that the medical needs of HIV-infected partners are 
addressed. 
• Partners who test positive for HIV should be linked as 
soon as possible to early intervention services, medical 
care, and HIV case management, through which they can 
receive complete medical evaluations and treatment, 
assessment, referral for psychosocial needs, and additional 
prevention counseling. 
• Follow-up should be conducted to verify that HIV-
infected partners have accessed medical care or HIV case 
management at least once. 
• Partner services programs implementing PEP should 
develop protocols to ensure that persons exposed to HIV 
within the previous 72 hours are informed of the option 
of PEP, including risks and benefits as they relate to the 
exposure risk. Staff members conducting partner services 
should be aware of the options for persons to access PEP, 
whether through existing programs, urgent care facilities, 
emergency departments, or private physicians. 
Referring Partners to Other Services 
Whether partners test positive or negative for a particular 
disease, underlying factors might impede their ability to access 
medical care effectively or adopt and maintain safer behaviors, 
and they might benefit from referral to various psychosocial 
services. Considerations regarding referrals for partners are 
essentially the same as those for referrals for index patients. 
Recommendations for Referring 
Partners to Other Services 
• Because of the diverse needs of partners, program managers 
should identify referral resources for psychosocial and 
other support services. DISs routinely should be provided 
updated information about referral resources. 
• Many referral needs of partners testing positive for HIV 
will be addressed through linkage to early intervention, 
medical care, and HIV case management; however, DISs 
should screen for immediate needs and make appropriate 
referrals. 
• Partners testing negative for HIV should be screened and 
referred for other medical and psychosocial needs and 
prevention services. 
Specific Populations 
The recommendations in this report generally apply to all 
lients with HIV infection or other STDs regardless of setting, 
opulation, or disease. However, certain populations such as 
ouths, migrant and immigrant populations, and persons in 
orrectional facilities have unique characteristics and 
ircumstances. 
ouths 
The rates of many STDs are highest among young 
opulations; each year in the United States, approximately 19 
illion new STD infections occur, almost half of them among 
ersons aged 15–24 years (53). Recent national HIV/AIDS 
urveillance data indicate that the estimated number of 
revalent HIV/AIDS cases increased from 1,465 to 2,478 
mong youths aged 15–19 years and from 3,910 to 5,367 
mong those aged 20–24 years during 2002–2006 (184). 
ouths are at higher risk for HIV infection and other types of 
TDs because they frequently have unprotected intercourse, 
re biologically more susceptible to infection (especially 
emales), are engaged in sexual partnerships of limited 
uration, and face multiple obstacles to using health care (185– 
89). The unique biologic and cognitive developmental 
oncerns associated with youths require that services for them 
e developmentally appropriate and as comprehensive and 
eamless as possible. 
artner Elicitation 
Approaching youths who have received a recent diagnosis 
f HIV or any other type of STD can be challenging. Before 
roaching the subject of partner elicitation with a young index 
atient, assessing immediate needs is important, especially for 
atients in need of housing or food. Youths might have many 
isperceptions and information gaps about partner services 
hat need to be addressed, such as understanding that partner 
ervices are voluntary and that they have the right to decline 
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confidentiality and that it includes not reporting to their 
parents unless the youth requests parent or guardian 
involvement. In addition, specific counseling skills might be 
necessary, especially for youths with a recent diagnosis of HIV, 
to ensure that they understand the ramifications of the 
diagnosis and how to prevent future acquisition of HIV and 
other types of STDs and transmission to others (190). 
Youths who fear losing partners and friends might find it 
especially difficult disclosing information about sexual or 
injection-drug partners and other social contacts (191). In 
addition, youths might be reluctant to provide information 
about adult partners because of fear of legal repercussions 
related to sex between an adult and a youth. In addition, fear 
of partner violence might prevent partner identification; 
therefore, assessing the potential for partner violence is essential 
for each partner identified. Assessing other potential violence 
or maltreatment situations that might occur involving parents, 
guardians, or friends also is critical. Finally, DISs providing 
services to youths should be sure to discuss the topic of sexual 
abuse with their clients; if sexual abuse is suspected, they should 
notify the appropriate authorities (e.g., child protective services 
agency) in accordance with applicable laws and regulations. 
Notifying, Counseling, and Testing Partners 
Although the process of notifying partners named by youths 
and named by adults is the same, legal concerns might exist in 
situations with youths, especially when an adult partner is 
named. Knowledge of state laws is essential; if sexual abuse or 
statutory rape is suspected, staff members must be prepared 
to report to the appropriate agency. 
Counseling skills of partner services providers are especially 
important when partners are very young or immature. 
Developing simple and clear messages regarding the STD and 
HIV notification process is needed to ensure that youths are 
able to understand the purpose of notification and the urgency 
of getting tested if testing is not provided in the field (190). 
Being able to assess the maturity of the partner is a fundamental 
skill for DISs so that they can ensure that an appropriate plan 
of action is developed. 
Young partners might also require specific types of assistance 
to obtain testing. For example, partner services staff members 
should be prepared to call previously identified testing sites, 
make an appointment for testing, and then follow up with 
the youths to verify that they received the test. Youths might 
be reluctant to access services because of financial and 
transportation limitations and because of fears that parents 
must give permission or be informed. Youths must understand 
that, with a few exceptions, all adolescents in the United States 
can legally consent to receiving a confidential diagnosis and 
treatment of STDs (3) In all 50 states and DC, medical care 
for STDs can be provided to adolescents without parental 
consent or knowledge. In addition, in the majority of states, 
adolescents can consent to HIV counseling and testing. 
Consent laws for vaccination of adolescents differ by state. 
Several states consider provision of vaccine similar to treatment 
of STDs and provide vaccination services without parental 
consent. Because confidentiality is crucial, health-care 
providers should follow policies that provide confidentiality 
and comply with state laws for STD services. Partner services 
staff members should remain knowledgeable and updated on 
related state and local laws and regulations. 
Treatment for Partners 
Because youths often are a medically underserved population 
compared with persons in other age groups, they might be 
less likely to receive office-based medical care or to use primary 
care services (192,193). Reasons for this include concerns 
about confidentiality, lack of health insurance, lack of 
adolescent-specific services including health-care providers 
with adolescent health experience, and appointment times that 
conflict with school schedules (185,194–198). HIV-infected 
youths might face additional challenges, and health care 
providers serving HIV-infected youths report that acceptance 
of HIV diagnosis and return for care and treatment can take 
many months. Programs might be able to increase the 
likelihood of successfully linking adolescents to care and 
treatment by developing relationships with medical facilities 
that are sensitive to youth concerns and that have a strong 
case-management component (199,200). 
Confidentiality and Privacy 
Although confidentiality is a basic principle for all steps of 
the partner services process, careful attention must be paid to 
providing a private and safe place for the interview and 
notification process for young index patients and their partners. 
However, ensuring confidentiality in cases involving suspected 
child or sexual abuse is not always possible. Local laws, statutes, 
and regulations define the limits of confidentiality in these cases. 
Recommendations for Youths 
• Programs should have specific protocols in place to guide 
partner services for youths. Protocols should address 
assessment of maturity and extent of social support, use 
of age-appropriate counseling and communication 
models, provision of services in youth-friendly 
environments, and assessment for physical and sexual 
abuse. These protocols should be developed in 
collaboration with legal counsel to ensure that they are 
consistent with all applicable laws and regulations. 
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• Program managers should ensure that all staff members 
are aware of state and local requirements related to 
reporting of suspected sexual activity involving an adult 
and a minor child, child abuse, and sexual crimes. DISs 
providing services to youths should be sure to discuss the 
possibility of sexual abuse with their clients and, if sexual 
abuse is suspected, should notify the appropriate 
authorities (e.g., child protective services agency) in 
accordance with applicable laws and regulations. 
• Program managers should ensure that partner services staff 
members remain knowledgeable and updated on state and 
local laws and regulations related to parental consent, 
diagnosis and treatment of STDs, and HIV counseling 
and testing. If doubt or confusion arises regarding a specific 
case, legal counsel should be sought. 
• Program managers should ensure that any staff person who 
conducts elicitation of partner names and notification of 
partners for youths has received training on conducting 
services in a way that is appropriate for each child’s age and 
developmental level. Training should include ways to 
recognize and address child abuse or sexual abuse situations. 
Immigrants and Migrants 
Data on the prevalence of HIV infection or other STDs 
among immigrant and migrant populations in the United 
States are limited. However, certain immigrant and migrant 
populations in the United States might be particularly 
vulnerable to HIV and other STDs because of inadequate 
knowledge about the infections, lack of information about 
and access to prevention and related health-care services, and 
delays in accessing HIV and other STD testing, treatment, 
and care (201,202). Immigrant and migrant women also might 
experience concerns related to power and economic disparities 
between men and women that make women more vulnerable 
to sexual abuse or domestic violence and decrease their ability 
to protect themselves from sexual exposures to infection (203). 
All of these concerns might contribute to HIV and other STD 
acquisition and transmission among these populations. Partner 
services programs can be an effective way to identify and reach 
members of immigrant and migrant populations who might 
not otherwise access HIV and other STD testing services. 
Partner Elicitation 
Concerns affecting partner elicitation among migrants and 
immigrants might include difficulty in locating such persons 
because of their transient movement within the United States 
or across international borders (e.g., U.S.-Mexico border) 
(204). Interviews might be difficult because of language and 
cultural barriers. Index patients might be reluctant to provide 
information if translators are family members or are from their 
own communities. A lack of understanding about the 
voluntary and confidential nature of partner services makes it 
essential that simple and clear messages are provided to 
encourage participation and gain the trust of index patients. 
Partner elicitation might be hindered by concerns that 
named partners could be deported (205). Concern about 
individual stigma related to STDs or HIV infection and 
activities related to transmission (e.g., male-to-male sex or 
injection drug use) also might be a barrier to full participation 
in partner services. Because of fears of partner violence, which 
might be substantial among immigrant and migrant women, 
DISs must be able to adequately assess the potential of partner 
violence before initiating partner notification (206). 
Notifying, Counseling, and Testing Partners 
Locating and notifying partners among immigrants and 
migrants might be difficult for the same reasons that partner 
elicitation is challenging. In addition, the usual counseling 
models might not be culturally appropriate because of cultural 
norms regarding discussion of sex and sexual behaviors. These 
concerns can make risk assessments or HIV and STD 
prevention counseling especially difficult. 
Treatment for Partners 
Treatment and care services might not be available or easily 
accessible to immigrant and migrant populations because of a 
lack of financial resources, transportation, and child care 
resources. Concerns about confidentiality, loss of employment, 
and fear of deportation or other legal consequences also might 
make immigrant and migrant populations reluctant to access 
care. If they do access care, medical care providers might lack 
linguistically and culturally appropriate services. 
Recommendations for Immigrants 
and Migrants 
• Program managers should review epidemiologic and other 
data to identify potential immigrant and migrant 
populations at high risk for infection in their jurisdictions 
and be prepared to provide partner services that are 
linguistically and culturally appropriate. 
• Based on the immigrant and migrant needs identified in 
the community, program managers should develop 
partnerships with CBOs and health-care providers that 
can deliver linguistically and culturally appropriate care, 
treatment, prevention, and support services. 
• Program managers should consider the diversity training 
needs of DISs who are working with the immigrant and 
migrant populations. In particular, staff members 
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conducting interviews should be sensitive to cultural 
norms governing the discussion of sex and sexual 
behaviors. To the extent possible, clients who have limited 
ability to speak English should be interviewed in their 
native language. 
• Programs should consider the literacy level of their clients 
as well as the primary (or only) language of the clients. 
Programs should ensure that HIV and other STD 
prevention educational materials are available in 
appropriate languages that reflect the cultural norms of 
the population. 
• Because of the geographic mobility of immigrants and 
migrants, program managers should consider use of rapid 
HIV tests and active outreach strategies for migrant and 
seasonal workers in nontraditional settings. 
• Health jurisdictions should consider developing 
collaborative agreements with bordering countries (i.e., 
Canada and Mexico) to assist with notification and follow-
up of partners. 
• Program managers should be aware of federal, state, and 
local laws and regulations that might affect partner services 
for undocumented immigrants. 
Incarcerated Populations 
The majority of the 2.2 million adults and juveniles residing 
in jails, detention centers, and state and federal prisons 
eventually will be released and rejoin the larger community. 
Persons in prisons are generally housed for longer periods of 
time than persons in other correctional facilities, such as jails. 
Certain persons in city and county jails and juvenile facilities 
are released in less than 24 hours, with the majority (93%) of 
jail inmates staying less than 1 year (207). Multiple studies 
and surveillance projects have demonstrated high rates of sexual 
risk and STD prevalence among persons entering prisons, jails, 
and juvenile correctional facilities (208–210). Data from the 
Bureau of Justice Statistics indicate that, as of December 31, 
2005, a total of 22,480 (1.8%) state and federal prison inmates 
were infected with HIV or had confirmed AIDS. The 
prevalence was higher in state prisons (20,888 inmates, 1.8%) 
than in federal prisons (1,592 inmates, 1.0%) and was higher 
among female than male inmates (2.3% and 1.7%, 
respectively) (211). A study of syphilis cases during 1997– 
2002 in Indianapolis, Indiana, and Nashville, Tennessee, found 
that 19% of cases in women and 27% of cases in men were 
identified through jail screening; in certain situations, the case-
finding yield of jail screening approached that for STD clinics 
(212). Many persons who are arrested are at high risk for STD 
and HIV infection because of high-risk behaviors (e.g., 
multiple sex partners or injection and other drug use) and 
poor health-care–seeking behaviors while in the community. 
Therefore, providing routine screening for HIV and other types 
of STDs during the correctional facility intake process offers 
an opportunity to identify infections, prevent complications, 
and reduce further transmission by improving access to 
treatment, care, and prevention. 
Many correctional facilities provide screening for HIV and 
other types of STDs. Conducting partner services for persons 
in correctional facilities who test positive presents a unique 
opportunity to access possibly hard-to-reach partners at high 
risk for infection both in the facility and in the community. 
Conducting partner services might lead to a better 
understanding of risk behaviors and prevention needs of 
inmates, help programs better target resources and evaluate 
prevention program performance, and possibly lead to a better 
understanding of disease transmission dynamics in the broader 
community. 
The extent to which partner services are conducted in 
correctional facilities varies with program resources and 
individual facilities. When public health staff members 
conduct these services in correctional facilities, formal 
collaboration mechanisms between the health department and 
the correctional facility are essential to help coordinate activities 
and ensure that all parties understand what is needed to 
conduct services within the facilities. Following are factors to 
consider when developing partner services programs for 
incarcerated populations. 
Partner Elicitation 
Inmates who receive a diagnosis of HIV infection or another 
STD while incarcerated might not want to identify sex or 
injection-drug partners that reside in the community or the 
facility. Partner services providers should be aware that partners 
might include other inmates, correctional facility staff 
members, or visitors. Reasons for not wanting to identify 
partners might include fears of partnership dissolution, loss 
of privileges within the facility, and concerns about revealing 
possible illegal activities. Before partner services providers ask 
inmates for information about partners, the providers should 
ensure that the inmates understand the confidential and 
voluntary nature of partner services and the limits of 
confidentiality related to disclosing information about sex 
partners who reside within the facility. In all states, sex with 
another inmate or with correctional facility staff members is 
prohibited and might be required to be reported (213). 
Therefore, partner services programs should have a full 
understanding of these laws and regulations as well as of 
individual facility policies before initiating any partner 
services activities. 
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Inmates have a right to privacy and confidentiality of their 
medical information, and DISs have a duty to protect all 
confidential information. However, maintaining the 
confidentiality of inmate health information might be 
challenging in correctional facilities. Partner services programs 
should work with medical staff members within the facilities 
to ensure that procedures are in place to reduce possible 
breaches of confidentiality. Breaches of confidentiality for 
inmates with HIV infection or other STDs might result in 
increased discrimination, stigmatization, and violence. 
Because incarcerated populations often are moved about 
within correctional systems, locating or accessing an index 
patient might be difficult. Partner services providers should work 
with correctional facility staff members to determine how best 
to locate and access inmates. In addition, other challenges might 
arise if a particular inmate has already been released, because 
released inmates are often transient, use aliases, or do not have 
a permanent address. If the inmate has already been released, 
DISs should obtain contact information from the correctional 
system to assist with partner services activities. 
Having a private space to conduct partner elicitation in 
correctional facilities might be a challenge. Correctional health-
care clinics often are busy, and space is not always available. 
In addition, security concerns often require that custodial staff 
members are able to see staff members and inmates at all times 
to ensure safety. Thus, clinic layout and proximity of non– 
health-care staff members can create an impression of lack of 
privacy or confidentiality. Partner services staff members must 
work with correctional facility staff members to identify a 
private area, whether in the clinic or in the housing area, to 
elicit partner names without compromising safety. 
The Prison Rape Elimination Act of 2003 (PREA) (Pub. L. 
108–79, Stat 117.972 4 [September 2003]) might affect the 
delivery of timely partner services. Under PREA, allegations 
of sexual assaults in correctional facilities are to be treated as 
criminal acts and investigated as such. The criminal 
investigation might take precedence over partner services 
activities and might cause partner services and notification to 
be delayed because of pending criminal charges. 
Notifying, Counseling, and Testing 
Partners 
For named partners who are located in the community (i.e., 
not in the correctional facility), the notification process is no 
different than for partners named by persons outside 
correctional facilities. However, legal concerns might exist 
related to named partners who are located within the 
correctional system (e.g., other inmates or correctional facility 
staff members). Knowledge of state laws and possible reporting 
requirements are essential, and partner services staff members 
must be prepared to adhere to these regulations and should 
consult with program managers or legal counsel when 
questions arise regarding specific situation. 
Treatment for Partners 
Ensuring medical care for partners who are inmates is the 
responsibility of the correctional facility. Facilities that release 
inmates before adequate care or treatment can be provided 
should provide referrals before the release. However, when 
program resources are available, partner services staff members 
can provide follow-up for recently released persons to verify 
that they are adequately treated or are linked to care. Correctional 
facilities or the health department also should consider 
partnering with local service providers, including CBOs, that 
provide transitional services. These agencies might be able to 
provide follow-up and possibly HIV case-management services 
especially for those who are HIV infected. 
Recommendations for Incarcerated 
Populations 
• Program managers should become familiar with the 
federal, state, or county jail and correctional facilities in 
their jurisdictions. They should meet with key personnel 
in correctional facilities to discuss the services offered and 
goals of partner services as a public health intervention, 
the need for public health staff members to have access to 
facilities and adequate private space to meet with clients, 
and ways that partner services activities can be integrated 
into the facility response plans that are required by PREA. 
Follow-up meetings to facilitate communications and 
coordination should be held periodically. 
• Program managers and key correctional facility personnel 
should establish a formal written agreement to clearly 
outline roles and responsibilities for both public health 
and correctional facility staff members. 
• Program managers should collaborate with correctional 
facility staff members to develop protocols for partner services 
staff members to follow while in the facility, especially during 
emergencies. Ensuring that partner services staff members 
know and adhere to facility rules and regulations also is 
essential. Not adhering to the rules and regulations of a 
correctional facility will jeopardize implementation and 
continuation of the partner services program. 
• Program managers should collaborate with correctional 
facility staff members to develop protocols regarding 
administration of partner services for named partners 
within a correctional facility. 
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Strategies to Enhance Case Finding 
and Partner Notification 
Core Areas 
A core area is a specific, typically geographically defined 
area, such as a neighborhood or census tract, that has a relatively 
high concentration of STDs and likely accounts for a large 
proportion of disease transmission in a community. Infected 
persons in a core area might not have any social or sexual 
connections; their only relationship might be geographic. An 
example of a core area is a zip code in which >50% of the 
gonorrhea cases in the county are identified. Core areas are 
different from core groups, which are socially defined groups 
of persons who are likely to be a source of continued disease 
transmission (i.e., core transmitters). 
In certain circumstances, programs might maximize resource 
use and prevention effectiveness by concentrating on specific 
core areas. For example, in New York state, targeting 100% of 
provider-referral partner-notification measures for gonorrhea 
in core areas (as defined by endemic prevalence, or census 
tracts containing 50% of reported annual gonorrhea cases) 
was associated with a substantial decline in incidence, even 
compared with a control area in which a larger proportion 
(60%–70%) of gonorrhea-infected persons were actually 
interviewed (7). In Colorado, partner notification services for 
gonorrhea that focused on a military base (the putative core 
area) and the surrounding civilian community produced a 13% 
decrease in overall gonorrhea cases and a 20% decrease in the 
civilian community (214). Military incidence was largely 
unchanged. Similar large-scale measures in the United 
Kingdom (i.e., the Tyneside scheme) have been associated with 
reductions in gonorrhea morbidity (215). Similar data for 
chlamydial infection are lacking, and whether core areas play 
a substantial role in chlamydial infections is uncertain (216). 
In general, syphilis is so geographically concentrated that 
syphilis infection-control measures, by definition, involve a 
core-area approach. 
Recommendation for Core Areas 
• Health departments should assess the geographic 
concentration of gonorrhea and consider focusing provider-
referral partner notification in core areas. 
Social Networks 
A social network is a group of persons connected by various 
types of social relationships, such as family, work, and 
recreational relationships; sexual partnerships; and drug-use 
relationships. A social network also can include the venues in 
which interactions among the members of a social network 
occur. The persons in a social network might share social, 
economic, cultural, or behavioral characteristics that influence 
their risk for various health conditions, including HIV and 
other STDs (217). Consequently, members of the social 
network of a person with HIV infection or other STDs might 
also be at increased risk for these infections, even though they 
might not have a sexual or drug-injection relationship 
specifically with the infected person. By exploring the social, 
sexual, and drug-use connections among persons and places 
and diagramming these links, HIV/STD prevention programs 
might uncover more cases than by relying on partner 
notification and testing alone. This approach also can provide 
helpful information about a disease in a core area by integrating 
epidemiologic, geographic, and sociodemographic 
information. Using social network methods to identify persons 
with HIV infection can help bring previously undiagnosed HIV-
infected persons into the partner services process and might 
also be used to identify persons who previously tested positive 
and left care or never received care. 
A program that uses this approach can track networks at 
several levels, first assessing persons and places and then 
possibly going further to look at geographically defined 
sociodemographic data. Although this approach can seem 
intimidating and labor intensive, DISs often collect much of 
these data during patient interviews and from field records, 
and certain programs use network approaches on a de facto 
basis. Other data can be added as resources permit. An 
established and periodically updated network diagram might 
aid in the investigation of outbreaks as they occur (rather than 
as a retrospective tool to explain why they occurred). Programs 
might also conduct more formal network analyses, which 
involve calculating various statistics that describe characteristics 
of a network (e.g., components, degree, betweenness, 
information centrality, and k-core) (158). However, the 
capacity to perform these analyses is not available in many 
health departments and might not be performed quickly 
enough to affect outbreaks as they occur. Nevertheless, analyses 
of outbreaks and endemicity can reveal details not otherwise 
identified and can therefore inform program needs and future 
actions (218,219). 
Peer referral is one type of social-network approach that has 
been used to identify HIV cases; clients are enlisted as recruiters 
and coached to refer persons from their social networks (peer 
referral) for counseling and testing. Those referred also can be 
enlisted to recruit others, creating a peer-driven cluster 
approach. With the peer-referral approach, virtually all contact 
with program staff members is at the point of care, and 
extensive field work is not needed. The approach can be refined 
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by assessing which persons are more effective at referring 
infected persons or those at high risk for infection and 
concentrating on the persons who are the most effective. In a 
demonstration project conducted in seven U.S. cities, nine 
CBOs enrolled HIV-positive persons and HIV-negative 
persons at high risk for infection to serve as peer recruiters. 
These persons agreed to refer persons in their networks who 
they thought to be at risk for HIV infection for counseling, 
testing, and referral services (220). The 6% prevalence of newly 
identified HIV infection found among social network 
associates tested in this project was five times the average 
prevalence reported by publicly funded HIV counseling and 
testing sites. An evaluation project conducted in King County, 
Washington, enlisted and trained MSM who had received a 
diagnosis of HIV or other STDs to become peer recruiters 
and yielded similar results (221). Of the 438 recruited peers 
who had not previously received a diagnosis of HIV, 22 
received a new diagnosis of HIV, an 8% increase in the health 
department’s total HIV case-finding yield. The approach was 
particularly useful for identifying non-white MSM with HIV 
infection, increasing the health department’s total case-finding 
yield for this group by 19%. This peer-referral approach was a 
more cost-effective strategy for identifying HIV cases among 
MSM in this area than other outreach approaches. (Additional 
information on implementing a social networks strategy for 
HIV case is available at http://www.cdc.gov/hiv/resources/ 
guidelines/snt.) 
Use of a network approach should not replace partner 
notification; instead, the approach should be used to enhance 
existing partner services practices. Initiation of a network 
approach can be labor intensive, and a full-scale network 
approach to describing disease in a given program area requires 
analytic capacity that not all programs possess. Nevertheless, 
basic network data are often already collected by DISs and 
other program staff members, and a program could link these 
data to produce a more complete representation of STDs/ 
HIV than previously possible. 
Additional research on the use of social networks for disease 
prevention is needed. Studies analyzing the use of social 
networks to enhance partner services and assess disease 
transmission for a particular area or population have produced 
encouraging results, but these results might not be 
generalizable. Peer-driven cluster referral has been most 
effective for finding cases of both HIV and HCV. As with 
cluster interviewing and clustering, the effectiveness of the 
approach in detecting cases is affected by the prevalence of 
the disease. For example, in Seattle, where the prevalences of 
gonorrhea and chlamydial infection are relatively low, peer-
driven referral among MSM detected minimal numbers of 
cases of gonorrhea and chlamydial infections (221). The 
approach needs to be tested among groups with higher 
prevalence of bacterial STDs. 
Recommendations for Social Networks 
• Programs should assess the social networks that influence 
disease transmission in the area as a strategy for finding 
persons who are at risk for disease but have not been 
identified by an index patient or partner. 
• This strategy should be used to enhance case finding, 
considering relevant epidemiological and behavioral 
information. 
The Internet 
The Internet is used to facilitate formation of sexual 
partnerships and is a potential contributing factor in situations 
involving high-risk behaviors and transmission of HIV and 
other STDs (222–225). Although most of the published 
research evaluating links between sexual risk behaviors and 
Internet use has focused on MSM, findings from studies of 
heterosexual male and female groups indicate trends that are 
similar to those identified among MSM; seeking sex partners 
online is associated with high-risk behaviors and acquisition 
of HIV and other types of STDs (222,226–230). 
Certain partner services programs have used the Internet 
for partner notification when the only contact information 
available for a partner is an e-mail address or Internet screen 
name. Two studies have documented outcomes for HIV 
Internet partner notification, and the rate of response (i.e., 
number of partners who responded to contact attempts) 
differed substantially between the two studies. Public health 
staff members who conducted a cluster investigation among 
MSM in Minnesota used the Internet to contact 50 persons 
who had been exposed to HIV or other STDs but for whom 
the only available contact information was an e-mail address 
or screen name; responses were received from 30 (60%) (231). 
In Los Angeles, California, an HIV-infected index patient had 
111 sex partners for whom he could provide only an e-mail 
address; of these, 29 (26%) responded to e-mails sent by staff 
members at the Los Angeles County Department of Health 
Services (LACDHS) (232). None of these partners would have 
been notified without Internet partner notification. In a survey 
of 1,848 U.S. MSM recruited by a banner advertisement on 
an MSM-targeted website for meeting sexual partners, 
acceptance of Internet partner notification was high: >92% 
of respondents indicated that they would use Internet partner 
notification in some way (i.e., use the health department to 
notify sex partners via e-mail, notify sex partners themselves 
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via e-mail, or do both) to inform their sex partners if infected 
with an STD in the future (233). 
Available data regarding use of the Internet to notify partners 
exposed to other STDs such as syphilis are sparse but 
encouraging. In 1999, the San Francisco Department of Public 
Health (SFDPH) conducted a case-control study of seven early 
syphilis cases in persons that were associated with an online 
chat room (234). The mean number of partners per index 
patients was 5.9, and the only locating information for the 
sex partners was online screen names. Using the Internet to 
notify the partners of exposure resulted in 42% of the named 
partners being notified and confirmed as having been tested. 
In a review of early syphilis cases among MSM interviewed 
for partner management during January–April 2003, SFDPH 
identified 67 men who reported meeting sex partners through 
the Internet; 14 of these men provided information about 44 
sex partners for whom the only locating information was an 
Internet e-mail address (235). Health department staff 
members were able to locate 15 (34%) of the Internet partners 
and ensure that they were evaluated and treated appropriately. 
In addition, LACDHS reported a case of recently diagnosed 
syphilis in an index patient who reported having met 16 sex 
partners through the Internet during his infectious period 
(232). The patient contacted 13 of these partners via e-mail; 
seven replied and made arrangements for evaluation. Finally, 
the Austin/Travis County Health Department sent e-mail 
messages to sex partners of persons infected with syphilis or 
HIV when e-mail contact was all that was available to DISs 
(236). Fifty percent of partners responded, and 81% of those 
(40% of all partners e-mailed) were evaluated. Thus, although 
response rates and overall proportion of partners evaluated 
were substantially lower than for in-person provider referral 
from the same health department, e-mail provider referral 
resulted in numerous partner notifications and evaluations 
when in-person notification was not possible. 
Internet-based partner notification services are available 
online for several U.S. cities and states (http://www.inspot.org). 
Website users can learn the individual- and community-level 
rationales for partner notification, find locations for testing 
resources, and send a notification card via e-mail (an e-card) 
to each partner exposed to an STD (of any type) through 
sexual contact. E-cards come in several designs and may be 
sent anonymously or with sender information attached; senders 
can tailor personal messages. All cards provide information 
on how to get tested. Both the site and cards provide the basic 
information that should be shared through any other form of 
patient-led referral: 1) that the recipient has been exposed to 
an STD; 2) to seek medical evaluation and where to do so; 
and 3) the importance of seeking medical evaluation. Use of 
Internet-based partner services programs is not necessarily 
restricted to health departments; health departments in areas 
where these services are available on the Internet generally 
facilitate access to them (e.g., by providing an index patient 
access to an on-site computer). The nature of the program 
makes the effectiveness difficult to evaluate, and no 
effectiveness data are available. 
Partner notification programs recognize that the Internet is 
a potential route for partner notification in certain situations 
and the only route in others. Nevertheless, certain programs 
face specific challenges when conducting partner notification 
using the Internet. Certain challenges are structural or 
bureaucratic, such as lack of access to computers in clinics or 
computer firewalls on agency computers meant to bar 
employees from visiting websites with sexual content (237). 
Other challenges include program staff members who need 
training regarding appropriate use of Internet partner 
notification or health department staff members who have 
difficulty reaching index patients’ partners who rarely enter 
chat rooms during typical business hours. 
Compared with in-person notification, e-mail contact 
presents certain unique challenges for DISs. Ensuring that an 
e-mailed notification or a chat request is received only by the 
person for whom it is intended can be difficult. In addition, 
as with letters and telephone messages, confidentiality 
constraints often lead to nonspecific initial contacts; this 
nonspecific contact might increase the likelihood of a recipient 
deleting the notification e-mail or ignoring a chat request, 
especially when the sender is unknown. One study aimed at 
assessing the acceptability of various forms of electronically 
mediated interventions found that only 45% of 4,601 
interviewed persons indicated that they would open an e-mail 
providing information on HIV and other STDs, and even fewer 
(30%) indicated that they would chat about the topic (226). 
Although the study was not directly related to online partner 
notification, the reasons provided by those surveyed are likely 
relevant. A substantial proportion of study respondents indicated 
that they were generally unwilling to open e-mail from unknown 
senders (40%); a smaller proportion (10%) also considered 
health department attempts to reach them through e-mail or 
chat venues to be an invasion of privacy. 
Strategies to increase the likelihood of a response have not 
been formally evaluated. However, e-mails that contain the 
name, occupation, and, particularly, contact numbers of DISs 
provide a channel for communication and might increase the 
likelihood of a response. Similar techniques might be used with 
persons contacted in chat rooms through instant messaging. 
Patient-led Internet-based partner notification mitigates 
certain structural and confidentiality concerns related to 
provider referral, although the approach has some drawbacks. 
First, malicious notification is a concern (i.e., using the 
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notification process inappropriately, such as to frighten a 
partner who has not actually been exposed). However, the 
likelihood might decrease if the website posts injunctions 
against such use and incorporates protection against automated 
programs that attempt to use the site for mass e-mailing. 
Massachusetts offers a verification step that allows the e-mail 
recipient to contact the customer service department of the 
website and confirm the validity of the public health account 
used for partner notification. Second, because Internet-based 
approaches are easy to use and require less time and resources 
than the provider referral approach, DISs might use them 
instead of provider referral; however, verifying that the partner 
has actually been notified is easier with provider referral. 
Recommendations for the Internet 
• When an index patient indicates having Internet partners, 
the DIS should attempt to obtain identifying and locating 
information about the partners (e.g., e-mail addresses, chat 
room handles, and names of chat rooms or websites where 
the partner might be located). 
• Internet partner notification is recommended for partners 
who cannot be contacted by other means or can be more 
efficiently contacted and notified through the Internet. 
This type of notification includes ensuring policies and 
protocols are in place to 1) ensure that confidentiality or 
anonymity of the index patient and partners are 
maintained on the Internet and 2) eliminate structural 
and bureaucratic barriers to staff member use of the 
Internet for partner notification. 
• Partner services programs should collaborate with 
community partners to develop strategies for addressing 
structural challenges to health department–mediated 
Internet partner notification. 
Program Collaboration 
and Service Integration 
HIV and other STDs often occur simultaneously, and many 
populations at risk for these diseases are at risk for other 
infections (e.g., TB and viral hepatitis). Program collaboration 
and service integration is a method of organizing related health 
concerns, activities, and services to maximize the public health 
impact and facilitate comprehensive delivery of services. 
Improving collaboration, coordination, and communication 
can increase program efficiency, reduce duplication of services, 
and result in fewer missed opportunities for providing 
comprehensive prevention services to individual clients. 
Through linkages with other programs, greater flexibility and 
responsiveness to changes in the epidemics of HIV infection 
and other STDs can occur. Finally, by using local information 
from surveillance and essential monitoring and evaluation data 
among multiple programs, prevention services can be more 
comprehensive. 
The extent to which a state or local program can effectively 
coordinate and integrate STD/HIV partner services activities 
could substantially influence the success of the services. Service 
integration might best be achieved through program 
integration; however, program collaboration, if effective, can 
achieve the same goal. At a minimum, addressing all elements 
of partner services, especially for persons with more than one 
STD, requires collaboration among health department units 
responsible for conducting HIV and other STD reporting and 
surveillance, as well as among HIV and STD prevention 
programs (if any of these programs operate separately from one 
another). Ideally, program collaboration and service integration 
includes TB and hepatitis. Regardless of the way a health 
department is organized, the HIV and STD programs should 
be functionally arranged to ensure that the following occur: 
• resources (human and financial) are used efficiently; 
• all persons who receive a diagnosis of HIV or syphilis are 
offered partner services; 
• coinfected index patients are not interviewed separately 
(i.e., by different DISs) for HIV and other STDs; 
• partners of coinfected index patients are not notified of 
exposure to HIV and other STDs separately (i.e., by 
different DISs); 
• partners receive appropriate and comprehensive clinical 
services, including testing for HIV and other STDs, 
treatment or linkage to medical care or HIV case 
management, and prevention counseling; and 
• information needed to conduct and evaluate partner 
services is readily accessible to partner services providers 
and designated evaluators, respectively. 
Barriers to program collaboration and service integration 
exist. Separate funding mechanisms for HIV prevention, HIV 
care, STD services, substance abuse treatment, mental health 
care, hepatitis prevention, and TB prevention and treatment 
can present challenges to service integration. Other challenges 
include ideological differences in approaches to service delivery; 
distrust among the various entities involved; concern about 
loss of program identity; political, legislative, or regulatory 
obstacles; staff member resistance; and lack of staff member 
training. Despite these challenges, the potential benefits of 
program collaboration and service integration are substantial 
enough that program managers should attempt to align partner 
services programs with other health department units and 
service entities. Service alignment can lead to increased 
efficiency in program administration, service delivery, and use 
of resources and to more knowledgeable staff members (i.e., 
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through training), increased flexibility in providing 
interventions for both HIV infection and other STDs, and 
more efficient data collection and analysis. 
Coordination and Collaboration Within 
Health Departments 
The organization of HIV and STD prevention programs 
determine the mechanisms used to ensure a coordinated 
approach to partner services. To facilitate this process within 
HIV and STD programs, including disease reporting, 
surveillance, and other health department units (e.g., TB, 
hepatitis, vaccination, and reproductive health), programs 
might need to develop shared policies, memoranda of 
agreement, shared information systems, shared staffing plans 
and cross-training of staff. For example, staff members who 
conduct surveillance and staff members who conduct partner 
services might each have or develop information important 
to the other person’s function. Having information-sharing 
agreements that encourage timely, accurate, and secure 
exchange of information can ensure early identification of 
potential index patients and more complete surveillance data. 
For STD programs that provide all partner services, defining 
how the STD program and the HIV program coordinate 
services for index patients, partners, social contacts, and 
associates is important. The level of coordination needed with 
other health department programs depends partly on local 
epidemiologic factors and needs of populations at high risk 
for infection. 
Coordination and Collaboration 
Among Jurisdictions 
Secure and confidential sharing of information on patients, 
partners, and other social contacts among jurisdictions 
facilitates disease prevention. Index patients often name 
partners who live in a location other than the state or 
jurisdiction where the diagnosis was made. In addition, a 
person who tests positive for HIV or other STDs might move 
to another state or jurisdiction before the test result can be 
delivered or an interview conducted. Both situations require 
communication of confidential information from one state 
or jurisdiction to another; success depends on the willingness 
of each program manager to take the steps necessary to ensure 
that security and confidentiality standards are upheld and to 
hold others accountable when breaches occur. Trust, mutual 
cooperation, and shared professional ethics are essential. 
Coordination and Collaboration 
with Medical Providers 
Organizations and agencies that are not part of a health 
department but are involved in particular aspects of partner 
services must collaborate to maximize results. HIV partner 
services program managers should work actively with health-
care providers who provide testing for HIV and other STDs, 
HIV care providers and case managers, and other social service 
agencies who provide services to HIV-infected persons to 
identify patients who have not received HIV partner services 
or who need additional services. In addition, educating private 
medical providers about the public health benefits of partner 
services might lead to increased referrals for partner services. 
Following are important topics to consider when conducting 
outreach and education activities with medical providers: 
• the potential benefits of partner services for medical care 
providers and their patients; 
• the role of medical providers in partner services (e.g., 
timely and accurate reporting of HIV/AIDS and other 
STD cases to the health department, encouraging clients 
to use health department partner services, and use of EPT 
and reporting that use); 
• health department goals and principles in the provision 
of partner services; 
• the importance of evaluating and treating partners of 
clients; and 
• the benefits of obtaining assistance from the health 
department (rather than medical care providers attempting 
to notify partners themselves), which include the 
following: 1) trained professionals contact clients and 
discreetly inform partners of risk, 2) client confidentiality 
is maintained, 3) clients can be coached on ways to notify 
partners, 4) patients can be linked to counseling and other 
prevention and social services support not readily available 
from medical providers, and 5) partner services are 
voluntary and free of charge. 
When medical providers want to provide any aspects of 
partner services themselves (e.g., partner elicitation, partner 
notification via dual referral, or EPT), the health department 
should collaborate with them to provide training and support. 
However, evidence suggests such collaboration is rare (238). 
For example, certain providers might be willing and able to 
elicit partner information that can then be provided to the 
health department, but most do not have the time or training 
needed to perform partner notification services for clients. 
These medical providers should be encouraged to use partner 
services provided by local health departments. In addition, 
program managers should consider any applicable legal or 
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regulatory limits on medical care providers being involved in 
partner services. 
Coordination and Collaboration with 
Other Agencies and Organizations 
Many CBOs and other health and human services 
organizations (e.g., community health centers) provide HIV 
prevention services, including HIV counseling and testing, to 
populations that are hard to reach and at high risk for 
transmitting or acquiring HIV. Therefore, CBOs can act as a 
partner services entry point for clients who might not otherwise 
be offered these services, and staff members can promote 
partner services to the communities. CBOs also might be adept 
at gaining trust and establishing rapport with wary, untrusting, 
and fearful clients and their partners. CBO staff members might 
effectively elicit partner information from HIV-infected clients 
and provide counseling and testing to partners who come to 
the CBOs for services. (Additional information is available from 
CDC’s Provisional Procedural Guidance for Community Based 
Organizations [239]). Before partner services program managers 
determine how best to use CBOs in the partner services process, 
they should consider local laws and regulations. In certain 
jurisdictions, health departments and medical providers are the 
only entities with legal authority to notify persons of their 
exposure to HIV and other types of STDs. 
Because many index patients and their partners have multiple 
referral needs that cannot be solely addressed by the health 
department or CBOs, partner services program managers 
should coordinate and collaborate with other service 
organizations. Such needs include violence prevention 
programs, drug treatment programs, mental health agencies, 
reproductive health programs, community health centers, 
parole and probation agencies, faith-based organizations, 
agencies funded by the Ryan White CARE Act, homeless 
shelters, legal services, and homeless support services. 
Collaboration can be used to promote partner services, identify 
referral resources, establish formalized referral mechanisms, 
and minimize duplication of effort in the jurisdiction. 
Communication with Communities 
and Community Planning Groups
 Although data indicate that clients are generally accepting 
of partner services, misperceptions still exist, especially 
regarding concerns about breaches in confidentiality (39). 
Program managers should consider developing educational 
campaigns directed to members of affected communities, 
advocacy groups, and medical care providers to address 
concerns and misperceptions about the partner services process. 
In addition, partner services programs should keep their 
respective HIV community planning groups (CPGs) informed 
of partner services activities and ensure that CPGs have access 
to analyses of current data, including potential implications 
for HIV prevention in the jurisdiction. Given the comorbidity 
of HIV and other STDs, as well as relationships among these 
conditions and various social behavioral risk factors, 
communication also is warranted among health departments, 
CPGs, and CBOs about early syphilis, gonorrhea, and 
chlamydial infection, even if the community groups are 
primarily focused on HIV. 
Recommendations for Program 
Collaboration and Service Integration 
• To the extent possible, partner services program managers 
should ensure that persons receive coordinated HIV and 
STD prevention and related social services, particularly 
when the persons are affected by more than one disease. 
• Partner services program managers should assess and 
eliminate barriers to programmatic collaboration and 
service integration within the jurisdiction so that, at a 
minimum, services are well integrated at the client (i.e., 
service delivery) level. 
• Partner services program managers should ensure that 
shared protocols and policies are developed to help 
coordinate partner services for persons identified through 
HIV or STD clinics or other health department clinics. 
• Partner services program managers should encourage 
private medical care providers to support partner services 
through active communication mechanisms (e.g., by 
visiting key medical providers, making presentations about 
partner services at local and state meetings of providers of 
HIV care, mailing educational brochures, or providing a 
summary of these recommendations). 
• Partner services program managers should establish 
systems of communication and information to ensure 
widespread distribution of these recommendations to 
health department partners, medical providers, and CBOs. 
• HIV program managers should ensure that communica­
tion and information about the partner services recommen­
dations are shared with HIV prevention CPGs. 
• Partner services programs should ensure that clearly 
defined, written protocols and procedures that address 
confidentiality and data security are in place to address 
incoming and outgoing requests for intrastate and 
interstate transmission of information. 
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Program Monitoring, Evaluation, 
and Quality Improvement 
Partner services programs should be monitored to assess 
program performance and identify areas that need 
improvement. Additional information is available from the 
CDC’s Practical Use of Program Evaluation Among Sexually 
Transmitted Disease (STD) Programs and CDC’s Framework 
for Program Evaluation in Public Health (240,241). Specific 
performance measures for CDC-funded HIV and STD 
programs are published in CDC funding opportunity 
announcements. Recommendations in this section are 
intended for assessment of programs and not of individual 
staff members. Program monitoring includes the following: 
• tracking program productivity, including number of 
partners identified, initiated for follow-up, located and 
notified, examined, tested, treated or linked to care 
services, and, for HIV, newly identified as infected; 
• assessing essential steps in the partner services process to 
identify areas in which program performance can be 
improved; 
• gathering information that can be used to guide resource 
allocation and improve accountability to funders and 
stakeholders; 
• identifying demographic, geographic, and behavioral 
characteristics of index patients and partners to improve 
services to clients and better target screening and 
prevention activities to ensure that they are focused on 
subpopulations at most risk; 
• tracking temporal trends in demographic, geographic, and 
behavioral characteristics of index patients and partners 
to identify initial indications of shifts in the epidemic and 
identify potential outbreaks at early stages, when they are 
easier to control; and 
• identifying social, sexual, and drug-using networks that 
might be facilitating transmission in the community so 
that appropriate screening and preventive measures can 
be developed and implemented. 
Monitoring Program Processes 
and Outcomes 
Program monitoring should be designed to address specific 
questions about program performance, both processes and 
outcomes; all data collected should be clearly related to 
answering these questions. Program monitoring data should 
be accessible to and used by program staff members and all 
levels of management to improve program effectiveness and 
efficiency. Program managers should review the data at least 
quarterly, and more frequently (e.g., monthly) for 1) new 
programs; 2) programs that are introducing substantial changes 
in policies, procedures, or program design; and 3) programs 
that have identified potential problems with any of their 
processes or outcomes. 
Essential Questions 
The following four questions and measures that can be used 
to assess them must be addressed by managers of partner 
services programs. These questions were developed by 
identifying the steps involved in conducting partner services 
programs and then identifying essential processes and 
outcomes that can provide measures of program performance 
(Figure 2). 
For curable STDs such as syphilis, chlamydial infection, 
and gonorrhea, the term index case (question number 1) refers 
to individual episodes of infection. If an individual patient 
has recurrent episodes of an infection during the defined time 
period, each episode is counted as a separate index case; an 
index case does not represent an individual person. For 
example, a person who has three reported episodes of 
gonorrhea over a 1-year time period represents three index 
cases during that year. In contrast, once a person is infected 
with HIV, the person remains infected. Therefore, once 
identified as having an index case of HIV infection, the person 
does not count as another index case in the future (i.e., each 
index case of HIV infection represents a unique person). 
Named partners (question number 2) are partners for whom 
the index patient provides sufficient identifying and other 
information that the partner can reasonably be considered 
locatable. Identifying information includes an actual name, 
an alias, a specific e-mail address or chat-room screen name, 
or enough other descriptive information that the person can 
reasonably be considered identifiable. 
1. How completely is the program identifying newly 
reported cases and interviewing patients for partner 
services? 
Assess cases of HIV infection, syphilis, gonorrhea, and 
chlamydial infection separately, for a defined time period [e.g., 
past month, past quarter, or past year]): 
• Number of new cases reported to the health department, 
including cases identified through surveillance activities 
• Of new cases reported to the health department, the 
number and proportion of patients who were eligible for 
partner services (i.e., not deceased or out of jurisdiction 
at the time of report [i.e., index patients]) 
• Of new patients eligible for partner services (i.e., index 
patients), the number and proportion who were 
interviewed to elicit partner information 
Partner notified 
Partner previously HIV 
positive (by record review) 
New patient eligible for partner services (i.e., index patient) 
Patient deceased or out of jurisdiction 
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Index patient reported to partner services program 
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Index patient counseled and interviewed (verified) 
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FIGURE 2. Steps in the process for partner services programs for human immunodeficiency virus (HIV) infection, syphilis, 
gonorrhea, and chlamydial infection 
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2. How effectively is the program identifying partners, 
notifying them of their risk, and examining or testing 
them for infection? 
Assess cases of syphilis, gonorrhea, and chlamydial infection 
separately, for a defined time period [e.g., past month, past 
quarter, or past year]): 
• Number of partners claimed per index patient interviewed 
• Number of named partners elicited per index patient 
interviewed 
• Of named partners elicited, the number and proportion 
initiated (i.e., attempted to notify) 
• Of named partners initiated, the number and proportion 
notified 
• Of named partners initiated, the number and proportion 
examined or tested 
Assess cases of HIV infection for a defined time period [e.g., 
past month, past quarter, or past year]): 
• Number of partners claimed per index patient interviewed 
• Number of named partners elicited per index patient 
interviewed 
• Of named partners elicited who were not found by record 
review to be previously HIV infected, the number and 
proportion initiated 
• Of named partners initiated, the number and proportion 
notified 
• Of named partners initiated, the number and proportion 
tested for HIV 
3. How effectively is the program identifying new cases 
of syphilis, gonorrhea, and chlamydial infection through 
partner services? How effectively is the program treating 
patients through partner services? How effectively is the 
program identifying new cases of HIV infection and 
linking the patients to care services through partner 
services? 
Assess cases of syphilis, gonorrhea, and chlamydial infection 
separately, for a defined time period [e.g., past month, past 
quarter, or past year]): 
• Of partners examined or tested, the number and 
proportion found to be infected 
• Of all named partners, the number and proportion found 
to be infected 
• Of all named partners, the number and proportion treated 
preventively 
• Of all named partners, the number and proportion treated 
for cure (i.e., infected and brought to treatment) 
• Number of partners brought to treatment per index patient 
interviewed 
Assess cases of HIV infection for a defined time period [e.g., 
past month, past quarter, or past year]): 
• Of partners tested, the number and proportion newly 
testing HIV positive 
• Of partners newly testing HIV positive, the number and 
proportion who receive their test results 
• Number of new HIV-positive partners identified per index 
patient interviewed 
• Of all partners newly testing HIV positive, the number 
and proportion linked to medical care services (i.e., 
referred to medical care services and attending first 
appointment) 
• Number of new HIV-positive partners identified and 
linked to medical care services per index patient 
interviewed 
4. Do any of the preceding measures indicate variations 
by index patient age, race/ethnicity, sex, or risk behavior? 
(Demographic and behavioral risk characteristics might not 
be known for partners who are not notified.) 
Additional Assessments 
In addition to addressing the previous four questions, most 
programs benefit from more detailed monitoring. For example, 
by considering how successfully the program is performing 
each step throughout the partner services process, program 
managers can identify specific steps that need improvement 
to enhance overall program performance. Qualitative 
information can be collected to identify factors contributing 
to areas of concern and aid in improvement. Stratifying the 
analysis by demographic and behavioral risk characteristics 
might provide information that allows services to be tailored 
to the needs of particular subpopulations. The timeliness with 
which various steps of the process are completed also can be 
examined. Following is an example: 
• the number of partners preventively treated within 7, 14, 
and 30 calendar days from day of interview of index 
patient per index case of primary and secondary syphilis 
and 
• the number of partners with new syphilis cases brought 
to treatment within 7, 14, and 30 calendar days from day 
of interview of index patient per index case of primary 
and secondary syphilis. 
Following are examples of stepwise process monitoring ques­
tions that programs should address for index patients, based 
on the detailed steps in the partner services process (Figure 2): 
• Among persons with newly reported infection who are 
not deceased or out of jurisdiction, what proportion is 
reported to the partner services program? 
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• Among persons reported to the partner services program, 
what proportion is successfully contacted? 
• Among index patients who are contacted, what proportion 
is interviewed? 
• For index patients who are contacted but decline to be 
interviewed, what reasons do they give for declining? 
• Among index patients who are interviewed, what 
proportion claims any partners and what proportion 
claims no partners? 
• Among index patients who are interviewed, what 
proportion identifies any locatable partners and what 
proportion identifies none? 
• From interviewed index patients, how many total partners 
are claimed and how many locatable partners are 
identified? 
The step process (Figure 2) can be used to create a similar 
series of stepwise questions for locatable partners that are 
identified from index patient interviews, such as, “Among 
identified partners of HIV index patients, how many are 
already known via record review to be HIV infected? Of these, 
what proportion is contacted and provided HIV prevention 
counseling?” 
Another important consideration for program managers is 
how the success of provider referral compares with that of 
self-referral (or third-party referral) for notifying partners of 
their risk. Outcomes for partners designated to be notified 
through self-referral usually are challenging to measure, because 
verifying that the partners have been notified and tested, what 
their test results are, and whether they have been linked to 
medical services, HIV case management, or prevention services 
are difficult. Several strategies have been used in attempts to 
obtain this information, but none have been adequately tested 
for reliability. Examples of such strategies include the following: 
• requesting that, after notification has occurred, the index 
patient ask the partner to contact the DIS to verify that 
the notification has occurred; 
• providing coded referral cards to the index patient, who 
then gives a card to each partner to be turned in when the 
partner arrives for counseling and testing; and 
• requesting that the index patient accompany the partner 
to the counseling and testing site, rather than simply 
referring the partner, which allows the index patient to 
validate that the partner has been notified. 
Finally, similar monitoring can be conducted to assess 
outcomes of clustering and cluster interviewing (e.g., assessing 
the relative number of new cases of syphilis and gonorrhea 
identified or of newly identified HIV-positive partners, social 
contacts, and associates). 
Monitoring Program Objectives 
In addition to monitoring program processes and outcomes, 
program managers should monitor achievement of program 
objectives. Annually, programs should establish clear, specific, 
realistic, time-phased, measurable objectives for each key step 
or process in the program, as well as expected program 
outcomes. Progress toward achieving these objectives should 
be tracked continuously. If progress on one or more processes 
is unsatisfactory, possible reasons should be considered and 
processes modified accordingly. Certain originally established 
objectives might later be determined to be unrealistic and also 
can be modified. 
Monitoring Use of Staff Members 
and Other Resources 
Program managers also should monitor program staff 
members and resource use to identify and quantify activities 
being performed by staff members, the number of staff 
members and amount of time required to perform each activity, 
the types and level of other resources required to implement 
and maintain the program, and the overall cost of the program. 
Using a combination of qualitative and quantitative data, this 
information can be used to adjust use of staff members and 
resources and plan future program activities. 
Program Evaluation
 In general, evaluations require more rigorous design, 
analysis, and interpretation than monitoring and frequently 
require more resources. In certain situations, programs might 
need to consult with experts in evaluation. Following are 
examples of questions that might be addressed through 
evaluation: 
• Compared with other strategies (e.g., outreach counseling 
and testing), how effective are partner services as a case-
finding method? 
• What are the most effective strategies for linking infected 
partners to medical services, HIV case management, and 
other prevention services? 
• Who more effectively elicits information regarding spouses 
and other partners and notifies them of their exposure to 
HIV: health department specialists, clinicians, counseling 
and testing providers, or others? 
• What are the most effective strategies for recruiting persons 
at high risk for infection into counseling and testing and 
ensuring that they receive their results? 
• How cost-effective are partner services compared with 
other strategies for identifying and testing persons at high 
risk for infection? 
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• Do certain staff members seem to provide partner services 
more successfully than others? If so, what are some possible 
explanations? 
• Are partner services more effective with certain subpopu­
lations (e.g., men, women, youths, or racial/ethnic 
minority groups) or behavioral risk groups (e.g., MSM, 
injection-drug users, or heterosexuals at high risk for 
infection) than with others? 
Quality Improvement 
Program managers should implement quality improvement 
systems to help ensure that services are delivered as intended, 
programs are responsive and accountable to the funders and 
consumers of the services, and program performance and 
quality of care are continuously improved. Quality 
improvement activities typically focus on the following areas: 
• awareness of services among all potential consumers and 
easy accessibility to such services; consumers include 
clinicians and counseling and testing providers who are 
diagnosing STD/HIV infections; persons with newly 
diagnosed STD/HIV infections; and persons with a 
previous STD/HIV diagnosis who might not have received 
partner services at the time of diagnosis or might need 
subsequent partner services; 
• appropriateness of services for client needs, including 
availability of services and materials appropriate for the 
culture, language, sex, sexual orientation, age, and 
developmental level of the clients; 
• continuity, availability, and accessibility of referral services 
appropriate for the clients, especially medical evaluation 
and management for persons with a new HIV diagnosis; 
• development, implementation, and accessibility of written 
program guidelines, protocols for provision of services, 
and performance standards; 
• adherence to program guidelines, protocols, and 
performance standards by all program staff members; 
• performance and proficiency (e.g., initial and ongoing 
competence and skill and appropriate training and 
credentialing) of staff members; and 
• supervision and support of staff members, including 
routine, timely feedback and record-keeping procedures 
that support efficiency and ensure client confidentiality 
and data security. 
Various methods can be used to help improve program 
quality, including the following: 
• regular, direct supervisor observation of staff performance 
and demonstration of appropriate skills and behavior; 
• case-management sessions that facilitate discussion of 
specific cases, safety concerns, social network analysis, 
newly developed investigative resources, interviewing and 
investigative techniques and approaches, and program 
expectations; 
• periodic review of training requirements and the 
proportion of staff members who have met all training 
requirements; 
• periodic review to ensure staff members are maintaining 
appropriate credentialing; 
• periodic surveys of potential consumers of partner services 
regarding awareness and accessibility of services; 
• periodic client or consumer satisfaction surveys; 
• regularly scheduled review of written guidelines, protocols, 
and performance standards to ensure they are complete 
and updated; 
• regularly scheduled review of services and materials to 
assess their appropriateness to the cultures, languages, sex, 
sexual orientations, ages, and developmental levels of 
clients served by the program; 
• periodic review of the inventory of referral services to 
ensure that the referral agencies are still available and that 
listed services, contact information, and referral procedures 
are updated; 
• periodic follow-up of a random sample of referrals to assess 
the extent to which client needs were met; 
• periodic review of record-keeping practices to ensure that 
staff members are adhering to procedures required for 
client confidentiality; and 
• periodic review of a random sample of client records to 
assess completeness. 
ecommendations for Program 
onitoring, Evaluation, and Quality 
mprovement 
• Partner services programs should be monitored closely to 
assess program performance and identify areas that need 
improvement. 
• Monitoring should be designed to answer specific 
questions about program performance; all data collected 
should be clearly related to answering these questions. 
• Data should be analyzed and reviewed regularly and used 
to improve program effectiveness and efficiency. 
• At a minimum, the following questions should be 
addressed through monitoring: 
— How completely is the program identifying newly 
reported cases and interviewing patients for partner 
services? 
— How effectively is the program identifying partners, 
notifying them of their risk, and examining or testing 
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— How effectively is the program identifying new cases 
of syphilis, gonorrhea, and chlamydial infection 
through partner services? How effectively is the 
program treating patients through partner services? 
How effectively is the program identifying new cases 
of HIV infection and linking the patients to care 
services through partner services? 
— Do any measures indicate variations by index patient 
age, race/ethnicity, sex, or risk behavior? 
• Programs should establish specific objectives for essential 
steps in the partner services process and continuously track 
progress toward achieving these objectives. 
• All partner services programs should develop and 
implement quality improvement procedures and ensure 
that program staff members receive orientation and 
training on quality improvement. 
• Responsibility for conducting quality improvement 
procedures should be clearly assigned to a specific person 
or persons. 
• Quality improvement activities should be conducted at 
regular, scheduled intervals (e.g., quarterly or more often 
if needed). 
• Program staffing infrastructure should include enough 
staff members who have specific training and expertise in 
technical supervision of partner services activities to 
supervise DISs. Quality improvement and review of 
performance of staff members should be made clear 
priorities for supervisors. 
Support of Staff Members 
Staff Development and Assessment 
Staff assessment and staff development, training, and support 
have an important association: staff members who are not 
adequately prepared for and supported while performing their 
jobs have difficulty performing satisfactorily. Staff development 
and support begins with a clear description of staff roles and 
responsibilities, as well as of the knowledge and skills required 
for the job. This information is used to recruit staff members 
and identify an appropriate training curriculum to follow 
initially and at periodic intervals. In addition, assessment of 
individual strengths and weaknesses of staff members allows 
supervisors to help them design specific training plans for 
building their skills. All staff members conducting partner 
services activities need in-depth training on partner services 
goals and principles, methods of partner services, and any 
specific concerns related to specific infections. Training can 
be obtained through the CDC-supported Prevention Training 
Centers. After the initial training, updates should occur 
periodically; close supervision, observation, and mentoring 
of staff members is critical, especially for those new to the job. 
In addition, staff members should have easy access to all 
materials, tools (e.g., cellular telephones), and resources needed 
to perform the job efficiently and effectively; this is not the 
responsibility of individual staff members. 
Staff assessments should include both qualitative and 
quantitative outcome measures that are constructive and not 
punitive. These types of assessments are more likely to result 
in improvement of staff skills and performance than using a 
single, quantitative outcome measure. For example, the 
number of partners tested per index patient interviewed can 
be used as a single measure of staff proficiency; however, an 
assessment of each essential step in the process (e.g., proportion 
of index patients located and interviewed, number of partners 
elicited per index patient interviewed, proportion of partners 
located and notified, and proportion of located partners 
counseled, examined, and tested), supplemented with 
qualitative information, would provide a better assessment of 
the staff. 
Qualitative assessments can begin with supervisors routinely 
meeting with individual DISs to review the timeliness and 
completeness of specific cases, with a focus on barriers 
encountered in managing the case and strategies for 
overcoming these barriers. These one-on-one meetings provide 
supervisors an opportunity to review the quantitative measures 
of important steps with the staff member, discuss the validity 
of the measures, consider potential factors contributing to the 
performance of the staff member, and discuss strategies for 
improving certain skills. These meetings also provide an 
opportunity to assess staff member awareness of and adherence 
to program guidelines, protocols, and performance standards. 
Routine, periodic supervisor observation of DISs in all 
aspects of activities, with immediate feedback, can be very 
useful. Direct observation can be an important tool in assessing 
whether staff members have the necessary skills and knowledge 
to conduct interviews, provide referrals, and satisfy other client 
needs (242). For example, successful staff-client interactions, 
in which staff members demonstrate sensitivity to and interest 
in the client, as well as adherence to current policies and 
procedures, are essential for effective partner services. 
Observation and feedback should be structured and 
constructive and not punitive. Supervisors should reinforce 
positive performance and provide specific, constructive 
comments regarding areas that need improvement. A 
reasonable initial time frame for supervisor observation of DISs 
is twice monthly for the first 6 months, monthly for the second 
6 months, and quarterly for staff members with more than 1 
year of experience, depending on individual performance. This 
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schedule might need to be modified depending on program 
experience. 
Case conferences also can be very useful for staff support as 
well as for quality improvement. Regularly scheduled group 
DIS meetings allow supervisors to understand the skills and 
areas that need improvement among staff members and provide 
an opportunity for staff members to learn from one another. 
Case conferences are a valuable forum for staff members to 
discuss specific concerns, address difficult situations, and share 
resources. Case conferences also give supervisors an 
opportunity to emphasize that conducting partner services is 
a team effort and that competitive behavior interferes with 
collaboration and sharing of valuable information and 
resources. Frequency of case conferences should be balanced 
with workload, with attempts to conduct such conferences at 
least monthly. Finally, although staff member assessments often 
focus on DISs, ensuring that supervisors and program 
managers themselves are adequately trained, supported, and 
assessed is equally if not more important. 
Staff Safety 
Certain field activities can include unsafe situations for DISs. 
Program managers should develop and maintain detailed 
guidelines for ensuring staff safety. Examples of safety 
procedures that are often used by partner services programs 
include the following: 
• training that includes a common-sense approach to field 
work, such as appropriate dress, including not wearing 
jewelry that appears expensive; locking purses and other 
valuables out of sight; locking car doors and keeping 
windows rolled up; remaining aware of surroundings; and 
relying on instincts; 
• ensuring that program staff members carry photo 
identification when in the field; 
• maintaining an employee file, including name, address, 
physical description, emergency locating information, a 
recent photo of the employee, and a description of the 
employee’s vehicle and vehicle license number, that can 
be shared with authorities in case of emergency; 
• encouraging field workers to work in pairs if needed; 
• providing cellular telephones, pagers, or electronic 
navigation systems and requiring staff members to call in 
when changing plans or when an investigation becomes 
problematic; 
• requiring field staff members to submit a daily route sheet 
of intended stops to the supervisor so that the route can 
be traced if an emergency arises; 
• having immediate supervisors or other experienced staff 
members accompany new field staff members to point 
out community locations that could be risky (e.g., drug 
houses, parks, bars, prostitution stroll areas, or areas 
controlled by gangs) and to model desired behavior; and 
• routinely discussing safety concerns and emerging problem 
areas during staff meetings and daily debriefings. 
The primary way staff members can avoid unsafe situations 
is to have knowledge of the community; consequently, 
spending time establishing personal rapport with members of 
the community is important. This can be accomplished while 
performing health department outreach activities, organizing 
field screenings, and participating with CBOs in outreach 
activities. 
Other safety concerns involve occupational infections in the 
workplace, particularly for programs that use DISs to draw 
blood or collect other specimens in the field. These programs 
should review all relevant state and local health and safety 
codes and local public health protocols to determine required 
training and certification procedures before performing these 
activities. They also must have in place an Occupational 
Infections in the Workplace policy that is at least as restrictive 
as applicable Occupational Safety and Health Administration 
(OSHA) policies in their areas. Policies and procedures should 
specifically address management of occupational exposure to 
HBV, HCV, and HIV, including PEP (243). DISs who might 
be collecting specimens in the field are strongly encouraged 
to receive an orientation to state or local Occupational 
Infections in the Workplace policies and supporting procedural 
manuals. 
Recommendations for Support for Staff 
Members 
• Programs should develop and implement comprehensive 
training plans for partner services staff members at all 
levels, including program managers and supervisors. All 
staff members should receive initial training at the time 
of employment and updates at least annually. Initial 
training for DISs should include the CDC training course 
Introduction to STD Intervention or equivalent, and 
training for managers should include the CDC training 
course Fundamentals of STD Intervention or equivalent 
(course information available at http://www.cdc.gov/std/ 
training/courses.htm). Staff members also should receive 
training in public health laws and regulations relevant to 
partner services. 
• Programs should use a balance of quantitative and 
qualitative methods for assessing the performance of 
individual staff members at all levels (including program 
managers and supervisors) and developing strategies for 
improvement. 
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• Programs should develop and maintain written policies 
and procedures for maximizing safety of staff members, 
including policies and procedures that help staff members 
avoid occupational exposure to infections and procedures 
for addressing any exposure that occurs. Policies and 
procedures should be reviewed and updated at least 
annually. 
• DISs should receive initial and periodic (at least annually) 
training and orientation on policies and procedures related 
to workplace safety and should be required to follow them. 
• At a minimum, local policies and procedures should 
encompass applicable OSHA policies (available at http:// 
www.osha.gov). 
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Appendix A 
Summary of Recommendations for Partner Services Programs 
for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection 
Legal and Ethical Concerns 
• Public health agencies responsible for partner services 
should conduct a thorough review of all laws relevant to 
their provision of these services. This review should serve 
as a basis for developing policies and procedures for partner 
services programs. Program managers should also ensure 
that program staff members understand the implications 
these laws have for conducting partner services. Laws 
relevant to provision of these services include the 
following: 
— the legal authority for the public health agencies for 
partner services; 
— provisions related to privacy and confidentiality (e.g., 
requirements of the Health Insurance Portability and 
Accountability Act [HIPAA]); 
— provisions related to duty or privilege to warn and 
criminal transmission and exposure; 
— the ability of the public health agencies to coordinate 
with other agencies (e.g., law enforcement). 
• Program managers should ensure that their staff members 
understand the legal basis for their work, legal restrictions 
on their practice (e.g., duty or privilege to warn), the extent 
to which they are protected from civil litigation, and how 
to coordinate with law enforcement officials in ways that 
protect the civil and procedural rights of the persons 
involved. 
• To ensure that program staff members invoke their duty 
or privilege to warn appropriately, partner services 
programs should have written policies and procedures to 
guide staff members in handling complex cases. Guidelines 
and protocols should be based on the jurisdiction’s 
statutory and case law and developed in consultation with 
legal counsel. Legal counsel should also be consulted 
regarding specific cases in which duty to warn or privilege 
to warn might apply. 
• Program managers should be aware of the applicable laws 
regarding criminal transmission and exposure in their 
jurisdictions and should coordinate with legal counsel 
regarding specific cases in which allegations of criminal 
transmission or exposure are made. 
Identifying Index Patients 
eneral 
• All persons with newly diagnosed or reported early syphilis 
infection should be offered partner services. All persons 
with newly diagnosed or reported HIV infection should be 
offered HIV partner services at least once, typically at 
diagnosis or as soon as possible after diagnosis. Partner services 
program managers should develop strategies with written 
policies, procedures, and protocols for identifying as many 
persons as possible with newly diagnosed or reported infection 
and ensuring that they are offered services. 
• Resources permitting, all persons with newly diagnosed or 
reported gonorrhea should be offered partner services. 
Programs should consider which resources and services they 
can devote to partner services for chlamydial infection. 
Persons with newly diagnosed or reported chlamydial 
infection should either be offered partner services (e.g., as 
are those with gonorrhea), or programs should plan 
alternative strategies to enable partners to be notified. 
• Partner services programs should use surveillance and 
disease reporting systems to assist with identifying persons 
with newly diagnosed or reported HIV infection, syphilis, 
gonorrhea, or chlamydial infection who are potential 
candidates for partner services. To maximize the number 
of persons offered partner services, health departments 
should strongly consider using individual-level data, but 
only if appropriate security and confidentiality procedures 
are in place (Appendix D). At a minimum, health 
departments should use provider- and aggregate-level data 
from their surveillance systems to help guide partner 
services. 
• Strategies for identifying potential index patients for 
partner services should be carefully monitored and 
evaluated for completeness, timeliness, effectiveness, and 
cost-effectiveness. 
• Partner services programs should establish and adhere to 
strict, jurisdiction-specific guidelines, policies, and 
procedures for information security and confidentiality. 
These should incorporate the guiding principles and 
program standards (Appendix D) and should adhere to 
all applicable laws. They should be applied to all 
individual-level information used by partner services 
G
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programs, including hard-copy case records and electronic-
record systems or data-collection systems. 
• All partner services and surveillance programs that share 
information should meet the minimum security and 
confidentiality standards (Appendix D). 
• Penalties for unauthorized disclosure of information 
should exist for both surveillance and program staff 
members. All staff members should be informed of these 
penalties to ensure that data remain secure and 
confidential. 
• For successful sharing of individual-level information, 
open communication channels between surveillance and 
partner services programs, adequate resources, clear 
quality-assurance standards, community inclusion and 
awareness of the processes, recognition of the rights of 
infected persons, and sensitivity to health-care providers’ 
relationships with their patients are all needed. 
• Jurisdictions that plan to initiate use of disease reporting 
data to prompt partner services should consider 
information flow, develop written protocols, and pilot test 
the proposed system. Protocols should cover practical 
considerations, such as which types of information will 
be shared and who will have access, staffing, security 
measures, and methods for evaluating the system. 
• To ensure that appropriate policies and procedures are 
developed and followed, partner services programs should 
designate an overall responsible party (ORP) who has 
responsibility for the security of the program’s information 
collection and management systems, including processes, 
data, information, software, and hardware. Preferably, a 
single person should serve as the ORP of both the 
surveillance and partner services programs. 
• Partner services programs that involve community-based 
organizations (CBOs) in partner services (e.g., for 
interviewing index patients receiving diagnoses in their 
counseling and testing programs) should assess the CBOs’ 
ability to meet the minimum standards for data security. 
CBOs that cannot meet these minimum standards should 
have limited access to data, although they can still 
participate in partner services. 
HIV Infection 
• HIV partner services programs should collaborate with 
health-care providers who provide HIV screening or 
testing, other HIV counseling and testing providers, HIV 
care providers, and HIV case managers to ensure that their 
clients and patients are offered HIV partner services as 
soon as possible after diagnosis and on an ongoing basis, 
as needed. 
• HIV partner services programs should work with providers 
of anonymous HIV testing services to develop strategies 
for providing partner services to persons who test positive, 
even if the person decides not to enter a confidential 
system. These providers should be trained on how to offer 
partner services and elicit partner information from 
persons with newly diagnosed HIV infection. 
Prioritizing Index Patients 
General 
• Program managers should establish criteria for prioritizing 
index patients to determine which patients will be 
interviewed first. In general, these criteria should include 
behavioral and clinical factors that affect the likelihood 
of additional transmission. Pregnant women should always 
be considered a high priority, regardless of behavioral or 
other clinical factors. 
• Persons with evidence of ongoing risk behaviors for 
transmission (e.g., recurrent sexually transmitted diseases 
[STDs] or being repeatedly named as a partner of other 
infected persons) might be playing an important role in 
transmission in the overall community and should be 
prioritized for partner services. 
Syphilis 
• Many program areas use a reactor grid to assist with 
determining investigative priorities for syphilis reactors. 
The reactor grid is based on age and syphilis serology 
laboratory results (titers). Programs that use a reactor grid 
are strongly encouraged to validate its performance 
annually and during suspected outbreaks. 
Interviewing Index Patients 
General 
• In general, partner names should be elicited (partner 
elicitation) during the original interview. If this is not 
possible, a reinterview should be scheduled. 
• Programs should establish clear policies and procedures 
for the timing of interviews relative to date of diagnosis 
or report. 
• Index patients should be provided information about the 
following: 
— the purpose of partner services; 
— what partner services entail; 
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— benefits and potential risks of partner services for index 
patients and their partners, and steps taken to minimize 
any risks; 
— how and to what extent privacy and confidentiality 
can be protected; 
— the right to decline participation in partner services 
without being denied other services; and
 
— options available for notifying partners.
 
• Program managers should ensure that policies and 
protocols are in place to safeguard the confidentiality of 
information shared with health department staff members 
during the partner notification process. Specifically, staff 
members must be trained to maintain confidentiality in 
both their professional and private lives. Confidentiality is 
particularly salient in rural areas, where a disease 
intervention specialist (DIS) might have substantial contact 
with clients outside of the professional environment (e.g., 
because they are neighbors, parents of children’s classmates, 
or members of the same church) (101). 
• To ensure confidentiality, interviews should not be 
conducted with other persons present, except for quality 
assurance or for interpreting. 
• In general, partner-elicitation interviews should be 
conducted by trained health department specialists. 
However, to expand partner services coverage, health 
departments should consider enlisting other types of 
providers to conduct interviews on their behalf. 
Successfully eliciting information about partners requires 
skilled counseling and interviewing; therefore, all providers 
conducting interviews on behalf of the health department 
should receive appropriate training. The yield of interviews 
conducted by other providers should be carefully 
monitored. 
• In general, interviews should be conducted in person. 
Telephone interviews might be conducted if no reasonable 
alternative exists, with strict safeguards in place to verify 
the identity of the person being spoken with and ensure 
that privacy and confidentiality are protected. 
• Programs should use interview techniques that maximize 
the amount of information gathered in the original 
interview about the index patient’s partners. Policies, 
procedures, and protocols should establish criteria for 
instances in which reinterviews should be done, how soon 
they should be done, and when they are unnecessary. The 
yield of original interviews and reinterviews should be 
monitored closely and policies, procedures, and protocols 
adjusted accordingly. 
• In addition to information about partners, interviewers 
also can elicit information about the index patient’s social 
network, including venues frequented, for use in planning 
additional prevention activities. 
• Policies, procedures, and protocols should address 
circumstances that might require specific consideration 
in interviews with index patients (e.g., age and 
developmental level, literacy, language barriers, hearing 
or visual impairment, alcoholism or abuse of other 
substances, mental health concerns, or potential violence). 
yphilis, Gonorrhea, and Chlamydial 
nfection 
• For early stages of syphilis, policies, procedures, and 
protocols should specify that all index patients receive an 
original interview as close to the time of diagnosis and 
treatment as possible. Every reasonable effort should be 
made to ensure the partner notification process begins on 
the date of the original interview. 
• For cases of gonorrhea and chlamydial infections that 
partner services staff members will follow up, policies, 
procedures, and protocols should specify that all index 
patients receive an original interview as close as possible 
to the time of diagnosis and treatment. Unless the index 
patient has evidence of recent infection, notification 
primarily serves case-finding goals and might be briefly 
delayed, if necessary. 
• For cases of gonorrhea and chlamydial infection that 
partner services staff members will not follow up, patient 
referral instructions should be provided as close as possible 
to the time of diagnosis and treatment. 
• For STDs other than HIV, partner services programs 
should follow established recommendations for interview 
periods (Table 1). 
IV Infection 
• Policies, procedures, and protocols should specify that all 
index patients receive an original interview as soon as 
possible after diagnosis, ideally within a few days. For index 
patients who are not willing or able to provide partner 
information during the original interview, a reinterview 
should be scheduled, preferably no later than 2 weeks after 
contact was first made (and sooner, if possible, for index 
patients with acute infections). 
• Programs should develop criteria for establishing the 
interview period for index patients with HIV infection 
(Table 1). Criteria for prioritizing partners should be 
developed in consultation with persons who have expertise 
in clinical and laboratory aspects of HIV (e.g., viral and 
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• Program managers should ensure that policies and 
procedures regarding notification of spouses adhere to 
requirements of the Ryan White CARE Act Amendments 
of 1996 and any other applicable laws. 
• Policies, procedures, and protocols should address 
interviews for persons with reactive rapid HIV tests, 
including when partner names should be elicited, when 
partners should be notified, and policies about notifying 
partners when a confirmatory test is not available. 
Risk-Reduction Interventions 
for Index Patients 
• Program managers should develop protocols that establish 
the minimum amount of information and prevention 
messages that should be provided to all index patients. 
For patients with HIV infection, the information should 
include the index patients’ responsibility for disclosing 
their HIV serostatus to current and future partners. 
• Program managers should develop protocols for screening 
HIV index patients for current or recent behavioral risks 
and other factors that facilitate transmission. Screening 
should include asking all HIV index patients about 
possible signs or symptoms of other STDs, which enhance 
risk for HIV transmission and indicate current or recent 
risky sex behaviors. 
• Protocols should address management of HIV index 
patients with risky sex or drug-injection behaviors or who 
have signs or symptoms of any type of STD. All index 
patients with ongoing risk behaviors or recurrent STDs 
of any type should be provided prevention counseling or 
referred for counseling or other prevention interventions. 
• Program managers should assess the program’s’ capacity 
for providing prevention counseling to all index patients 
without interfering with partner elicitation. For partner 
services programs that do not have the internal capacity 
to regularly provide prevention counseling to all index 
patients or are limited by resource or logistical factors, 
program managers should establish formal relationships 
with other agencies that can provide prevention counseling 
and more intensive behavioral intervention services and 
develop clear policies and procedures for making and 
following up on referrals. 
• Program managers should develop protocols to ensure that 
DISs conducting prevention counseling receive adequate 
training and supervision and should ensure that quality 
assurance plans are in place. 
Treatment for Index Patients 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
• Program managers should ensure that patients are treated 
according to CDC treatment guidelines for timely and 
efficacious treatment with appropriate instructions and 
attention to recommendations regarding the importance 
of follow-up testing. 
HIV Infection 
• Program managers should create strong referral linkages 
with HIV care providers and case managers to help ensure 
that the medical needs of index patients are addressed. 
• HIV-infected index patients who are not receiving medical 
care should be referred or directly linked to medical care 
or to case managers who can then link them to care 
services. 
Referring Index Patients 
to Other Services 
• Because of the diverse needs of many index patients with 
HIV infection and other STDs, program managers should 
identify resources for psychosocial and other support 
services. DISs routinely should be provided updated 
information about referral resources. 
• Many referral needs can be addressed through linkage to 
medical care and HIV case management; however, DISs 
should screen for immediate needs and make appropriate 
referrals. 
Notifying Partners of Exposure 
Partners 
• All identified partners should be notified of their possible 
exposure as soon as possible, typically within 2–3 working 
days of identification, unless a potential for partner 
violence exists. 
• Program managers should ensure that protocols include 
screening for potential violence with each partner named 
before notification. If the provider considers a violent 
situation possible, the provider should seek expert advice 
before proceeding with notification. DISs should follow 
up on referrals for partner violence services to verify that 
referred persons are safe and have accessed these services. 
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• Programs should establish criteria for prioritizing the order 
in which partners are notified. Criteria should be based 
on behavioral and clinical factors that confer a higher 
likelihood of the partner having been infected as a result 
of exposure or, if already infected, of transmitting infection 
to others. In addition, the Ryan White CARE Act 
Amendments of 1996 require that states receiving funds 
under part B of title XXVI of the Public Health Service 
Act should ensure that a good-faith effort is made to 
identify spouses of HIV-infected patients. Criteria should 
be reviewed at regular intervals (at least annually). 
• Programs should accommodate various notification 
strategies that allow the DIS and index patient to 
collaborate on the best approach for notifying each partner 
of exposure and ensure that the partner receives 
appropriate counseling and testing. Regardless of which 
strategy is used, the DIS and index patient should plan 
for potential unanticipated outcomes. 
• For partners for whom the index patient has provided a 
name (or other identifying information, such as an alias) 
and locating information, programs should strongly 
encourage provider referral but be supportive of index 
patients who choose contract referral for selected partners. 
• When contract referral is chosen, the DIS should establish 
an agreement with the index patient specifying when 
partners should be notified (typically within 24–48 hours), 
how the provider will confirm that partners were notified, 
and which follow-up services will be required for situations 
in which the index patient does not notify the partner 
within the allotted time frame. 
• Programs should allow for self-referral as permitted by 
state and local laws and regulations. Index patients who 
choose self-referral for certain or all partners should be 
informed of its disadvantages and informed about methods 
for accomplishing the notification safely and successfully. 
Self-referral should be discouraged if screening indicates 
a potentially violent situation. 
• Protocols for self-referral should, when possible, 
incorporate interventions that enhance its effectiveness 
and include instructing the index patient about the 
following: 
— when to notify the partner (e.g., within 24–48 hours); 
— where to notify the partner (e.g., private and safe 
setting); 
— how to tell the partner; 
— how to anticipate potential problems and respond to 
the partner’s reactions; 
— how and where the partner can access counseling and 
testing for HIV and other types of STDs; 
— for persons with HIV infection, how to address the 
psychological and social impact of disclosing infection 
status to others; and 
— how to contact the DIS with any questions or concerns 
that might arise. 
• To the extent possible, programs should develop methods of 
monitoring whether partners who are to be notified by the 
index patient (i.e., via contract or self-referral) are actually 
notified and receive appropriate counseling and testing. 
• Dual referral should be an option for index patients who 
prefer to be directly involved in the notification but express 
a need for assistance and support from the DIS. When 
dual referral is chosen, the DIS and index patient should 
plan in advance how the session will be conducted. 
• Program managers should ensure that policies and 
procedures, consistent with applicable laws, are in place 
to protect the identities of index patients when informing 
partners of their exposure and to ensure that information 
about partners is not reported back to index patients. 
• Local reporting laws relating to domestic violence, 
including child abuse and abuse of older adults, must be 
followed when clients report risk or history of abuse. 
• Program managers should ensure that DISs are the 
following: 
— knowledgeable about HIV and STD infections, 
transmission, and prevention; 
— well informed about relevant laws and regulations; 
— familiar with HIV and STD program standards, 
objectives, and performance guidelines; 
— culturally competent in providing partner services; 
— skilled at problem solving and dealing with situations 
that might be encountered in the field (e.g., personal 
safety, intimate partner violence, violence to others); and 




• In general, notification of partners should have a higher 
priority than notification of individual social contacts 
identified through clustering. Routine follow-up of social 
contacts should be carried out only after the program is 
successfully interviewing most new patients with cases and 
locating and notifying most partners and only after 
carefully considering the potential case-finding yield and 
resource implications. If this strategy is used, the number 
of cases identified should be carefully monitored, and the 
approach should be continued only if its effectiveness and 
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cost-effectiveness equal or exceed those of other case-
finding strategies. Notification of social contacts might 
be given higher priority during an outbreak. 
HIV Infection 
• For persons with HIV infection, information about social 
contacts should be used as an aid to understanding 
transmission dynamics in the community and to help 
guide additional prevention interventions at the 
community level (e.g., screening and social marketing). 
In general, if individual social contacts are to be recruited 
for HIV testing, a self-referral approach rather than 
provider referral should be used. A provider referral 
approach should be used only after careful consideration 
of potential individual and community concerns about 
privacy and confidentiality. Provider referral might be 
appropriate during an outbreak. 
Risk-Reduction Interventions 
for Partners 
• Program managers should develop protocols that describe 
the minimum amount of general information and 
prevention messages that should be provided to all partners 
at the time of notification. 
• All partners of STD/HIV-infected index patients should 
receive prevention counseling. 
• Because a substantial proportion of partners decline to or 
do not keep appointments for counseling and testing, 
prevention counseling should be provided by the DIS at 
the time of notification. 
• Prevention counseling should be based on counseling 
models that have demonstrated efficacy (e.g., the Project 
RESPECT model). 
• Program managers should develop protocols for screening 
partners to determine whether they need additional risk-
reduction interventions and refer them for such 
interventions. 
• Program managers should develop protocols to ensure that 
DISs conducting prevention counseling receive adequate 
training and supervision and ensure that quality 
improvement plans are in place. 
Cluster Interviewing Partners 
General 
• When notifying partners of their possible exposure, DISs 
might also elicit information about the partners’ social 
networks, including venues frequented, for use in planning 
additional prevention activities. 
• In general, notification of partners should be prioritized 
over follow-up of individual associates identified through 
cluster interviews. Routine follow-up of associates should 
be done only after the program is successfully interviewing 
most new patients with cases and locating and notifying 
most partners, and only after carefully considering the 
potential case-finding yield and resource implications. If 
this strategy is used, its case-finding yield should be 
carefully monitored, and the strategy should be continued 
only if its effectiveness and cost-effectiveness equal or 
exceed those of other case-finding strategies. Follow-up 
of associates might be given higher priority during an 
outbreak. 
HIV Infection 
• For persons with HIV infection, information about 
associates should be used as an aid to understanding 
transmission dynamics in the community and to help 
guide additional prevention interventions at the 
community level (e.g., screening and social marketing). 
In general, if individual associates are to be recruited for 
HIV testing, a self-referral approach rather than provider 
referral should be used. A provider referral approach 
should be used only after careful consideration of potential 
individual and community concerns about privacy and 
confidentiality. A provider referral approach might be 
appropriate during an outbreak. 
Testing Partners 
General 
• To the extent possible, testing for HIV and other types of 
STDs should be done at the time of notification. Partners 
who are not tested at the time of notification should be 
escorted or referred to the health department for testing 
or linked to other health-care providers who can provide 
these services. 
• DISs should follow up on partners not tested at the time 
of notification to verify that testing has occurred, test 
results were received and understood, and other referral 
services were accessed. If another health jurisdiction has 
been asked to contact a partner, follow up should be 
conducted by the initiating health department to 
determine whether services have been received. 
• Program managers should explore ways in which screening 
for HIV, screening and treatment for other types of STDs, 
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screening for hepatitis B and hepatitis C viruses, and 
vaccination for hepatitis A and hepatitis B viruses might 
be integrated in partner services programs. 
Syphilis 
• Blood should be drawn in the field when DISs are trained 
to do so and when specimen maintenance conditions can 
be met. Partners should be referred for evaluation 
regardless of whether a specimen has been collected. 
Gonorrhea and Chlamydial Infection 
• If provider referral is used, programs should consider 
protocols for collecting specimens in the field. 
HIV Infection 
• Partner services programs should consider using rapid HIV 
tests to maximize the number of partners who are tested 
and receive test results. 
• When notification is done in the field, rapid tests should 
be used or a blood or an oral fluid specimen should be 
collected for conventional testing. If neither of these is 
possible, the partner should be escorted or referred to the 
clinic for testing. 
• Partners who test negative for HIV antibody should be 
advised to be retested in 3 months. 
Treatment for Partners 
Syphilis, Gonorrhea, and Chlamydial 
Infection 
• Program managers should ensure that partners are treated 
according to CDC treatment guidelines as soon as possible 
after notification. 
• Programs should consider field-delivered therapy for 
gonorrhea and chlamydial infection when partners are 
notified via provider referral. 
• For STDs for which single-dose oral therapy is feasible 
(i.e., gonorrhea and chlamydial infection), programs 
should consider patient-delivered partner therapy for 
partners who will not be notified via provider referral. 
• Programs should be sure that all appropriate parties are 
consulted to ensure that any EPT strategy in the 
jurisdiction is medically and legally sound. Appropriate 
parties vary by jurisdiction but might include state health 
commissioners or legislative bodies. 
HIV Infection 
• Program managers should create strong referral linkages 
with HIV care providers and case managers to help ensure 
that the medical needs of HIV-infected partners are 
addressed. 
• Partners who test positive for HIV should be linked as 
soon as possible to early intervention services, medical 
care, and HIV case management, through which they can 
receive complete medical evaluations and treatment, 
assessment, referral for psychosocial needs, and additional 
prevention counseling. 
• Follow-up should be conducted to verify that HIV-
infected partners have accessed medical care or HIV case 
management at least once. 
• Partner services programs implementing postexposure 
prophylaxis (PEP) should develop protocols to ensure that 
persons exposed to HIV within the previous 72 hours are 
informed of the option of PEP, including risks and benefits 
as they relate to the exposure risk. Staff members 
conducting partner services should be aware of the options 
for persons to access PEP, whether through existing 
programs, urgent care facilities, emergency departments, 
or private physicians. 
Referring Partners to Other Services 
• Because of the diverse needs of partners, program managers 
should identify referral resources for psychosocial and 
other support services. DISs routinely should be provided 
updated information about referral resources. 
• Many referral needs of partners testing positive for HIV 
will be addressed through linkage to early intervention, 
medical care, and HIV case management; however, DISs 
should screen for immediate needs and make appropriate 
referrals. 
• Partners testing negative for HIV should be screened and 




• Programs should have specific protocols in place to guide 
partner services for youths. Protocols should address 
assessment of maturity and extent of social support, use 
of age-appropriate counseling and communication 
models, provision of services in youth-friendly 
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environments, and assessment for physical and sexual 
abuse. These protocols should be developed in 
collaboration with legal counsel to ensure that they are 
consistent with all applicable laws and regulations. 
• Program managers should ensure that all staff members 
are aware of state and local requirements related to 
reporting of suspected sexual activity involving an adult 
and a minor child, child abuse, and sexual crimes. DISs 
providing services to youths should be sure to discuss the 
possibility of sexual abuse with their clients and, if sexual 
abuse is suspected, should notify the appropriate 
authorities (e.g., child protective services agency) in 
accordance with applicable laws and regulations. 
• Program managers should ensure that partner services staff 
members remain knowledgeable and updated on state and 
local laws and regulations related to parental consent, 
diagnosis and treatment of STDs, and HIV counseling 
and testing. If doubt or confusion arises regarding a specific 
case, legal counsel should be sought. 
• Program managers should ensure that any staff person 
who conducts elicitation of partner names and notification 
of partners for youths has received training on conducting 
services in a way that is appropriate for each child’s age 
and developmental level. Training should include ways to 
recognize and address child abuse or sexual abuse 
situations. 
Immigrants and Migrants 
• Program managers should review epidemiologic and other 
data to identify potential immigrant and migrant 
populations at high risk for infection in their jurisdictions 
and be prepared to provide partner services that are 
linguistically and culturally appropriate. 
• Based on the immigrant and migrant needs identified in 
the community, program managers should develop 
partnerships with community-based organizations and 
health-care providers that can deliver linguistically and 
culturally appropriate care, treatment, prevention, and 
support services. 
• Program managers should consider the diversity training 
needs of DISs who are working with the immigrant and 
migrant populations. In particular, staff members 
conducting interviews should be sensitive to cultural 
norms governing the discussion of sex and sexual 
behaviors. To the extent possible, clients who have limited 
ability to speak English should be interviewed in their 
native language. 
• Programs should consider the literacy level of their clients 
as well as the primary (or only) language of the clients. 
Programs should ensure that HIV and STD prevention 
educational materials are available in appropriate languages 
that reflect the cultural norms of the population. 
• Because of the geographic mobility of immigrants and 
migrants, program managers should consider use of rapid 
HIV tests and active outreach strategies for migrant and 
seasonal workers in nontraditional settings. 
• Health jurisdictions should consider developing 
collaborative agreements with bordering countries (i.e., 
Canada and Mexico) to assist with notification and follow-
up of partners. 
• Program managers should be aware of federal, state, and 
local laws and regulations that might affect partner services 
for undocumented immigrants. 
Incarcerated Populations 
• Program managers should become familiar with the 
federal, state, or county jail and correctional facilities in 
their jurisdictions. They should meet with key personnel 
in correctional facilities to discuss the services offered and 
goals of partner services as a public health intervention, 
the need for public health staff members to have access to 
facilities and adequate private space to meet with clients, 
and ways that partner services activities can be integrated 
into the facility response plans that are required by PREA. 
Follow-up meetings to facilitate communications and 
coordination should be held periodically. 
• Program managers and key correctional facility personnel 
should establish a formal written agreement to clearly 
outline roles and responsibilities for both public health 
and correctional facility staff members. 
• Program managers should collaborate with correctional 
facility staff members to develop protocols for partner 
services staff members to follow while in the facility, 
especially during emergencies. Ensuring that partner 
services staff members know and adhere to facility rules 
and regulations also is essential. Not adhering to the rules 
and regulations of a correctional facility will jeopardize 
implementation and continuation of the partner services 
program. 
• Program managers should collaborate with correctional 
facility staff members to develop protocols regarding 
administration of partner services for named partners 
within a correctional facility. 
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Strategies to Enhance Case Finding 
and Partner Notification 
Core Areas 
• Health departments should assess the geographic 
concentration of gonorrhea and consider focusing 
provider-referral partner notification in core areas. 
Social Networks 
• Programs should assess the social networks that influence 
disease transmission in the area as a strategy for finding 
persons who are at risk for disease but have not been 
identified by an index patient or partner. 
• This strategy should be used to enhance case finding, 
considering relevant epidemiological and behavioral 
information. 
The Internet 
• When an index patient indicates having Internet partners, 
the DIS should attempt to obtain identifying and locating 
information about the partners (e.g., e-mail addresses, chat 
room handles, and names of chat rooms or websites where 
the partner might be located). 
• Internet partner notification is recommended for partners 
who cannot be contacted by other means or can be more 
efficiently contacted and notified through the Internet. 
This type of notification includes ensuring policies and 
protocols are in place to 1) ensure that confidentiality or 
anonymity of the index patient and partners are 
maintained on the Internet and 2) eliminate structural 
and bureaucratic barriers to staff member use of the 
Internet for partner notification. 
• Partner services programs should collaborate with 
community partners to develop strategies for addressing 
structural challenges to health department–mediated 
Internet partner notification. 
Program Collaboration 
and Service Integration 
• To the extent possible, partner services program managers 
should ensure that persons receive coordinated HIV and 
STD prevention and related social services, particularly 
when the persons are affected by more than one disease. 
• Partner services program managers should assess and 
eliminate barriers to programmatic collaboration and 
service integration within the jurisdiction so that, at a 
minimum, services are well integrated at the client (i.e., 
service delivery) level. 
• Partner services program managers should ensure that 
shared protocols and policies are developed to help 
coordinate partner services for persons identified through 
HIV or STD clinics or other health department clinics. 
• Partner services program managers should encourage 
private medical care providers to support partner services 
through active communication mechanisms (e.g., by 
visiting key medical providers, making presentations about 
partner services at local and state meetings of providers of 
HIV care, mailing educational brochures, or providing a 
summary of these recommendations). 
• Partner services program managers should establish 
systems of communication and information to ensure 
widespread distribution of these recommendations to 
health department partners, medical providers, and CBOs. 
• HIV program managers should ensure that 
communication and information about the partner 
services recommendations are shared with HIV prevention 
community planning groups. 
• Partner services programs should ensure that clearly 
defined, written protocols and procedures that address 
confidentiality and data security are in place to address 
incoming and outgoing requests for intrastate and 





• Partner services programs should be monitored closely to 
assess program performance and identify areas that need 
improvement. 
• Monitoring should be designed to answer specific 
questions about program performance; all data collected 
should be clearly related to answering these questions. 
• Data should be analyzed and reviewed regularly and used 
to improve program effectiveness and efficiency. 
• At a minimum, the following questions should be 
addressed through monitoring: 
— How completely is the program identifying newly 
reported cases and intervewing patients for partner 
services? 
— How effectively is the program identifying partners, 
notifying them of their risk, and examining or testing 
them for infection? 
— How effectively is the program identifying new cases 
of syphilis, gonorrhea, and chlamydial infection 
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through partner services? How effectively is the 
program treating patients through partner services? 
How effectively is the program identifying new cases 
of HIV infection and linking patients to care services 
through partner services? 
— Do any measures indicate variations by index patient 
age, race/ethnicity, sex, or risk behavior? 
• Programs should establish specific objectives for essential 
steps in the partner services process and continuously track 
progress toward achieving these objectives. 
• All partner services programs should develop and 
implement quality improvement procedures and ensure 
that program staff members receive orientation and 
training on quality improvement. 
• Responsibility for conducting quality improvement 
procedures should be clearly assigned to a specific person 
or persons. 
• Quality improvement activities should be conducted at 
regular, scheduled intervals (e.g., quarterly or more often 
if needed). 
• Program staffing infrastructure should include enough 
staff members who have specific training and expertise in 
technical supervision of partner services activities to 
supervise DISs. Quality improvement and review of 
performance of staff members should be made clear 
priorities for supervisors. 
Support of Staff Members 
• Programs should develop and implement comprehensive 
training plans for partner services staff members at all 
levels, including program managers and supervisors. All 
staff members should receive initial training at the time 
of employment and updates at least annually. Initial 
training for DISs should include the CDC training course 
Introduction to STD Intervention or equivalent, and 
training for managers should include the CDC training 
course Fundamentals of STD Intervention or equivalent 
(course information available at http://www.cdc.gov/std/ 
training/courses.htm). Staff members also should receive 
training in public health laws and regulations relevant to 
partner services. 
• Programs should use a balance of quantitative and 
qualitative methods for assessing the performance of 
individual staff members at all levels (including program 
managers and supervisors) and developing strategies for 
improvement. 
• Programs should develop and maintain written policies 
and procedures for maximizing safety of staff members, 
including policies and procedures that help staff members 
avoid occupational exposure to infections and procedures 
for addressing any exposure that occurs. Policies and 
procedures should be reviewed and updated at least 
annually. 
• DISs should receive initial and periodic (at least annually) 
training and orientation on policies and procedures related 
to workplace safety and should be required to follow them. 
• At a minimum, local policies and procedures should 
encompass applicable policies of the Occupational Safety and 
Health Administration (available at http://www.osha.gov). 
 





Associate. A person, named by another person who is not 
infected with the disease in question, as someone who might 
benefit from counseling, examination, or testing for human 
immunodeficiency virus (HIV) infection or other sexually 
transmitted diseases (STDs). Typically, associates are persons 
named by noninfected partners of index patients, but they 
also might be named by social contacts or other associates. 
Associates might include persons with symptoms suggestive 
of disease, partners of other persons known to be infected, or 
others who might benefit from examination. 
Client. Any person served by a health department or other 
health or social services provider. 
Client referral. See self-referral. 
Cluster interview. An interview with a noninfected partner 
(or social contact or associate), conducted to elicit information 
about persons within the social network (e.g., associates) who 
might benefit from counseling, examination, or testing for 
HIV and other STDs. Such persons might include persons 
with symptoms suggestive of disease, partners of other persons 
known to be infected, or others who might benefit from 
examination. 
Clustering. The process of eliciting information from index 
patients about persons in their social networks, other than 
partners, who might benefit from counseling, examination, 
or testing for STDs/HIV. These persons are referred to as social 
contacts (or suspects, in traditional STD program terminology) 
and might include persons with symptoms suggestive of 
disease, partners of other persons known to be infected, or 
others who might benefit from examination. 
Comprehensive risk counseling and services (CRCS). An 
intensive, client-centered counseling process aimed at ensuring 
the adoption and maintenance of HIV risk-reduction behaviors 
designed for HIV-infected persons who continue demonstrating 
risk behaviors and for HIV-negative persons who are at high 
risk for acquiring HIV infection and other types of STDs. 
Confidentiality. The ethical principle associated with the 
health profession (or the legal right of a client receiving health-
care services) in which health professionals do not disclose 
information relating to a patient unless the patient gives 
consent permitting disclosure or disclosure is necessary to 
protect public health. 
Contract referral. A partner notification strategy in which 
an index patient identifies a specific partner to notify the 
partner of possible exposure and agrees to do so within a 
specific time frame, with the understanding that if notification 
does not occur within the designated time frame, the disease 
intervention specialist (DIS) will notify the partner. 
Core area. A specific, typically geographically defined area, 
such as a neighborhood or census tract, in which a relatively 
high concentration of disease exists and which likely accounts 
for a large proportion of transmission in a community. 
Core groups. Socially defined groups of persons who, as a 
consequence of continuing risky sexual or drug-injecting 
behavior, are likely to be sources of continued disease 
transmission in a network or community (i.e., are core 
transmitters). 
Core transmitter. A person who, as a consequence of 
continuing risky sexual or drug-injecting behavior, is likely to 
be a source of continued disease transmission in a network or 
community. 
Disease intervention. The process of stopping the spread of 
a disease and the complications of disease. 
Disease intervention specialist (DIS). A health department 
staff member who is specially trained to interview persons 
infected with HIV or another STD (i.e., index patients); elicit 
information about their partners and associates; notify the 
partners of their possible exposure; ensure that the partners 
are offered appropriate services, including examination, 
treatment, and referrals; and provide prevention counseling 
to index patients, partners, social contacts, and associates. 
Drug-injection partner. A person with whom a patient shares 
drug-injection equipment (e.g., needles, syringes, cottons, 
cookers, or rinse water). These persons have been traditionally 
referred to as needle-sharing partners or syringe-sharing 
partners. 
Dual referral. A notification strategy in which an index patient, 
together with a health-care provider (typically a disease 
intervention specialist) notifies a partner of the partner’s possible 
exposure. The strategy allows the provider to provide direct 
support to the index patient during the notification process 
and provide the partner with immediate access to counseling, 
testing, and other information resources (e.g., referrals). 
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Duty to warn. A legal concept that a health-care provider 
who learns that an HIV-infected client is likely to transmit 
the virus to another identifiable person must take steps to 
warn that person. State laws determine which circumstances 
constitute a duty to warn. 
Early syphilis. Primary, secondary, and early latent syphilis. 
Expedited partner therapy (EPT). The process by which 
treatment for partners of persons diagnosed with gonorrhea 
or chlamydial infection is administered before clinical 
evaluation. Medications or prescriptions are delivered 
through either 1) the index patient (i.e., patient-delivered 
partner therapy) or 2) a disease intervention specialist (i.e., 
field-delivered therapy). 
HIV prevention community planning group (CPG). A 
planning group consisting of local health officials, 
representatives from affected communities, and technical 
experts who share responsibility for developing a 
comprehensive HIV prevention plan for their community. The 
intent of the process is to increase meaningful community 
involvement in prevention planning, to improve the scientific 
basis of program decisions, and to target resources to those 
communities at highest risk for HIV transmission and 
acquisition. 
HIV prevention counseling. An interactive process between 
client and counselor aimed at reducing risky sex and drug-
injection behaviors related to HIV acquisition or transmission. 
Index case. The first case recognized or reported during an 
outbreak or epidemic. In epidemiology, the term case generally 
refers to an episode of infection or disease, not to a unique 
person. An index case is not necessarily the source of an 
outbreak or epidemic; it is simply the first case identified. In 
the context of HIV/STD partner services, an index case is a 
newly reported case that prompts the initiation of an 
investigation to identify other possibly related cases. For curable 
STDs, the term index case refers to discrete episodes of 
infection. A person who has recurrent episodes of a curable 
STD during a defined time period is counted as a separate 
index case for each episode. For example, a person who has 
three reported episodes of gonorrhea during 1 year would 
represent three index cases during that year. In contrast, once 
a person is infected with HIV, the person remains infected; 
therefore, once a person with HIV infection is identified, the 
person will not be counted as an index case again in the future. 
Index patient. The person in whom an index case occurs and 
who prompts the initiation of an investigation to identify other 
possibly related cases. Index patients also are sometimes referred 
to as “original patients” (i.e., the original patient identified in 
an investigation, not necessarily the original patient in a chain 
of transmission). 
Indicator. A measure used to determine an organization’s 
performance of a particular element of care over time. The 
indicator might measure a particular function, process, or 
outcome 
Interview period. The period of time for which an index patient 
is asked to recall sex or drug-injection partners. Because of 
differences in biological factors and progression of various 
diseases, the recommended interview period varies by disease. 
Ongoing partner services. The concept that partner services 
should be available to persons with HIV infection at any time 
needed throughout the course of their life. 
Original interview. The first interview conducted with an 
infected patient. The primary purpose of the original interview 
is to gather information from index patients about partners 
they have had during the relevant interview period. 
Original patient. See index patient. 
Outcomes. Benefits or other results (positive or negative) for 
clients that might occur during or after their participation in 
a program. Outcomes can be client level or system level. 
Overall responsible party (ORP). The person who accepts 
overall responsibility for implementing and enforcing HIV/ 
AIDS and STD data security standards and who might be 
liable for any breaches of confidentiality. 
Partner. For persons with syphilis, gonorrhea, or chlamydial 
infection: refers to sex partners (i.e., persons with whom an 
index patient has had sex at least once, not just regular or 
main partners); for persons with HIV infection: refers to sex 
and drug-injection partners (i.e., persons with whom an index 
patient has had sex or shared drug-injection equipment at least 
once, not just regular or main partners). 
Partner elicitation. The process of obtaining the names, 
descriptions, and locating information of persons who are 
partners (or social contacts) of an index patient. Partner 
elicitation is one step in the process of partner referral 
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Partner notification. The process of locating and 
confidentially notifying partners that they have been exposed 
to an infection. Partner notification is one step in the process 
of partner referral. 
Partner referral. The process in which partner names are 
elicited (i.e., partner elicitation), partners are located and 
notified of their exposure (i.e., partner notification), and 
notified partners receive a combination of counseling and 
referrals for testing (or in some cases, testing in the field) and 
other social support services. 
Partner services. A broad array of services that should be 
offered to persons with HIV infection, syphilis, gonorrhea, or 
chlamydial infection and their partners. Identifying partners 
and notifying them of their exposure (i.e., partner notification) 
are two critical elements of these services. Other elements 
include prevention counseling, testing for HIV and other types 
of STDs, linkage to medical evaluation and treatment, and 
linkage or referral to other services, such as reproductive health, 
prenatal care, substance abuse treatment, social support, 
housing, legal services and mental health services. 
Patient. A client who is diagnosed with HIV infection or 
another STD. 
Patient referral. See self-referral. 
Performance measure. A quantitative tool that provides an 
indication of an organization’s performance in relation to a 
specified process or outcome. 
Personal identifier. A datum or collection of data that allows 
the identity of a single person to be determined with a specified 
degree of certainty. 
Postexposure prophylaxis (PEP). Administration of 
antiretroviral drugs to HIV-negative persons who have been 
exposed to HIV in an effort to prevent establishment of 
infection. The treatment is initiated within 72 hours of 
exposure and generally continues over the course of a 28-day 
period. 
Prevention counseling. An interactive process between client 
and counselor aimed at reducing risky sex and drug-injection 
behaviors related to acquisition or transmission of HIV and 
other types of STDs. 
Prison Rape Elimination Act of 2003 (PREA). A public 
law that provides for analysis of the incidence and effects of 
prison rape in federal, state, and local institutions and for 
information, resources, recommendations, and funding to 
protect persons in prison from rape. 
Privilege to warn. The legal concept that a health-care worker 
is legally permitted to warn the partners of an HIV-infected 
person of the risk of past or future exposure to HIV. 
Program collaboration and service integration. A 
mechanism of organizing and blending interrelated health 
concerns, separate activities, and services to maximize public 
health impact through new and established linkages among 
programs to facilitate delivery of services. 
Provider referral. A notification strategy in which a health 
department specialist (e.g., disease intervention specialist) 
confidentially notifies a partner of possible exposure. 
Quality. The degree to which a health or social service meets 
or exceeds established professional standards and user 
expectations. 
Quality improvement. An approach to the continuous study 
and improvement of the processes of providing services to 
meet the needs of the person and others. 
Reactor grid. The use of quantitative test results, age, and sex 
criteria to identify which persons with reactive syphilis tests 
are most likely to be untreated and infectious cases. 
Reinterview. An interview that follows the original interview 
with an index patient. The reinterview is used to gather 
additional locating information about partners identified by 
index patients during the original interview, monitor the status 
of partners index patients initially decided to notify themselves, 
elicit names of additional partners index patients might not 
have recalled in the original interview, and verify that index 
patients have received adequate treatment or additional tests. 
Ryan White CARE Act Amendments of 1996. The law 
reauthorizing the Ryan White HIV/AIDS Program, a program 
administered by the Health Resources and Services 
Administration that provides for grants to support the medical 
care needs of low-income, uninsured, and underinsured 
persons living with acquired immunodeficiency syndrome 
(AIDS) and HIV infection. 
Self-referral. A notification strategy in which an index patient 
accepts full responsibility for informing a partner of possible 
exposure and referring the partner to appropriate services. A 
health-care provider helps the index patient determine when, 
where, and how to notify the partner as well as how to cope 
with potential reactions. This process is also known as client 
referral and patient referral. 
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Social contact. A person named by the index patient during 
an interview as part of the social network who is not a sex or 
drug-injection partner of the index patient. Social contacts 
(referred to as suspects in previous STD partner services 
guidelines) might include persons with symptoms suggestive 
of disease, partners of other persons known to be infected, or 
others who might benefit from examination. 
Social network. A group of persons connected by various 
types of social relationships, such as family, work and 
recreational relationships, sexual partnerships, and drug-using 
relationships. The social network might also include venues 
in which interactions among members of a social network 
occur. Persons in a social network might share social, economic, 
cultural, or behavioral characteristics that influence their risk 
for various health conditions, including HIV infection and 
other STDs. 
Standards. Elements or procedures that must be followed by 
CDC grantees in virtually all instances in which CDC funds 
are used to support services. 
Suspect. A social contact. This term has historically been used 
to describe a person named by an index patient as part of the 
social network who is not a sex or drug-injection partner of 
the index patient. These persons might have symptoms 
suggestive of disease, might be partners of other persons known 
to be infected, or might be other persons who might benefit 
from examination. 
System. A group of related processes. 
Third-party provider. A health or social services professional 
not affiliated with a health department (e.g., physicians, nurses, 
or counselors) who might participate in certain aspects of 
partner services, such as partner elicitation or partner 
notification via dual referral 
Third-party referral. A notification strategy by which a 
partner is notified of exposure to HIV or another STD by a 
professional other than a health department staff member (e.g., 
a private physician). 
Window period. The time interval after infection during 
which a serologic test might be negative because antibodies 
have not reached a detectable level. 
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Appendix C
 
Abbreviations Used in This Report
 
AIDS acquired immunodeficiency syndrome 
ART antiretroviral therapy 
CBO community-based organization 
CDC Centers for Disease Control and Prevention 
CPG community planning group 
CRCS comprehensive risk counseling and services 
DIS disease intervention specialist 
EIA enzyme immunosorbent assay 
EPT expedited partner therapy 
FDT field-delivered therapy 
HAV hepatitis A virus 
HBV hepatitis B virus 
HCV hepatitis C virus 
HIV human immunodeficiency virus 
IPN Internet partner notification 
IRB Institutional Review Board 
MSM men who have sex with men 
NAAT nucleic acid amplification test 
ORP overall responsible party 
OSHA Occupational Safety and Health Administration 
PCRS partner counseling and referral services 
PEP postexposure prophylaxis 
PDPT patient-delivered partner therapy 
PREA Prison Rape Elimination Act of 2003 
STD sexually transmitted disease 
TB tuberculosis 
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Appendix D 
Guiding Principles and Standards for Record Keeping and Data Collection,
 
Management, and Security for Partner Services Programs for HIV Infection,
 
Syphilis, Gonorrhea, and Chlamydial Infection
 
Sharing data regarding cases of human immunodeficiency 
virus (HIV) or any other type of sexually transmitted disease 
(STD) between surveillance and prevention programs can help 
maximize the number of persons who are offered partner 
services. The five guiding principles and 32 program standards 
outlined in this appendix are essential to ensuring the 
confidentiality and security of shared data. These standards 
were adapted from CDC and Council of State and Territorial 
Epidemiologists Technical Guidance for HIV/AIDS Surveillance 
Programs, Volume III: Security and Confidentiality Guidelines 
(available at http://www.cdc.gov/hiv/topics/surveillance/ 
resources/guidelines/guidance/index.htm). Most of the 
standards in this appendix directly reflect the requirements in 
the technical guidelines. However, to better adapt the 
guidelines to partner services programs, certain standards have 
been modified or excluded based on input from the Partner 
Services Surveillance and Program Connections Workgroup 
and other committee members. 
All program standards and security considerations should 
be based on the following five guiding principles: 
Guiding Principle 1. Partner services information and 
data should be maintained in a physically secure 
environment. 
Guiding Principle 2. Electronic partner services data 
should be held in a technically secure environment, with 
the number of data repositories and persons permitted 
access kept to a minimum. Operational security 
procedures should be implemented and documented to 
minimize the number of staff members who have access 
to personal identifiers and to minimize the number of 
locations where personal identifiers are stored. 
Guiding Principle 3. Individual program staff members 
and persons authorized to access case-specific information 
are responsible for protecting confidential partner services 
case information and data; these persons will face legal 
action for confidentiality violations. 
Guiding Principle 4. Security breaches of partner services 
information or data will be investigated thoroughly and 
sanctions imposed as appropriate. 
Guiding Principle 5. Security practices and written 
policies will be reviewed and assessed continuously and, 
as necessary, changed to improve the protection of 
confidential partner services case information and data. 
Partner services programs should adhere to the following 
program standards when developing area-specific guidelines, 
policies, and procedures for individual-level record keeping and 
data collection, management, and security: 
Standard 1. All policies and procedures must be written 
and reviewed at least annually and revised as needed. 
Standard 2. A policy must name the persons who act as 
the overall responsible party (ORP) for the security of the 
data that might be stored in various data systems. 
Standard 3. A policy must describe the methods for review 
of security practices for data. Included in the policy should 
be a requirement for an ongoing review of evolving 
technology to ensure that information and data remain 
secure. 
Standard 4. The ORP must certify annually that these 
standards are met. 
Standard 5. Access to and use of individual-level 
information must be defined in a data-release policy. 
Standard 6. Policies must be readily accessible to any staff 
members having access to confidential, individual-level data. 
Standard 7. A policy must define the roles and access 
level for all persons with authorized access and describe 
which standard procedures or methods will be used when 
accessed. 
Standard 8. All authorized staff members must sign a 
confidentiality statement annually. Newly hired staff 
members must sign a confidentiality statement before access 
to individual-level information and data is authorized. 
Standard 9. A policy must outline procedures for handling 
incoming mail and faxes to the programs and outgoing 
mail and faxes from the programs. The amount and 
sensitivity of information contained in any piece of 
correspondence must remain minimal. 
Standard 10. All persons who are authorized to access 
individual-level information must be knowledgeable about 
the organization’s information security policies and 
procedures. 
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Standard 11. All staff members authorized to access 
individual-level information must be responsible for 
questioning persons who attempt to access this 
information but who are not authorized to do so. 
Standard 12. All staff members who are authorized to 
access individual-level information are responsible for 
protecting their own computer workstation, laptop 
computer, or other devices with confidential, individual-
level information or data. This responsibility includes 
protecting keys, passwords, and codes that would allow 
access to confidential information or data. Staff members 
must be careful not to infect program software with 
computer viruses and not to damage hardware through 
exposure to extreme heat or cold. 
Standard 13. Every person with access to individual-level 
information or data must attend security training annually 
or pass an annual proficiency test. The date of the training 
or test must be documented in the employee’s personnel 
file. Information technology (IT) staff members and 
contractors who require access to information and data must 
undergo the same training as partner services program staff 
members and sign the same agreements. This requirement 
applies to any staff members with access to servers, 
workstations, backup devices, etc. 
Standard 14. To the extent possible, workspace for persons 
working with individual-level information must be within 
a secure, locked area. 
Standard 15. Paper records and copies of individual-level 
information and data must be stored inside locked file 
cabinets that are inside a locked room with limited access. 
Standard 16. Program staff members must shred 
documents containing confidential information before 
disposing of them. Shredders should be of commercial 
quality, preferably with a crosscutting feature. 
Standard 17. Partner services analysis data sets must be 
stored securely with protective software (i.e., software that 
controls the storage, removal, and use of the data), and 
personal identifiers should be removed when possible. 
Standard 18. Partner services information and data 
transfers and methods for data collection must be approved 
by the ORP and incorporate the use of access controls. 
Individual-level information and data must be encrypted 
before electronic transfer. When possible, databases and 
files with individual-level data must be encrypted when 
not in use. 
Standard 19. When individual-level partner services 
information and data are electronically transmitted, any 
transmission that does not incorporate the use of an 
encryption package meeting the encryption standards of 
the National Institute of Standards and Technology 
(available at http://csrc.nist.gov/groups/stm/cmvp/ 
standards.html) and approved by the ORP must not 
contain identifying information or use terms easily 
associated with HIV, AIDS, or any other type of STD. 
The terms HIV and AIDS, terms that specifically identify 
other STDs, or specific behavioral information must not 
appear anywhere in the context of the transmission, 
including the sender and recipient address and label. 
Standard 20. When partner services information with 
personal identifiers or data are taken from secured areas 
and included in line lists or supporting notes, in either 
electronic or paper format, the documents must contain 
the least amount of information needed for completing a 
given task and, if possible, coded to disguise any 
information that could easily be associated with HIV, 
AIDS, or any other type of STD. 
Standard 21. Individual-level information or data with 
personal identifiers must not be taken to private staff 
members’ residences unless specific, documented 
permission is granted or the transfer is permitted according 
to a written policy established by the program manager 
or ORP. 
Standard 22. Prior approval must be obtained from the 
program manager or approved procedures must be 
followed when planned business travel precludes the return 
of information with personal identifiers to the secured 
area by the close of business on the same day. 
Standard 23. Access to any partner services program 
information or data containing names for research 
purposes (i.e., for other than routine program purposes) 
must be contingent on a demonstrated need for the names, 
institutional review board (IRB) approval, and the signing 
of a confidentiality statement regarding rules of access and 
final disposition of the information. Access to partner 
services program information or data without names for 
research purposes beyond routine program activities might 
still require IRB approval, depending on the numbers and 
types of variables requested in accordance with local data 
release policies. 
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Standard 24. Access to any secured areas where individual-
level partner services information are stored must be 
limited to authorized persons as documented within 
policies and procedures (e.g., cleaning or maintenance staff 
members). 
Standard 25. Access to confidential partner services 
information and data by personnel outside the partner 
services program must be limited to those authorized based 
on an expressed and justifiable public health need, must 
not compromise or impede program activities, must not 
affect the public perception of confidentiality of the data 
system, and should be approved by the ORP. 
Standard 26. Access to partner services information and 
data with identifiers by those who maintain other disease 
data stores should be limited to those for whom the ORP 
has weighed the benefits and risks of allowing access and 
can certify that the level of security established is equivalent 
to these standards. 
Standard 27. Access to partner services information or 
data for purposes unrelated to public health (e.g., 
litigation, discovery, or court order) can only be granted 
to the extent required by law. 
Standard 28. All staff members who are authorized to 
access partner services information and data must be 
responsible for reporting suspected security breaches. Non-
program staff members also must be informed of this 
directive. 
Standard 29. Any breach of protocol or procedures, 
regardless of whether personal information was released, 
must be investigated immediately to assess causes and 
implement remedies. 
Standard 30. A breach of confidentiality (i.e., a security 
infraction that results in the release of private information 
with or without harm to one or more persons) must be 
reported immediately to the ORP. In consultation with 
appropriate legal counsel, partner services staff members 
should determine whether a breach warrants reporting to 
law enforcement agencies. 
Standard 31. Laptop computers and other portable 
devices (e.g., personal digital assistants [PDAs], other 
handheld devices, and tablet personal computers [tablet 
PCs]) that receive or store partner services program 
information or data with personal identifiers must have 
encryption software. Program information with identifiers 
must be encrypted and stored on an external storage device 
or on the laptop removable hard drive. The external storage 
device or hard drive containing the information must be 
separated from the laptop and held securely when not in 
use. The decryption key cannot be on the laptop. Other 
portable devices without removable or external storage 
components must use encryption software that meets 
federal standards. 
Standard 32. All removable or external storage devices 
containing partner services information or data that 
contains personal identifiers must 1) include only the 
minimum amount of information necessary to accomplish 
assigned tasks as determined by the program manager; 2) 
be encrypted or stored under lock and key when not in 
use; and 3) be sanitized immediately after a given task 
(excludes devices used for backups). Before any device 
containing sensitive data is taken out of a secured area, 
the information or data must be encrypted. Methods for 
sanitizing a storage device must ensure that the information 
cannot be retrievable using “undelete” or other data-retrieval 
software. Hard drives that contain identifying information 
must be sanitized or destroyed before computers are labeled 
as excess or surplus, reassigned to non-program staff 
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15. After reading this report, I am confident I can describe ways to identify	 19. The learning outcomes (objectives) were relevant to the goals of this 
and prioritize index patient for partner services. report. 
A.	 Strongly agree. A. Strongly agree. 
B.	 Agree. B. Agree. 
C.	 Undecided. C. Undecided. 
D. Disagree.	 D. Disagree. 
E.	 Strongly disagree. E. Strongly disagree. 
16. After reading this report, I am confident I can identify ways to notify	 20. The instructional strategies used in this report (text, tables, and 
partners of their exposure to HIV infection, syphilis, gonorrhea, or appendices) helped me learn the material. 
chlamydial infection. A.	 Strongly agree. 
A.	 Strongly agree. B. Agree. 
B.	 Agree. C. Undecided. 
C.	 Undecided. D. Disagree. 
D. Disagree.	 E. Strongly disagree. 
E.	 Strongly disagree. 
21. The content was appropriate given the stated objectives of the report. 
17. After reading this report, I am confident I can describe options for	 A. Strongly agree.
treating partners. B.	 Agree. 
A.	 Strongly agree. C. Undecided. 
B.	 Agree. D. Disagree. 
C.	 Undecided. E. Strongly disagree. 
D. Disagree. 
E.	 Strongly disagree. 22 The content experts demonstrated expertise in the subject matter. 
A.	 Strongly agree.
18. After reading this report, I am confident I can identify ways to address B.	 Agree.
the needs of specific populations with regard to partner services. C.	 Undecided. 
A.	 Strongly agree. D. Disagree. 
B.	 Agree. E. Strongly disagree. 
C.	 Undecided. 
D. Disagree. 
(Continued on pg CE-4)E.	 Strongly disagree. 
Detach or photocopy. 
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23. Overall, the quality of the journal report was excellent. 




E. Strongly disagree. 
24. These recommendations will improve the quality of my practice. 




E. Strongly disagree. 
25. The availability of continuing education credit influenced my 
decision to read this report. 




E. Strongly disagree. 
26. The MMWR format was conducive to learning this content. 




E. Strongly disagree. 
27. Do you feel this course was commercially biased? (Indicate yes or no; 
if yes, please explain in the space provided.) 
A. Yes. 
B. No. 
28. How did you learn about the continuing education activity? 
A. Internet. 
B. Advertisement (e.g., fact sheet, MMWR cover, newsletter, or journal). 
C. Coworker/supervisor. 
D. Conference presentation. 
E. MMWR subscription. 
F. Other. 
Correct answers for questions 1–10. 1. B; 2. E; 3. A; 4. D; 5. C; 6. E; 
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